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Summary 
Aeromonas species are ubiquitous water-borne bacteria that are able to cause 
a variety of diseases in poikilothermics and humans. Aeromonas hydrophila is one 
of the most pathogenic species, responsible for aeromonad septicaemia in fish, 
gastroenteritis and wound infections in humans. The T3SS is utilized to inject 
protein effectors directly into host cells. One of the major genetic regulators of the 
T3SS in several Gram-negative bacterial species is the AraC-like protein ExsA. 
Lateral flagella are expressed by bacteria upon contact with host cells or a surface 
and are required for host cell adherence and biofilm formation. However, no direct 
link between the T3SS and the lateral flagella system has yet been found in A. 
hydrophila. Moreover, the genetic regulation of the T3SS that involves the master 
regulator ExsA has not been determined in A. hydrophila AH-3. 
The aim of this project is to determine the genetic regulation of the T3SS and 
the potential interaction between the T3SS and the lateral flagella system in A. 
hydrophila AH-3.  
The genes encoding the T3SS regulatory components including exsA, exsD, 
exsC and exsE were mutated and the activities of the T3SS promoters were 
measured in exs mutant backgrounds. The interactions between each of the Exs 
proteins were investigated using BACTH assay and Far-Western Blot. Together, the 
findings suggested a regulatory cascade that the effector protein ExsE was bound to 
the chaperone protein ExsC, which sequestered the anti-activator ExsD from 
inhibiting the T3SS master regulator ExsA via direct protein-protein interactions. 
The T3SS regulatory components were also shown to affect the expression of 
the lateral flagella system using swarming assays. The activities of the lateral 
flagella promoters were shown to be repressed by the absence of ExsD and ExsE, 
suggesting that the T3SS master regulator ExsA was a negative regulator of the 
lateral flagella system.   
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1.1 The genus Aeromonas 
Aeromonas species are ubiquitous water-borne Gram-negative facultative 
anaerobes that are able to cause a variety of diseases in poikilothermics and 
humans. The genus Aeromonas, since the first discovery in the 19
th
 century, has 
been studied by scientists for over 100 years (Janda & Abbott 2010).  
 
The first report of Aeromonas was identified in 1891 in a study of septicemia 
(‘red-leg’ disease) of frogs, which was linked with the bacterium Bacillus hydrophilus 
fuscus, now known as Aeromonas hydrophila (Farmer et al 2006). The taxonomy 
then became confusing regarding the species of the genus Aeromonas. Although 
several species were isolated before 1936, including A. hydrophila, Aeromonas 
caviae and Aeromonas salmonicida, which now belong to the genus Aeromonas, 
they were classified into different genera including Proteus, Pseudomonas, 
Bacterium and Vibrio (Farmer et al 2006). It was Kluyver and van Niel who proposed 
the name of the genus Aeromonas in 1936 based on the morphological and 
physiological features of Aerobacter liquefaciens, which is now known as A. 
hydrophila (Farmer et al 2006). However, A. hydrophila has been known as more 
than 15 synonymous species names such as Aerobacter liquefaciens, Bacillu 
ichthyosmius or Proteus hydrophilus in different genera. It was Stanier and 
collegues who replaced this species into genus Aeromonas because of the 
presence of the polar flagella and their ability to ferment carbohydrate (Stanier 
1943). This was the first description of the genus Aeromonas. They have also 
clarified that the A. liquefaciens and P. hydrophilus were identical species.  
 
Another important species of the genus Aeromonas, A. caviae, which used to 
be known as Bacillu punctatus, Bacterium punctatum or Pseudomonas caviae was 
not classified into the genus Aeromonas because it was isolated from guinea pigs, 
which are warm-blooded (Scherago 1937). However, it was later reported by Liu 
who had demonstrated the ability of P. caviae to produce acid from carbohydrates 
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under strictly anaerobic conditions (Liu 1962). As it was reported by Hugh and 
Leifson in 1953 that the Pseudomonas species could only oxidise carbohydrates but 
were unable to ferment carbohydrates, this was then utilized to distinguish between 
the genus Pseudomonas and Aeromonas (Hugh & Leifson 1953). Thus Liu 
proposed to relocate P. caviae into genus Aeromonas. Thereby the presence of 
polar flagella, the production of oxidase, the ability to ferment carbohydrates and the 
rod shape were used to characterise the genus Aeromonus in Gram-negative 
bacteria. 
 
The year of 1986 has become a milestone for the taxonomy of Aeromonas 
when Colwell and collegues proposed the removal of genus Aeromonas from 
Vibrionaceae family and re-classified into a new-recognised family named 
Aeromonadaceae (Colwell et al 1986). Using molecular genetic tools, including 16S 
rRNA and 5S rRNA sequences as well as rRNA-DNA hybridisation data, they 
suggested a phylogenetically distinct family for the genus Aeromonas, 
Aeromonadaceae. 
 
The uses of molecular genetic tools expanded the phylogenetic studies of the 
Aeromonas species rapidly. However, 16S rRNA sequence analysis was not 
sufficient to distinguish the intra-species relationships within the genus Aeromonas, 
since their 16S rRNA sequences were found to be almost identical (Yanez et al 
2003). Thereby alternatives have been applied to phylogenetic studies for the past 
20 years. It was reported by Martinez-Murcia and collegues in many phylogenetic 
studies of the genus Aeromonas that the utilisation of 16S rRNA group-specific 
signature using a more variable V2 region of rRNA rather than V3 region, the 
sequencing of a single house-keeping gene such as gyrB or rpoD, as well as the 
multilocus phylogenetic analysis (MLPA) of a series of house-keeping gene (gyrB, 
rpoD, rpoB, atpA, recA, dnaJ and gyrA), provided more powerful tools to incorporate 
both the intra-species and inter-species phylogenies in bacterial systematics 
(Carvalho et al 2012, Fontes et al 2010, Martinez-Murcia et al 1992a, 
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Martinez-Murcia et al 2011, Martinez-Murcia et al 2005, Saavedra et al 2007, Soler 
et al 2004, Yanez et al 2003). 
 
The number of species in the genus Aeromonas has grown rapidly in the 
molecular genetic era. Only four species including A. hydrophila, Aeromonas 
punctata (now known as A. caviae), A. salmonicida and Aeromonas sobria were 
classified in the genus Aeromonas in 1980 (Janda & Abbott 2010). In 2003, there 
were 13 species in the genus Aeromonas and then it was proposed by Janda and 
Abbott in 2010 that the number of species in genus Aeromonas showed increase to 
24 including Aeromonas allosaccharophila (Martinez-Murcia et al 1992b), 
Aeromonas aquariorum (Martinez-Murcia et al 2008), Aeromonas bestiarum (Ali et 
al 1996), Aeromonas bivalvium (Minana-Galbis et al 2007), Aeromonas culicicola 
(Pidiyar et al 2002), Aeromonas encheleia (Esteve et al 1995), Aeromonas 
enteropelogenes (Schubert et al 1991), Aeromonas eucrenophila (Schubert & 
Hegazi 1988), Aeromonas ichthiosmia (Schubert et al 1990), Aeromonas jandaei 
(Carnahan et al 1991), Aeromonas media (Allen et al 1983), Aeromonas 
molluscorum (Minana-Galbis et al 2004), Aeromonas popoffii (Huys et al 1997), 
Aeromonas schubertii (Hickman-Brenner et al 1988), Aeromonas sharmana (Saha 
& Chakrabarti 2006), Aeromonas simiae (Harf-Monteil et al 2004), Aeromonas trota 
(Husslein et al 1992) and Aeromonas veronii (Hickman-Brenner et al 1987).  
 
To date, according to the List of Prokaryotic names with Standing in 
Nomenclature (LPSN www.bacterio.net), the number of valid Aeromonas species in 
the genus Aeromonas has increased to 31, including 7 newly discovered species 
since 2010, namely Aeromonas australiensis (Aravena-Roman et al 2013), 
Aeromonas diversa (Minana-Galbis et al 2010), Aeromonas fluvialis (Alperi et al 
2010b), Aeromonas piscicola (Beaz-Hidalgo et al 2010), Aeromonas rivuli (Figueras 
et al 2011), Aeromonas sanarellii (Alperi et al 2010a) and Aeromonas taiwanensis 
(Alperi et al 2010a). However, it was recently reported that the A. aquariorum and A. 
hydrophila subsp. Dhakensis have now synonymized into the same taxon named 
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Aeromonas dhakensis species (Beaz-Hidalgo et al 2013).  
 
Since the first DNA hybridisation analysis carried out in 1979, the aeromonads 
have been classified into two genotypical groups, a more diverse group of motile 
aeromonads and a more homogeneous non-motile group (Macinnes et al 1979). 
The motile aeromonads represent the mesophilic strains of Aeromonas such as 
A.caviae and A. hydrophila that are able to swim in the liquid environments using a 
single polar flagellum, while the non-motile aeromonads represent the psychrophilic 
strains of Aeromonas such as A. salmonicida (Farmer et al 2006). Moreover, in 1985, 
a Japanese group observed peritrichous lateral flagella in mesophilic Aeromonas 
strains A. caviae and A. hydrophila by electron microscopy (Shimada et al 1985). 
The details of the lateral flagella system are discussed later in section 1.5. 
 
1.2 Ecology  
The Aeromonas speices are ubiquitous in aquatic environments such as marine 
water, ground water and inhabitants of aquatic environments like fish or frogs, 
whereas they can also be isolated from domesticated animals, invertibrates, birds, 
insects and even natural soil (Farmer et al 2006). They are widely distributed in 
basically every environmental niche of the ecosystem. The Aeromonas species are 
able to adapt to a wide range of environments as they have shown tolerance to 
various growth factors, including a temperature range from 4°C to 45°C, and a pH 
range from 3.5 to 9.8. They have also been shown to survive in both oligotrophic 
and hypereutrophic environments, and a wide range of salinities from 0% to 6% (v/v) 
(Beaz-Hidalgo & Figueras 2013, Delamare et al 2000, Janda & Abbott 2010, 
Knochel 1990, Lambert & Bidlas 2007, Palumbo et al 1985, Wang & Gu 2005). 
 
As the first isolated Aeromonas species and one of the four earliest classified 
species in genus Aeromonas species in the 20
th
 century, A. hydrophila was not 
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found by chance. In a recent study A. hydrophila was shown to be the most 
frequently isolated Aeromonas species from both human clinical material and 
environmental samples, 54.8% and 45.3% respectively (Aravena-Roman et al 2011). 
An earlier report by Hazen and collegues indicated that A. hydrophila species were 
isolated from 91.8% of natural aquatic inhabitats in the U.S.A. with a wide range of 
temperatures, pHs, salinities and conductivities. The numbers of A. hydrophila were 
higher in lotic than in lentic systems, higher in saline systems than in freshwater, 
only habitats that were extreamly saline, thermal or polluted were excepted (Hazen 
et al 1978). Similarly, it was reported by Karem and collegues that A. hydrophila 
exhibited an adaptive acid tolerance response to allow the pathogen to survive at a 
pH as low as 3.5 (Karem et al 1994). The bacteria undergo a physiological change 
as the pH decreases to 5.0, when the signal triggers an increased production of 28 
proteins and decreased synthesis of 10 proteins in order to allow bacteria to 
withstand the acidic environments, reflecting the fact that they are mostly 
gastrointestinal pathogens (Karem et al 1994). 
 
Like all aeromonads, A. hydrophila species are falcutative anaerobic 
non-endospore forming rod-shaped Gram-negative bacteria, ranging in size from 
1.0-3.5μm in length and from 0.3-1.0μm in width (Horneman et al 2007, Joseph et al 
1988). The A. hydrophila strains can express dual flagella systems, using a single 
polar flagellum to swim in liquid environment while expressing peritrichous lateral 
flagella upon contact with the host cell or solid surfaces. A. hydrophila strains can 
grow on the commonly used noninhibitory laboratory media including Luria-Bertani, 
MacConkey and blood agar, on which the colonies of A. hydrophila are typically 
circular, 1-3mm in diameter and showing effect of β-haemolysis on blood agar 
(Janda & Abbott 2010). 
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1.3 Epidemiology 
As introduced before, the Aeromonas species consist of two major groups 
defined by the DNA-hybridisation analysis, including the non-motile pigmented 
psychrophilc species and the motile mesophilic non-pigmented species. The 
psychrophilic Aeromonas species represented by A. salmonicida predominantly 
causes furunculosis in salmonid fish as well as many other fish species such as cod, 
carp and goldfish (Cipriano & Austin 2011, McCarthy & Rawle 1975). The fish 
infected by A. salmonicida may develop skin hyperpigmentation, furuncles or ulcers 
on the skin, anaemia and internal haemorrhage (Beaz-Hidalgo et al 2012, Bernoth 
et al 1997). On the other hand, infections mostly associated with humans are 
caused by mesophilic aeromonads. In this case, similar clinical signs are only visible 
in the skin or the internal organs (Beaz-Hidalgo et al 2012, Bernoth et al 1997). The 
first association of Aeromonas species with human infections was reported in 1951, 
when Aeromonas was recovered from autopsy samples of an acute fulminant 
metastatic myositis patient (Caselitz 1996). It was reported that three mesophilic 
Aeromonas species, including A. hydrophila, A. caviae and A. veronii biovar sobria, 
account for 85% of human infections and clinical isolations (Chopra & Houston 
1999). Human infections by aeromonads often result in gastrointestinal disease and 
wound infection, while septicaemia less commonly occurs in the 
immunocompromised host (Janda & Abbott 2010). Additionally, skin infections 
related to aeromonads were discovered in a post-tsunami study in southern 
Thailand, in which A. hydrophila was identified as the major pathogen to infect 
wounds exposed to contaminated water (Hiransuthikul et al 2005). 
 
1.3.1 Gastroenteritis 
The Aeromonas species were first associated with gastrointestinal disease in 
1961 when A. punctata (now known as A. caviae) was isolated from 7 out of 8 
patients with intestinal disease (Gilardi 1967). However, the role of Aeromonas 
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species in causing gastrointestinal disease is still not conclusive, as there has been 
no well-defined outbreak of Aeromonas gastroenteritis and it has yet to fulfil Koch’s 
postulates, both convential and molecular (Janda & Abbott 2010). A study carried 
out by Morgan and collegues in 1985 failed to establish gastrointestinal disease in 
volunteers when they were inoculated with as many as 10
10
 CFU of A. hydrophila 
(Morgan et al 1985). Furthermore, as Koch’s postulates require the isolated 
pathogen to re-induce the disease in a healthy organism, several animal models 
were attempted but still failed to associate Aeromonas with the gastroenteritis. For 
example, one of the recent attempts made by Kelleher and Kirov in 2000 using 
Rattus norvegicus (clindamycin-pretreated rats) successfully linked Pseudomonas 
aeruginosa with chronic diarrhoea but failed for Aeromonas species (Kelleher & 
Kirov 2000). Although the genes responsible for the production of enterotoxins and 
haemolysins in Aeromonas species were analyzed in order to fulfill the molecular 
standard of Koch’s postulates 1, the genes and the phenotypes were not found to be 
exclusive in the pathogenic members of the genus Aeromonas (von Graevenitz 
2007).  
 
Despite the perplexing association of the Aeromonas species with 
gastroenteritis, there have been many reports. For instance, in 2004 an acute 
diarrhea outbreak was reported in Sao Bento with 2710 cases, in which Aeromonas 
species were the most abundant enteric pathogen isolated from stool samples of 
diarrhea patients (Hofer et al 2006). Among all types of gastroenteritis, Aeromonas 
species were found to be associated mostly with secretory enteritis, which 
accounted for nearly 80% of all Aeromonas gastroenteritis cases (Chan et al 2003, 
Essers et al 2000, Sinha et al 2004). It was also reviewed by Ghenghesh and 
collegues that pathogenic Aeromonas species were commonly found in foods and 
drinking water, and were isolated more from diarrhoeic children than non-diarrhoeic 
children in developing countries of Africa, Asia and Latin America (Ghenghesh et al 
2008). Although there were cases, such as in Libya, where more Aeromonas 
species were found in non-diarrhoeic children (22.3%) than in diarrhoeic children 
9 
(17.2%), the level of the virulence factors such as mannose-resistant haemagglutin 
were found to be significantly higher in Aeromonas diarrhoeic children (26%) than in 
healthy controls (3%) (Ghenghesh et al 2008). 
 
1.4 Pathogenicity and virulence factors 
As discussed before, the determination of the virulence factors are perplexing 
in Aeromonas species as the genes encoding for the potential virulence factors such 
as enterotoxins were found in both the pathogenic and non-pathogenic Aeromonas 
species. However, various approaches and animal models, including in vitro cell 
lines such as HEp-2 or Caco-2, clindamycin-pretreated rats and medicinal leech, 
have been used to investigate the virulence factors of Aeromonas species 
(Indergand & Graf 2000, Kelleher & Kirov 2000, Silver et al 2007, Thornley et al 
1996). For instance, the genes encoding the Type III secretion system (T3SS) were 
identified in A. veronii using the Hirudo verbena (medicinal leech) model, since the 
digestive tract of the leech was inhabited by a simple microbial community (Silver et 
al 2007). The pathogenicity of Aeromonas species is associated with a variety of 
virulence factors and colonization factors such as the lipopolysaccharide, S-Layer, 
enterotoxins, the polar and lateral flagella systems as well as the secretion systems 
(Austin 1996, Vilches et al 2004). 
 
1.4.1 Lipopolysaccharide (LPS) 
Lipopolysaccharides are found uniquely in Gram-negative bacteria, including A. 
hydrophila and A. salmonicida, and are embedded in the outer membrane of the 
bacterial cell envelope. They are comprised of three main components, the 
extremely variable O-antigen, the core oligosaccharide and the most conserved lipid 
A (Tomas 2012). The hydrophobic lipid A domain, which anchors the LPS to the 
outer membrane, contributes the most to the pathogenicity of Gram-negative 
bacteria (Luderitz et al 1978). The immunostimulatory ability of lipid A resulting from 
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the activation of monocytes or macrophages via Toll-like receptor 4 (TLR4) or CD14 
can lead to the release of inflammatory mediators, followed by Gram-negative 
sepsis, which is clinically recognised by fever, hypotension, respiratory and renal 
failure as well as disseminated intravascular coagulation (Cohen 2002, Tomas 
2012).  
 
1.4.2 S-layers 
The surface-layers (S-layers) are found in both Gram-positive and 
Gram-negative bacteria and are comprised of a single protein or glycoprotein with a 
size of 40-200kDa (Tomas 2012). In Aeromonas, the S-layers form a 5-10nm thick 
pore-containing tetragonal structure surrounding the bacteria, contributing to 
adhesion, protection against protease and phagocytes and resistance to the 
complement-mediate killing (Beveridge et al 1997, Tomas 2012). The S-layers have 
been described in A. salmonicida, A. hydrophila and A. veronii.The S-layers were 
identified first in A. salmonicida, and reported to be the major virulence factor 
contributing to the septicaemia in fish (Kay et al 1981). However, the S-layers are 
less commonly found in mesophilic Aeromonas species (Esteve et al 2004, Kokka et 
al 1990). 
 
1.4.3 Enterotoxins 
The exotoxins produced and secreted by Aeromonas species are usually found 
to target intestinal epithelial cells,and are thus refered to as enterotoxins. There are 
two main types of enterotoxins in Aeromonas, cytotoxic and cytotonic (Tomas 2012). 
The cytotoxic enterotoxins represented by Act isolated from A. hydrophila SSU are 
generally pore-forming proteins, associated with cytotoxicity, enterotoxicity and 
hemolysis (Asao et al 1984, Chopra & Houston 1999, Galindo et al 2006). The 
hemolysis ability of Act results from its pore-forming nature, which leads to the 
swelling of the host cells upon water entry (Sha et al 2002, Tanoue et al 2005). 
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The cytotonic enterotoxins are divided into two groups, heat-labile (56° for 10 
min) and heat stable (100°C for 30 min). The heat-labile cytotonic enterotoxins are 
represented by Alt from A. hydrophila SSU, while the heat-stable cytotonic 
enterotoxins are represented by Ast from the same species. Both of these can 
induce cAMP production in the intestinal epithelial cells resulting in the accumulation 
of fluid via cAMP pathway, thus causing diarrhoea (Chopra & Houston 1999, Ljungh 
& Kronevi 1982). 
 
1.5 Flagella Systems 
In order to help with localization, moving towards attractants and infection of 
host cells, bacteria exploit several ways to provide them with surface motility, 
including swimming, swarming, sliding, twitching, gliding and drafting. The 
colonization approaches that involve the presence of flagella systems are swimming 
and swarming (Harshey 2003). Rather than the movement of a single bacterium 
involved in swimming motility, swarming motility involves a group of bacteria moving 
to colonize solid surfaces, such as laboratory media. Aeromonas cells demonstrate 
swarming motility on 0.5%-1% (w/v) agar (Harshey 1994, Kirov et al 2002). 
 
A single flagellum normally consists of a long helical filament (10-15μm in 
length and ~20nm in diameter) projecting out from the cell and a hook structure 
connecting the filament to the basal body, which is embedded in the cytoplasmic 
membrane. The basal body is comprised of a central rod structure and several 
surrounding ring structures, on which the motor is attached that rotates the filament 
in either a counterclockwise or clockwise sense. The motor rotation in 
counterclockwise causes the flagellar filament, which is usually a left-handed helix, 
to bundle together along the long axis of the cell and push the bacterium in one 
direction at a speed of 20-30μm/s until the chemotaxic signal response switches the 
motor to rotate in a clockwise sense (Surette & Stock 1996). When the motor rotates 
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in clockwise direction, the bacterial cell tumbles and moves in random directions 
until it senses environmental signal, such as an increase of attractants or a 
decrease of repellents. The signal transduction is dependent upon a two-component 
regulatory system, including a sensor kinase and a response regulator, which 
involves the movement of a phosphoryl group via phosphorelay (Harshey et al 2003, 
Hoch 2000, Rowsell et al 1995). 
 
Most Gram-negative bacteria express only one flagella system, either a polar 
flagella system for swimming motility or a lateral flagella system for swimming and 
swarming motility, whereas bacteria such as some strains of Vibrio and Aeromonas 
can express dual flagella systems and switch between the two flagella systems in 
response to environmental signals (McCarter 1999, Merino et al 2006).  
 
More than half of the mesophilic Aeromonas strains, including A. caviae and A. 
hydrophila, contain dual flagella systems, in which the constitutively expressed polar 
flagella system allows the bacteria to swim in liquid environment, while the inducible 
lateral flagella system allows the bacteria to swarm over solid surfaces. These two 
flagella systems not only allow the bacteria to move towards and to colonize onto 
host cells, but also provide ability to adhere onto the host cell surface and form a 
biofilm in order to accumulate together (Gavin et al 2002). The accumulation of the 
bacterial cells will result in a polysaccharide matrix to gain them more resistance to 
anti-bacterial defences of the host than they have as individual cells (Canals et al 
2006a, Costerton et al 1999). Additionally, the massive population of the bacteria 
may also trigger the quorum sensing system to activate certain virulence genes 
(Whitehead et al 2001). 
 
1.5.1 Structural composition of the flagella system 
The assembly of the flagellum starts from the basal body which is embedded 
into the bacterial cell membrane, followed by the hook-associated proteins and the 
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filament (Rabaan et al 2001). The basal body consists of an M ring and S ring in the 
inner membrane, as well as a periplasmic P ring and an L ring in the outer 
membrane.The MS ring is assembled first that forms a secretion apparatus 
associated with the Type III secretion system (T3SS) to export extracytoplasmic 
components of the flagella (Macnab 2003). The motor structure that is responsible 
for the rotation of the flagella consists of two components, the stator and the rotor. 
The stationary stator, such as Mot A and MotB proteins in E. coli, is attached to the 
peptidoglycan layer and the C ring, which is assembled at the cytoplasmic side of 
the MS ring. The rotor, which is comprised of polymers of FliG in E. coli, is attached 
to the MS ring (Macnab 2003).  
 
The motor can be powered solely by proton-motive force, like in E. coli and 
Streptococcus spp, or solely by sodium-motive force like in alkaliphilic Bacillus 
strains and Caloramator fervidus, while in Vibrio parahaemolyticus the polar flagella 
system and the lateral flagella system are powered by sodium-motive force and 
proton-motive force respectively (Atsumi et al 1992, Blair & Berg 1990, Imae & 
Atsumi 1989, McCarter 1999, Mulkidjanian et al 2008). Recent studies in A. 
hydrophila AH-3 showed that the polar flagella system involves the stator complex, 
MotXY, with another two redundant set of stator proteins PomAB and PomA2B2, all 
of which are driven by sodium-motive force, while the lateral flagella system is 
driven by proton-motive force like in Vibrio species (Molero et al 2011, Wilhelms et al 
2009).  
 
The flagellar filament structure is comprised of either a homopolymer of a single 
flagellin protein, as in E. coli, or a heteropolymer of different flagellin proteins, as in 
the polar flagella system in Campylobacter or Vibrio species (Guerry et al 1991, 
McCarter 1995, Rabaan et al 2001). In A. hydrophila AH-3, the polar flagella system 
was reported to possess two tandem repeats of flagellin genes, flaA and flaB, while 
only one flagellin gene lafA was found in the gene loci encoding the lateral flagella 
system (Canals et al 2006a, Canals et al 2006b, Gavin et al 2002). Although most 
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lateral flagella systems in Vibrio and Aeromonas species contain only one flagellin 
gene, the lateral flagella systems in A. caviae and A. hydrophila AH-1 were found to 
possess two flagellin genes, lafA1 and lafA2, indicating intraspecies difference in 
flagella composition (Gavin et al 2002). The flagellin proteins of both flagella 
systems are important for the adherence and biofilm formation of the bacteria. In a 
study carried out by Kirov and collegues, A. caviae cells with mutations in the polar 
flagellin genes flaA and flaB were non-adherent to the intestinal cell lines Henle 407 
and Caco-2, while mutations in the lateral flagellins lafA1 and lafA2 resulted in 60% 
reduction of adherence. Moreover, biofilm formation was reduced by approximately 
30% in both a flaB mutant and lafA1A2 mutant strains of A. caviae (Kirov et al 2004).  
 
The flagella systems are important colonization factors, but the synthesis of the 
flagella is highly energy-consuming and requires plentiful resources of cell 
machinery, thus the production of flagella systems are tightly controlled in bacteria. 
The details of the genetic composition and regulation of the lateral flagella system in 
A. hydrophila AH-3 are discussed below. 
 
1.5.2 Lateral flagella system in A. hydrophila 
Early in 1985, a Japanese group observed peritrichous lateral flagella in A. 
caviae and A. hydrophila by electron microscopy (Shimada et al 1985). Later in 
2002, it was found that more than half of the mesophilic Aeromonas spp. possessed 
both flagella systems. Among these species, A. caviae and A. hydrophila are the 
most clinically isolated strains (Kirov et al 2002). However the lateral flagella system 
was described to be involved in the pathogenic association with the host cells in 
E.coli and Salmonella typhimurium in 1994 (Harshey 1994). This led to a rapid 
progress in understanding the function of the lateral flagella system in other 
Gram-negative bacteria including Aeromonas species. The lateral flagella system in 
A. hydrophila was found to be involved in host cell adherence and biofilm formation, 
as it was reported by Gavin and collegues that mutations in the lateral flagella gene 
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lafB and lafS led to ~85% reduction in HEp-2 cell adhesion and ~63% reduction of 
biofilm formation in A. hydrophila AH-3 (Gavin et al 2002, Kirov 2003).  
 
As the bacteria which possess the dual flagella systems are relatively rare, the 
study of the flagella systems in A. hydrophila is often compared with Vibrio 
parahaemolyticus, which is the best-studied organism containing the dual flagella 
systems (Canals et al 2006a) (Figure 1.1). Based on the homology studies with 
V.parahaemolyticus, the genes of the lateral flagella system in A. hydrophila were 
identified and the functions of these genes were proposed (Table 1.1). 
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Figure 1.1 Genetic organization of the lateral flagella systems in V.parahaemolyticus and A. hydrophila. The arrows with the same colour 
represent homologous genes while unique genes such as motY in V.parahaemolyticus, maf-5 and lafX in A. hydrophila are shown in different 
colours (Canals et al 2006a, Merino et al 2006, Stewart & McCarter 2003).  
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Table 1.1 Characteristics of the lateral flagella system genes in A. hydrophila AH-3  
Gene name Function of protein product Homologues 
Putative operon fliM-flhA 
fliM 
fliN 
fliP 
fliQ 
fliR 
flhB 
flhA 
Switch (C ring) 
Switch (C ring) 
Export/assembly 
Export/assembly 
Export/assembly 
Export/assembly 
Export/assembly 
fliM in V. parahaemolyticus 
fliN in V. parahaemolyticus 
flip in V. parahaemolyticus 
fliQ in V. parahaemolyticus 
fliR in V. parahaemolyticus 
flhB in V. parahaemolyticus 
flhA in V. parahaemolyticus 
Putative operon lafK-fliJ 
lafK 
fliE 
fliF 
fliG 
fliH 
fliI 
fliJ 
Regulation 
Basal body component 
M ring 
Switch 
Export/assembly 
Export ATP synthase 
Export/assembly 
lafK in V. parahaemolyticus 
fliE in V. parahaemolyticus 
fliF in V. parahaemolyticus 
fliG in V. parahaemolyticus 
fliH in V. parahaemolyticus 
fliI in V. parahaemolyticus 
fliJ in V. parahaemolyticus 
Putative operon flgM-flgN 
flgN 
flgM 
Chaperone 
Anti-σ28 
flgN in V. parahaemolyticus 
flgM in V. parahaemolyticus 
Putative operon flgA-flgN 
flgA P ring addition protein flgA in V. parahaemolyticus 
Putative operon flgB-flgL 
flgB 
flgC 
flgD 
Rod 
Rod 
Rod 
flgB in V. parahaemolyticus 
flgC in V. parahaemolyticus 
flgD in V. parahaemolyticus 
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flgE 
flgF 
flgG 
flgH 
flgI 
flgJ 
flgK 
flgL 
Hook 
Rod 
Rod 
L ring 
P ring 
Peptidoglycan hydrolase 
HAP1 
HAP3 
flgE in V. parahaemolyticus 
flgF in V. parahaemolyticus 
flgG in V. parahaemolyticus 
flgH in V. parahaemolyticus 
flgI in V. parahaemolyticus 
flgJ in V. parahaemolyticus 
flgK in V. parahaemolyticus 
flgL in V. parahaemolyticus 
Putative operon maf-5 
maf-5 Glycotransferase No known homologue in V. 
parahaemolyticus 
Putative operon lafA-lafU 
lafA Flagellin lafA in V. parahaemolyticus 
Putative operon lafB-lafU 
lafB 
lafC 
HAP2 
Flagellar protein chaperone 
fliD in V. parahaemolyticus 
fliS in V. parahaemolyticus 
Putative operon lafX-lafU 
lafX 
lafE 
lafF 
lafS 
lafT 
lafU 
unknown 
Hook length control 
Flagellar protein 
σ28 
Motor protein 
Motor protein 
unknown 
fliK in V. parahaemolyticus 
fliT in V. parahaemolyticus 
fliA in V. parahaemolyticus 
motA in V. parahaemolyticus 
motB in V. parahaemolyticus 
Table 1.1 Characteristics of the lateral flagella system genes in A. hydrophila AH-3. All 
of the putative operons are transcribed from 5’ to 3’ except for operon flgA-flgN and 
flgM-flgN, both of which are transcribed from 3’ to 5’ and share the same terminator 
downstream of flgN. The putative operons lafA-lafU, lafB-lafU and lafX-lafU also share 
the same terminator downstream of lafU. This table is based on the information in Gavin 
et al. 2002, Canals et al. 2006a and Merino et al. 2006.  
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Although homologues of most of A. hydrophila lateral flagella genes can be 
found in V. parahaemolyticus, the lateral flagella system in A. hydrophila is different 
to that of V. parahaemolyticus at a genetic level. In V. parahaemolyticus, the lateral 
flagella system consists of 38 genes, located on two distinct regions of 
chromosomal DNA, while in A. hydrophila, the 38 genes of the lateral flagella 
system remain in one chromosomal region as shown in Figure 1.1 (Canals et al 
2006a, Merino et al 2006).  
 
In A. hydrophila AH-3, 38 genes of the lateral flagella system are categorized 
into 9 putative operons, fliM-flhA, lafK-fliJ, flgM-flgN, flgA-flgN, flgB-flgL, maf-5, 
lafA-lafU, lafB-lafU and lafX-lafU (Table 1.1). Although some of the operons share 
the same terminators, each of the operons is regulated by a single putative promoter. 
However, it has been reported in many bacteria including V. parahaemolyticus and 
A. hydrophila that the lateral flagella system expression is controlled in a hierarchal 
fashion (Wilhelms et al 2013).  
 
The Class I genes including fliM-flhA, lafK-fliJ, flgA and lafTU, are 
σ70-dependent and are transcribed first. These genes are involved in encoding the 
major regulator LafK and structural components such as C ring (FliM and FliN), M 
ring (FliF) and the motor (LafTU). The enhancer-binding protein LafK, which 
functions as the major genetic regulator of the lateral flagella system, together with 
an alternative sigma factor RpoN (σ54) are required for the transcription of the Class 
II genes, including flgB-flgL and lafX-lafU. These genes are responsible for 
encoding the lateral flagella-specific sigma factor LafS (σ28) and the other structural 
components forming the rod and the hook, such as FlgB, FlgC, FlgD and FlgE. 
Class III genes, including flgM-flgN, maf-5, lafA and lafA-lafC, are σ28-dependent 
and are involved in encoding the cognate anti-σ28 factor FlgM, the filament capping 
protein (LafB), the putative glycotransferase protein (Maf-5) and and the flagellin 
protein (LafA) (Canals et al 2006a, Wilhelms et al 2013). The structural composition 
of the lateral flagella system is shown in Figure 1.2.  
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Figure 1.2 Illustration of putative structural composition of the lateral flagella system in 
A. hydrophila AH-3. Protein components were assembled from the cytoplasm outwards. 
The motor (LafT and LafU) and the basal body with the ring structures (FliM, FliN, FliG, 
FliF and FliE)  are assembled first, followed by the rod (FlgB, FlgC, FlgD, FlgF and 
FlgG), P-ring (FlgI), L-ring (FlgH) and the hook (FlgE) along with hook-associated 
proteins (HAP) (FlgK and FlgL). The flagellin protein (LafA) and the capping protein 
(LafB) are secreted and assembled at last. 
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The complete mechanism of how the lateral flagella system is regulated 
remains unclear in A. hydrophila. In V. parahaemolyticus, the lateral flagella system 
is under control of the polar flagella system and physical sensors, which sense the 
disturbance in the environment and trigger the V. parahaemolyticus cells to 
differentiate into an elongated swarmer cell formation and to express the lateral 
flagella system (McCarter & Silverman 1990). In more recent studies of the 
regulation between the polar and lateral flagellar in V. parahaemolyticus and A. 
hydrophila, it was shown that a mutation in the polar flagellar regulator FlrA 
abolished the production of the polar flagella system in A. hydrophila, as its 
homologue FlaK also abolished the polar flagella system in V.parahaemolyticus. But 
the mutation in FlaK eliminated the production of the lateral flagella as well as the 
polar flagella in V.parahaemolyticus while the mutation in FlrA did not affect the 
lateral flagella expression in A. hydrophila. Furthermore the lateral flagella regulator 
LafK is able to complement the lack of FlaK in V.parahaemolyticus while the LafK 
homologue in A. hydrophila cannot compensate for the mutation in FlrA (Wilhelms et 
al 2011). This suggested that the polar flagella system was not responsible for the 
regulation of the lateral flagella system in A. hydrophila, therefore the signal 
transduction that triggers the expression of lateral flagella system still remains 
unclear in A. hydrophila. 
 
It was recently reported that cyclic di-GMP, produced by diguanylate cyclase 
that contains GGDEF domains, was directly involved in the regulation of biofilm 
formation and motility in V.cholerae (FlrA) as well as the flagella biosynthesis in P. 
aeruginosa (FleQ) (Hengge 2009, Hickman & Harwood 2008, Krasteva et al 2010). 
The intracellular concentration of cyclic-di-GMP was responsible for switching the 
bacteria between the sessile and motile lifestyle. High intracellular concentration of 
the cyclic-di-GMP is coupled with increased biofilm formation and decreased lateral 
flagella expression while low concentration of cyclic-di-GMP increases the 
expression of the lateral flagella system, hence improving swarming motility and 
reducing biofilm formation. It was reported in A. hydrophila SSU that the 
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cyclic-di-GMP functions as the second messenger modulating biofilm formation and 
swarming motility in a quorum-sensing-dependent manner (Kozlova et al 2012, 
Kozlova et al 2011). However, a detailed mechanism of how cyclic-di-GMP regulates 
the lateral flagella system in A. hydrophila still remains unknown. 
 
Moreover, evidence in A. hydrophila AH-1 has shown that the expression level 
of two tandem lateral flagellin gene lafA1 and lafA2 are significantly decreased in 
mutants of the T3SS-associated genes, exsD and aopN. However, ΔexsA ΔexsD 
and the ΔexsA ΔaopN double deletions restored the secretion level of the LafA 
flagellin protein (Yu et al 2007). This finding indicated potential cross-talk between 
the lateral flagella system and the T3SS in A. hydrophila, which will be discussed 
and investigated in detail in this project. 
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1.6. Type III secretion system 
The secretion systems in Gram-negative bacteria have been discovered and 
intensively studied for the last three decades. To date, there are more than six 
different types of secretion systems discovered, however the Type I to Type VI 
secretion systems have been studied intensively. The Type I secretion system 
(T1SS) represented by the E. coli haemolysin secretion system that involves only 
three proteins is the simplest among all secretion systems (Gentschev et al 2002, 
Letoffe et al 1996). The Type II secretion system (T2SS) and Type V secretion 
system (T5SS) are both two-step pathways that secret proteins distinctively across 
the outer membrane after they have been transported across the inner membrane 
into the periplasm through Sec or Tat (two-arginine translocation) systems 
(Cianciotto 2005, Stathopoulos et al 2000, Voulhoux et al 2001). The Type IV 
secretion system (T4SS) built from the conjugation apparatus is involved in genetic 
exchange and delivery of effectors directly into eukaryotic host cells (Cascales & 
Christie 2003, Christie & Vogel 2000). The Type VI secretion system (T6SS), which 
was discovered in V. cholerae in 2006, is a bacteriophage-like system that 
punctures the target cells (either eukaryotic host cells or bacterial competitors) and 
delivers the effectors directly into their cytoplasm (Bonemann et al 2010, Coulthurst 
2013, Hood et al 2010, Pukatzki et al 2006). Recently, a novel Type VII secretion 
system (T7SS) was discovered in the Gram-positive bacteria, Mycobacterium 
marinum, Staphylococcus aureus and Bacillus subtilis. The secreted proteins via 
T7SS are co-dependent on each other and are different from the secreted proteins 
in other secretion systems (Abdallah et al 2007). 
 
The Type III secretion system has been reported in more than 25 species of 
Gram-negative bacteria including Yersinia spp., Pseudomonas spp., Vibrio spp., 
Salmonella spp. and Shigella spp. (Cornelis et al 1998, Cornelis & Van Gijsegem 
2000, Galan & Collmer 1999, Park et al 2004, Yahr et al 1997). Unlike Type I, Type II 
or Type V secretion systems, the T3SS can inject protein effectors across the 
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plasma membrane directly into host cell cytosol or to secrete pore-forming 
translocators that helps effector proteins to get through (Cornelis & Van Gijsegem 
2000). The structural composition of the T3SS is similar to the flagella systems. The 
T3SS is comprised of more than 20 proteins and forms a needle-like complex, most 
of which share homology with the export proteins of the flagella systems. The basal 
body of the T3SS is composed of multiple ring structures with a central rod that 
function as a syringe to ‘pump’ protein effectors through the needle, thus the T3SS 
is often call the injectisome (Galan & Wolf-Watz 2006, Marlovits & Stebbins 2010).  
 
1.6.1 Effector proteins of T3SS in Aeromonas spp. 
The effector proteins that are injected from the bacteria into the target host cells 
have been broadly studied in Vibrio, Yersinia and Pseudomonas species. In 
Aeromonas species, A. salmonicida is the best-studied model of T3SS-secreted 
toxins. To date, there are seven different kinds of toxins discovered in A. 
salmonicida, including AexT, AopP, Ati2, AopN, ExsE, AopO and AopH, of which 
AexT and AopP have been investigated intensively.  
 
The exoenzyme T (AexT), which is homologous to the exotoxin ExoT/S in 
P.aeruginosa and cytotoxin YopE in Yersinia spp., is a bifunction toxin that 
possesses an ADP-ribosylating domain and a GTPase-activating domain. As an 
ADP-ribosyltransferase or a GTPase-activating protein, AexT targets the host cell 
cytoskeleton to depolymerize the actin filament, which leads to cell morphological 
change and cytotoxicity. Furthermore, it was reported that the muscular and 
non-muscular actin were the substrates of the ADP-ribosylating domain while the 
monomeric GTPase of the Rho family is the target of the GTPase-activating domain 
(Braun et al 2002, Burr et al 2003, Fehr et al 2007).  
 
The second T3SS-secreted toxin identified in A. salmonicida is AopP, which 
affects the nuclear factor kappa B (NF-κB) signaling pathways downstream of IκBα 
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phosphorylation, preventing NF-κB entering the nucleus and leading to apoptosis of 
the host cells. Unlike its homologue YopJ in Yersinia spp., AopP does not interfere 
with the mitogen-activated protein kinase (MAPK) signaling pathway (Fehr et al 
2006). 
 
Recent studies by Bergh and collegues have identied the effector proteins Ati2, 
AopN and ExsE in A. salmonicida. The effector protein Ati2 and its homologue 
VPA0450 in V. parahaemolyticus disrupt the cytoskeletal binding site on the inner 
surface of the host cell membrane, compromising host membrane integrity and 
leading to cell lysis (Broberg et al 2010, Vanden Bergh et al 2013). AopN, which was 
reported to be the gate protein controlling the secretion of translocator proteins, has 
now been shown to be a secreted effector as well, potentially suppressing host 
immune response based on the homology studies in Pseudomonas, Chlamydia and 
Bordetella species (Archuleta et al 2011, Crabill et al 2012, Nagamatsu et al 2009, 
Vanden Bergh et al 2013). The effector protein ExsE was intensively studied in 
P.aeruginosa, in which the ExsE was shown to be involved in the regulation of the 
T3SS but the effect of ExsE within the host cell is still unknown (Rietsch et al 2005, 
Urbanowski et al 2005). The regulatory role of ExsE effector protein will be 
discussed and investigated in detail in this study. 
 
However, in A. hydrophila AH-3, the first protein effector AexT was identified in 
2007 and was found to be smaller than the AexT protein in A. salmonicida. The 
putative function of A. hydrophila AexT is similar to A. salmonicida AexT, both of 
which possess an ADP-ribosylating domain and a GTPase-activating domain 
(Vilches et al 2008). In another mesophilic strain of Aeromonas, A. hydrophila SSU, 
an AexT-like protein effector was identified in the same year, named as AexU. The 
N-terminal of AexU shares high homology with the N-terminal of AexT in 
A.salmonicida, both of which exhibit the ADP-ribosylating activity. A study carried out 
by Sierra and collegues showed reduced ADP-ribosylating activity of the N-terminal 
truncated AexU (amino acid residues 232-512) (Sierra et al 2007). So far, no other 
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T3SS-secreted effector proteins have been identified in A. hydrophila. 
 
1.6.2 The chaperone proteins and the constitution of T3SS in A. hydrophila 
The formation of the injectisome involves three classes of T3SS chaperone 
proteins. The first class of chaperones is to prevent the premature polymerization of 
the extracellular structural subunits of the T3SS, and is similar to the lateral flagellar 
chaperone protein FlgN for hook-associated proteins FlgK (HAP1) and FlgL (HAP3) 
in A. hydrophila (Auvray et al 2001, Fraser et al 1999).  
 
The second class of the chaperone proteins is associated with the pore-forming 
proteins in T3SS. These pore-forming proteins are not only capable of penetrating 
target cell membranes but also toxic to bacteria themselves, hence the chaperone 
proteins are required to neutralize the toxicity of these pore-forming proteins before 
they are secreted (Neyt & Cornelis 1999b).  
 
The final class of the chaperone proteins is the dedicated chaperones for the 
effector proteins. Many of these chaperones and their cognate effector proteins are 
encoded adjacent to each other, and they interact with each other through the 
chaperone binding domain, which is located just downstream of the N-terminal 
export signal of the effector protein (Cornelis 2006). This class of chaperones does 
not share any sequence similarity but a conserved structure that consists of 5 
β-strands and 3 α-helices (Evdokimov et al 2002, Luo et al 2001, Stebbins & Galan 
2001). Additionally these chaperones are often dimerized and interact with the 
chaperone binding domain of the effector proteins via the hydrophobic surfaces 
(Birtalan et al 2002).  
 
So far, the putative chaperone proteins identified in A. hydrophila and encoded 
from the T3SS regulon include Acr2, AcrG, AcrH, ExsC, AscB, AscE and AscG, of 
which the chaperone proteins Acr2, AcrG, AscB, AscE and AscG are responsible for 
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binding the extracellular structural subunits, the AcrH is coupled with the 
pore-forming proteins, while the ExsC is a chaperone for the effector protein. 
 
The chaperone protein Acr2 has not been studied intensively in Aeromonas, but 
its homologue Pcr2 has been investigated in detail in P. aeruginosa. It was reported 
that Pcr2 interacted with an important translocator PopN, which acted as a gate 
blocking the T3 secretion when the T3SS was not triggered. Furthermore, the 
mutation in pcr2 gene resulted in reduced T3 secretion (Yang et al 2007a). 
 
The AcrG chaperone protein is coupled with AcrV protein, which is a needle-tip 
protein involved in the translocation of the effector protein. It was reported in A. 
salmonicida that the acrV mutant was unable to translocate the toxin AexT into the 
host cell but constantly secrete the toxin regardless of the calcium effect.This 
suggested that both the chaperone protein AcrG and the translocon protein AcrV are 
involved in low-calcium response (Burr et al 2003).  
 
The AcrH chaperone protein is responsible for binding and inhibiting the 
activities of two proteins, AopB and AopD, which are encoded downstream of the 
acrH gene. The homologues of AopB and AopD in Yersinia spp. are YopB and YopD, 
which are known to be the pore-forming proteins that facilitate effector proteins to 
translocate into the host cell cytosol (Hakansson et al 1996, Neyt & Cornelis 1999a). 
The binding of AcrH to AopB and AopD is extensively studied by Leung’s group, 
who suggested a stable 1:1 monomeric complex of AcrH-AopD while the 1:1 
monomeric complex of AcrH-AopB is metastable (Tan et al 2009). 
 
Both of the chaperone proteins AscE and AscG bind the structural subunit AscF, 
which polymerizes and forms the needle structure of the injectisome. A recent study 
of the crystal structure of the AscE-AscG hetero-molecular chaperone suggested 
that the the AscE functions as a chaperone of the chaperone protein AscG in order 
to bind the AscF protein (Chatterjee et al 2011). This model correlates with the 
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complex formation of their homologues YscE-YscF-YscG and PscE-PscF-PscG in 
Yersina and Pseudomonas respectively (Quinaud et al 2005, Sun et al 2008). 
 
Little is known about the chaperone protein AscB in Aeromonas, except that it 
binds to an extracellular T3SS structural protein AscC. The homologues of AscC in 
Yersinia, YscC is a channel-forming protein that forms a secretin complex on the 
outer membrane of the bacteria (Koster et al 1997). 
 
Most of the T3SS genes in A. hydrophila were identified and studied in 
comparison with their homologues in P. aeruginosa. The genetic organization of the 
A. hydrophila T3SS is shown in Figure 1.3 and the putative functions of each gene 
are listed in Table 1.2. The putative structural composition of the T3SS in A. 
hydrophila AH-3 is shown in Figure 1.4.  
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Figure 1.3 Genetic organizations of the T3SS in A. hydrophila AH-3 and P. aeruginosa. The arrows with the same colour represent homologous 
genes. The T3SS regulon in both bacteria contains five putative operons, ascN-ascU (pscN-pscU), aopN-aopD (popN-popD), exsC-exsB, 
exsA-ascL and exsD-ascL, in which the exsA-ascL and exsD-ascL share the same terminator. All putative operons are transcribed from 5’ to 3’ 
except for ascN-ascU (pscN-pscU), which is transcribed from 3’ to 5’. This figure is adapted from Vilches et al. 2004.  
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Table 1.2 Characteristics of the T3SS genes in A. hydrophila AH-3 
Gene 
names 
Putative function of proteins Homologues 
Putative operon ascN-ascU 
ascU 
ascT 
ascS 
ascR 
ascQ 
ascP 
ascO 
ascN 
Regulation of secretion 
T3SS apparatus 
T3SS apparatus 
T3SS apparatus 
Secretion apparatus 
Regulation of secretion 
Regulation of secretion 
ATPase 
pscU in P. aeruginosa 
pscT in P. aeruginosa 
pscS in P. aeruginosa 
pscR in P. aeruginosa 
yscQ in Yersinia pestis 
pscP in P. aeruginosa 
pscO in P. aeruginosa 
yscN in Y. pestis 
Putative operon aopN-aopD 
aopN 
acr1 
acr2 
ascX 
ascY 
ascV 
acrR 
acrG 
acrV 
acrH 
aopB 
aopD 
Translocation regulation, effector 
Secretion apparatus 
Chaperone 
T3SS apparatus 
T3SS apparatus 
Secretion apparatus 
Low-Ca
2+
 response 
Translocation regulation, chaperone 
Secreted protein 
Chaperone 
Pore-forming protein 
Pore-forming protein 
yopN in Y.pestis 
pcr1 in P. aeruginosa 
pcr2 in P. aeruginosa 
pcr3 in P. aeruginosa 
pcr4 in P. aeruginosa 
yscV in Y. pestis 
lcrR in Y. pestis 
acrG in A. salmonicida 
acrV in A. salmonicida 
acrH in A. hydrophila AH-1 
aopB in A. hydrophila AH-1 
aopD in A. hydrophila AH-1 
Putative operon exsC-exsB 
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exsC 
exsE 
exsB 
Chaperone 
Secreted protein 
Regulatory mRNA 
exsC in P. aeruginosa 
exsE in P. aeruginosa 
exsB in P. aeruginosa 
Putative operon exsA-ascL 
exsA Transcriptional activator of T3SS exsA in P. aeruginosa 
Putative operon exsD-ascL 
exsD 
ascB 
ascC 
ascD 
ascE 
ascF 
ascG 
ascH 
ascI 
ascJ 
ascK 
ascL 
Regulatory protein 
Chaperone 
Secretion apparatus, channel-forming 
T3SS apparatus 
Chaperone 
Translocon, needle-forming 
Chaperone 
Translocon 
T3SS apparatus 
T3SS apparatus 
T3SS apparatus 
ATPase regulator 
ExsD in P.aeruginosa 
yscB in Y. pestis 
yscC in Y. pestis 
pscD in P.aeruginosa 
pscE in P.aeruginosa 
pscF in P.aeruginosa 
pscG in P. aeruginosa 
yscH in Y. pestis 
yscI in Y. pestis 
yscJ in Y. pestis 
yscK in Y. pestis 
yscL in Y. pestis 
Table 1.2 Characteristics of the T3SS genes in A. hydrophila AH-3. The putative 
function of the protein products are based on information of their homologues in 
Y.pestis, P. aeruginosaI or other strains of Aeromonas spp. (Blaylock et al 2006, 
Burr et al 2003, Chatterjee et al 2011, Goranson et al 1997, Koster et al 1997, 
Quinaud et al 2005, Silva-Herzog et al 2008, Sun et al 2008, Tan et al 2009, Yang et 
al 2007a, Yang et al 2007b). The T3SS apparatus proteins are involved in the 
formation of the T3SS basal body, while the secretion apparatus and translocons 
are required for the export and translocation of the extracellular structural subunits, 
pore-forming proteins and the effector proteins. It should be noted that only exsB 
gene is not translated into protein but functions as an mRNA in regulating exsA 
mRNA stability and translation.  
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Figure 1.4 Illustration of putative structural composition of the T3SS in A. hydrophila 
AH-3. The proteins involved in the assembly of the T3SS apparatus are shown in 
squares, while the proteins in oval represent secreted proteins or proteins responsible 
for export and translocation (secretion apparatus and translocons). The exported 
extracellular structural subunits (AscF and AscV), pore-forming proteins (AopB and 
AopD) and effector proteins (ExsE) are bound to their cognate chaperones before they 
are secreted.  
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1.6.3 Regulation of the T3SS 
The assembly of the T3SS requires a high level of energy and resources; thus it 
is regulated by many intracellular and extracelluar factors. One of the major 
transcriptional factors in P. aeruginosa is the AraC family protein ExsA. As the 
transcriptional activation of ExsA was required for the expression of the T3SS 
secretion apparatus, translocation machinery and secreted effectors, ExsA has 
been described as the master regulator of the P. aeruginosa T3SS (Hovey & Frank 
1995, Yahr et al 1995). Moreover, ExsA in A. hydrophila shares 76% amino acid 
homology with ExsA in P. aeruginosa, both of which belong to the AraC family of 
transcriptional activators (Frank & Iglewski 1991, Vilches et al 2009, Yahr & Frank 
1994).  
 
In both P. aeruginosa and A. hydrophila AH-3, the ExsA-dependent promoters 
usually contain a consensus ExsA binding site centred 15bp upstream of the -35 
RNA polymerase binding site and the sequence of the ExsA consensus binding site 
is TNAAAANA (Vilches et al 2009, Yahr & Wolfgang 2006). In P. aeruginosa, the 
recruitment of RNA polymerase (RNAP) onto the promoters requires sigma factor 
σ70, and the primary function of ExsA is to facilitate RNAP-σ70 binding onto the T3SS 
promoter sequences (Vakulskas et al 2009). As the role of ExsA in P.aeruginosa 
was defined as the transcriptional activator by facilitating the RNAP-σ70 binding onto 
the T3SS promoter regions, the role of ExsA in A. hydrophila was proposed to be 
similar.  
 
As in most AraC/XylS family proteins, P. aeruginosa ExsA consists of a 
carboxyl-terminal helix-turn-helix (HTH) DNA-binding motif and an amino-terminal 
oligomerization and ligand binding domain (Brutinel et al 2009, Martin & Rosner 
2001). The potential ExsA DNA-binding model proposed by Brutinel and collegues 
involves the binding of a monomeric ExsA onto the -35 RNA polymerase site and 
then the recruitment of another ExsA molecule binding the ExsA-consensus binding 
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site (TNAAAANA) located 15bp upstream -35 region (Brutinel et al 2008). This 
model suggested potential ExsA-ExsA cooperative binding of the T3SS promoter 
sequences in P. aeruginosa. 
 
It was reported in 2002 that the master regulator ExsA was negatively regulated 
by an anti-activator protein named ExsD in P. aeruginosa through direct 
protein-protein interaction. This was demonstrated using bacterial LexA two-hybrid 
assay (McCaw et al 2002). Later on, structural analysis of ExsA protein in P. 
aeruginosa suggested that the C-terminal domain (CTD) of ExsA consisted of 2 
HTH DNA-binding motifs while the N-terminal domain (NTD) functions in 
oligomerization and ligand binding. The same study also demonstrated that the 
C-terminal HTH domain of P.aeruginosa ExsA is incapable of cooperative 
DNA-binding and unaffected by the inhibition of ExsD, suggesting that the 
N-terminal domain of ExsA is required for interactions with ExsD and ExsA itself 
(Brutinel et al 2009). Thereby it is proposed that in P. aeruginosa the binding of 
ExsD to the NTD of ExsA disrupts the self-association of ExsA, which is required to 
bind to the second binding site on the ExsA-dependent promoter sequences.  
 
Meanwhile, the chaperone protein ExsC was found to be an anti-anti-activator 
of T3SS in P. aeruginosa. Mutagenesis and complementation experiments have 
shown that ExsC de-represses the T3SS transcription via ExsD, since Bacterial 
LexA two-hybrid assay and co-purification assay have suggested that ExsC 
interacts with ExsD through direct protein-protein interactions (Dasgupta et al 2004).  
 
Later in 2005, the same group discovered that the secreted protein ExsE sat at 
the top of the signalling cascade by binding to its cognate chaperone protein ExsC 
through direct protein-protein interactions (Urbanowski et al 2005). Thus the 
regulatory cascade of the P. aeruginosa T3SS is fully uncovered. The secreted 
protein ExsE binds to the chaperone protein ExsC, which antagonizes the 
anti-activation activity of ExsD on the master regulator ExsA (Figure 1.5).   
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Figure 1.5 The regulatory cascade of the T3SS in P. aeruginosa. A. When the T3SS is 
not activated, the effector protein ExsE is bound to its cognate chaperone ExsC, 
allowing the de-activator protein ExsD to bind the activator protein ExsA, thus no 
transcription activation of the T3SS. B. When the T3SS is triggered upon contact with 
host cells or by other stimulus, the effector protein ExsE is secreted out from the 
bacteria, allowing the chaperone protein ExsC to bind to the de-activator ExsD, thus 
releasing ExsA to activate the transcription of the T3SS. This model is also proposed in 
A. hydrophila AH-3.  
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In P. aeruginosa, Gel Filtration Chromatography (GFC) and Analytical 
Ultracentrifugation (AUC) analysis of co-expressed ExsA-ExsD suggested the 
complex formation at 1:1 ratio (Thibault et al 2009). Moreover, Gel shift assays and 
a monohybrid study indicated that the anti-activator ExsD inhibit ExsA-dependent 
activation by affecting the ExsA self-association but not blocking the DNA target 
sites (Brutinel et al 2010). It was also reported that ExsD could only bind to ExsA 
when they were synthesized at the same time as both proteins were 
folding-intermediates (Bernhards et al 2013, Brutinel et al 2010, Thibault et al 2009). 
 
Furthermore, a recent study carried out by Bernhards and collegues indicated 
that ExsD forms a homotrimer at 30°C, which prevent ExsD from inhibiting the 
activator ExsA. The trimerization of ExsD disrupts when the temperature rises to 
37°C. Also the engineered monomeric ExsD is fully capable of inhibiting ExsA at 
30°C. Taken together the findings, they suggested that the self-association of ExsD 
is temperature-sensitive and competes with the inhibition for ExsA in P. aeruginosa 
(Bernhards et al 2013).  
 
In P.aeruginosa, the ExsA-ExsD complex is dissociated by the addition of ExsC, 
which has a higher affinity to bind ExsD to form a 2:2 heterocomplex, thus releasing 
ExsA to activate the T3SS regulon (Figure 1.5). As it was reported in P. aeruginosa, 
the size of the ExsC-ExsD complex consisted of two molecules of both ExsC and 
ExsD proteins using GFC and AUC, together with the Isothermal Titration 
Calorimetry (ITC) data, which indicated an equal molar binding ratio of ExsC and 
ExsD, suggesting a heterotetramer complex formation of ExsC-ExsD at 2:2 ratio, 
with a binding affinity of 18nM (Zheng et al 2007). The binding affinity of ExsA to 
ExsD is still unknown, but given the fact that ExsA-ExsD complex is readily 
dissociated by ExsC, the binding affinity of ExsA to ExsD may be more than 100nM. 
 
It was first identified by Urbanowski and collegues in P. aeruginosa that ExsC, 
as the chaperone for the effector protein ExsE, released ExsD in the presence of 
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ExsE (Urbanowski et al 2005). This corresponds to the Isothermal Titration 
Calorimetry studies carried out by Zheng’s group, who has determined the binding 
affinities for ExsC-ExsD (18nM) and ExsC-ExsE (1nM) in P. aeruginosa (Zheng et al 
2007). This suggests that the ExsC chaperone protein prefers to bind to the effector 
protein ExsE rather than the anti-activator ExsD. When the concentration of ExsE 
decreases, the abundant ExsC proteins bind to ExsD and antagonize the inhibition 
of ExsD on ExsA. Thereby the concentration of the effector protein ExsE plays a 
crucial role in the regulation of the ExsA transcriptional activation. 
 
In comparison with P .aeruginosa, the regulation of the T3SS is not intensively 
studied in A. hydrophila. In 2004, the complete T3SS that consisted of 35 genes in A. 
hydrophila AH-3 was sequenced but the regulation of the T3SS in A. hydrophila still 
remained unknown (Vilches et al 2004). It was then reported by Sha and collegues 
in 2007 that the Exs proteins in A. hydrophila SSU strain had similar effects on the 
regulation of the T3SS to those found in P. aeruginosa using mutagenesis and 
over-expression assays (Sha et al 2007). In the meantime, proteomic study in A. 
hydrophila AH-1 has shown that the T3SS secreted translocon protein AcrV was 
abundant in ΔexsD and ΔaopN mutants while absent in ΔexsD ΔexsA and ΔaopN 
ΔexsA double mutants (Yu et al 2007). Furthermore, in A. hydrophila AH-3, 
quantitative RT-PCR results for aopN and aexT mRNA production showed 60-85% 
decrease in ΔexsA mutant background compared with the results of the wild type. In 
the same study, the activities of promoters upstream of aopN and aexT genes were 
significantly decreased in the exsA mutant when compared to the wild type strain 
(Vilches et al 2009). All these findings suggest that ExsA, like its homologue in 
P.aeruginosa, is likely to be the master regulator of the T3SS in A. hydrophila as well. 
However, there is no evidence of ExsC and ExsE involvement in the regulation of 
the T3SS in Aeromonas species. In this study, the putative regulatory cascade that 
involves ExsA, ExsD, ExsC and ExsE proteins will be investigated in detail.  
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1.7 Project hypothesis and objectives 
A previous study in our laboratory investigating the lateral flagella system of A. 
hydrophila discovered two non-swarming transposon mutants that were found to be 
mutated in the exsD gene, which encodes one of the regulators of the A. hydrophila 
T3SS. Since the T3SS regulatory cascade that involves the ExsA, ExsD, ExsC and 
ExsE proteins was well-described in P. aeruginosa, the aim of this study is to 
determine whether the regulatory cascade of the T3SS in A. hydrophila is the same 
as in P. aeruginosa and if the T3SS cross-talks with the lateral flagella system via 
the T3SS regulatory proteins. 
 
Thereby, insertional knockouts of the regulatory components of the T3SS and 
the lateral flagella system are required. Mutations in exsA and lafK have already 
been constructed previously in the laboratory, but the insertional knockouts of exsC, 
exsD and exsE genes were required. To understand what roles these exs genes 
played in the regulation of the T3SS, the activities of the T3SS promoters were to be 
measured in the wild type and exs mutant backgrounds.  
 
Furthermore, protein-protein interactions interactions within the T3SS were 
investigated. The Exs proteins were to be over-expressed using the pET system 
and the pMAL system, followed by the investigation of direct protein-protein 
interactions using Far-Western Blot. In addition to protein over-expression, the 
Bacterial Adenylate Cyclase Two-Hybrid (BACTH) system was utilized to study the 
protein-protein interactions in between Exs proteins in vivo. 
 
Finally, when the T3SS regulatory cascade was determined in A. hydrophila 
AH-3, the relationship between the T3SS and the lateral flagella system was 
investigated by carrying out the swarming assay on the exs mutants and measuring 
the lateral flagella promoter activities in the exs mutant backgrounds. 
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Chapter 2 
Methods and Materials 
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2.1 Media, bacterial strains, plasmids and antibiotics used in this study 
All media components used in this project were purchased from Oxoid™, 
Fisher™ or Difco™. Horse blood added Columbia Blood Agar (CBA) was provided 
by the Department of Infection and Immunity in the Medical School of the University 
of Sheffield. All media were autoclaved at 121°C and 15 psi for 20 min. Appropriate 
antibiotics and supplements were added when required. 
2.1.1 Luria Bertani Agar (LB agar) 
10g              Tryptone 
10g              NaCl 
5g               Yeast Extract 
15g              Bacteriological Agar 
(Made up to 1000ml with dH2O and autoclaved to sterilize) 
2.1.2 Luria Bertani Broth (LB broth) 
2g              Tryptone 
2g              NaCl 
1g              Yeast Extract 
(Made up to 200ml with dH2O and autoclaved to sterilize) 
2.1.3 Brain Heart Infusion Broth (BHIB) 
37g of Brain Heart Infusion powder was dissolved in 1L of distilled water and 
autoclaved to sterilize. 
2.1.4 Swarming agar 
Tryptone             1% (w/v) 
Glucose             0.5% (w/v) 
NaCl                0.5% (w/v) 
Eiken Agar           0.6% (w/v) 
(Dissolve in dH2O and autoclave to sterilize)  
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Table 2.1 Bacterial strains used in the study 
Name of strains Description Reference 
Aeromonas hydrophila AH3 strains 
AH3R Wild type Aeromonas hydrophila 
AH3 strain, Rif
R
 
Dr. J. Tomás 
University of 
Barcelona 
exsA mutant AH3R strain with exsA knocked out 
by the insertion of Km
R 
cassette 
Laboratory collection 
exsC mutant AH3R strain with exsC knocked out 
by the insertion of Km
R 
cassette 
This study 
exsD mutant AH3R strain with exsD knocked out 
by the insertion of Km
R 
cassette 
This study 
exsE mutant AH3R strain with exsE knocked out 
by the insertion of Km
R 
cassette 
This study 
lafK mutant AH3R strain with lafK knocked out by 
the insertion of Km
R
 
Laboratory collection 
AH3R-PascN Reporter plasmid pKAG-PascN 
conjugated into AH3R wild type 
This study 
AH3R-PaopN Reporter plasmid pKAG-PaopN 
conjugated into AH3R wild type 
This study 
AH3R-PexsC Reporter plasmid pKAG-PexsC 
conjugated into AH3R wild type 
This study 
AH3R-PexsA Reporter plasmid pKAG-PexsA 
conjugated into AH3R wild type 
This study 
AH3R-PexsD Reporter plasmid pKAG-PexsD 
conjugated into AH3R wild type 
This study 
AH3R-PfliM Reporter plasmid pKAG-PfliM 
conjugated into AH3R wild type 
This study 
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AH3R-PlafK Reporter plasmid pKAG-PlafK 
conjugated into AH3R wild type 
This study 
AH3R-PflgM Reporter plasmid pKAG-PflgM 
conjugated into AH3R wild type 
This study 
AH3R-PflgA Reporter plasmid pKAG-PflgA 
conjugated into AH3R wild type 
This study 
AH3R-PflgB Reporter plasmid pKAG-PflgB 
conjugated into AH3R wild type 
This study 
AH3R-Pmaf Reporter plasmid pKAG-Pmaf 
conjugated into AH3R wild type 
This study 
AH3R-PlafA Reporter plasmid pKAG-PlafA 
conjugated into AH3R wild type 
This study 
AH3R-PlafB Reporter plasmid pKAG-PlafB 
conjugated into AH3R wild type 
This study 
AH3R-PlafX Reporter plasmid pKAG-PlafX 
conjugated into AH3R wild type 
This study 
Escherichia coli strains 
DH5α F–, Φ80lacZΔM15, Δ(lacZYA-argF), 
U169, recA1, endA1, hsdR17, (rK–, 
mK+), phoA, supE44, λ– thi-1, 
gyrA96, relA1 
(Hanahan 1983) 
CC118-λpir phoA20, thi-1, rspE, rpoB, argE, 
(Am), recA1, phage λpir  
(Herrero et al 1990) 
S17-1-λpir SmR, F–, recA, hsdR, RP4-2 (Tc::Mu) 
(Km::Tn7), phage λpir 
(Miller 1972) 
Sm10-λpir KmR, thi-1, thr, leu, tonA, lacY, supE, 
recA::RP4-2-Tc::Mu, phage λpir 
(Miller & Mekalanos 
1988) 
HB101 F
-
 mcrB mrr hsdS20(rB
-
 mB
-
) recA13 
leuB6 ara-14 proA2 lacY1 galK2 
(Hanahan 1983) 
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xyl-5 mtl-1 rpsL20(Sm
R
) glnV44 λ- 
BL21(DE3) F
–
 ompT gal dcm lon hsdSB(rB
-
 mB
-
) 
λ(DE3) 
Novagen™ 
C41(DE3) ompT hsdSB (rB- mB-) gal 
dcm (DE3) 
Lucigen™ 
BL21Star™(DE3) F– ompT hsdSB(rB–, mB–) gal dcm 
rne131 (DE3) 
Invitrogen™ 
BTH101 F-, cya-99, araD139, galE15, galK16, 
rpsL1(Str
r
), hsdR2, mcrA1, mcrB1 
Euromedex™ 
E. coli ER2523 
(NEB Express) 
fhuA2 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] 
R(zgb-210::Tn10--TetS) endA1 Δ
(mcrC-mrr)114::IS10 
New England 
BioLabs™ 
Table 2.1 Bacterial strains used in this study. 
2.1.5 Bacterial Growth 
All bacterial strains used in this study are listed in table 2.1 while plasmids used 
are listed in table 2.2. A. hydrophila strains were incubated at 30℃ on LB agar, CBA 
or in broth cultures with shaking at 200rpm, in which antibiotics were added when 
required (Table 2.3), while no antibiotics were present in swarming agar. 
E. coli strains were grown at 37℃ on LB agar or in broth cultures with shaking 
at 200rpm, in which antibiotics were added when required.  
  
44 
Table 2.2 Plasmids used in the study 
Name of 
plasmids 
Characteristics Reference 
pBBR1MCS Broad-host-range plasmid, Cm
R
 (Kovach et al 
1994) 
pBBexsA exsA cloned into pBBR1MCS Laboratory 
collection 
pBBexsCEB exsCEB region cloned into pBBR1MCS Laboratory 
collection 
pBBexsCKm
R
 exsC::Km
R
 knockout ligated with 
pBBR1MCS 
This study 
pBBR1MCS-5 Broad-host-range plasmid, Gm
R
 (Kovach et al 
1994) 
pBBR5exsA exsA ligated with pBBR1MCS-5 This study 
pUC4KIXX Source of Km
R
 cassette (nptII) Amersham 
Pharmacia™ 
pJMK30 pUC19 derivative, containing a Km
R
 
cassette (AphA-3) from Campylobacter 
coli 
(van Vliet et al 
1998) 
pKNG101 RK6 derived suicide plasmid, SacB, Sm
R
   (Kaniga et al 1991) 
pKNGexsAKm
R
 exsA::Km
R
 knockout ligated with 
pKNG101 suicide plasmid 
This study 
pKNGexsCKm
R
 exsC::Km
R
 knockout ligated with 
pKNG101 suicide plasmid 
This study 
pKNGexsDKm
R
 exsD::Km
R
 knockout ligated with 
pKNG101 suicide plasmid 
This study 
pKNGexsEKm
R
 exsE::Km
R
 knockout ligated with 
pKNG101 suicide plasmid 
This study 
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pGEM-3Zf(+) Standard cloning vector, used for 
ISA-cloning in this study, Amp
R
 
Promega™ 
pGEMexsDKm
R
 exsD:Km
R
 knockout ligated with 
pGEM-3Zf(+) 
This study 
pGEMexsEKm
R
 exsE:Km
R
 knockout ligated with 
pGEM-3Zf(+) 
This study 
pET28a Over-expression vector, T7 promoter, 
N-terminal His tag, Km
R
 
Novagen™ 
pET28exsA exsA ligated in frame with His-tag in 
pET28a 
This study 
pET28exsC exsC ligated in frame with His-tag in 
pET28a 
This study 
pET28exsD exsD ligated in frame with His-tag in 
pET28a 
This study 
pET28exsE exsE ligated in frame with His-tag in 
pET28a 
This study 
pMAL-c5x Over-expression vector, malE-, MBP5 
coding, Amp
R
 
New England 
BioLabs™ 
pMALexsA exsA ligated in frame with MBP5 gene in 
pMAL-c5x 
This study 
pMALexsC exsC ligated in frame with MBP5 gene in 
pMAL-c5x 
This study 
pMALexsD exsD ligated in frame with MBP5 gene in 
pMAL-c5x 
This study 
pMALexsE exsE ligated in frame with MBP5 gene in 
pMAL-c5x 
This study 
pKAGb-2(-) Broad-host-range reporter vector, ori1600 
carrying promoter-less lacZ gene, Cm
R
 
M.S.Thomas, 
unpublished 
pKAG-PascN Promoter upstream of ascN cloned into This study 
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pKAG-b2(-) 
pKAG-PaopN Promoter upstream of aopN cloned into 
pKAG-b2(-) 
This study 
pKAG-PexsC Promoter upstream of exsC cloned into 
pKAG-b2(-) 
This study 
pKAG-PexsA Promoter upstream of exsA cloned into 
pKAG-b2(-) 
This study 
pKAG-PexsD Promoter upstream of exsD cloned into 
pKAG-b2(-) 
This study 
pKAG-PfliM Promoter upstream of fliM cloned into 
pKAG-b2(-) 
This study 
pKAG-PlafK Promoter upstream of lafK cloned into 
pKAG-b2(-) 
This study 
pKAG-PflgM Promoter upstream of flgM cloned into 
pKAG-b2(-) 
This study 
pKAG-PflgA Promoter upstream of flgA cloned into 
pKAG-b2(-) 
This study 
pKAG-PflgB Promoter upstream of flgB cloned into 
pKAG-b2(-) 
This study 
pKAG-Pmaf Promoter upstream of maf-5 cloned into 
pKAG-b2(-) 
This study 
pKAG-PlafA Promoter upstream of lafA cloned into 
pKAG-b2(-) 
This study 
pKAG-PlafB Promoter upstream of lafB cloned into 
pKAG-b2(-) 
This study 
pKAG-PlafX Promoter upstream of lafX cloned into 
pKAG-b2(-) 
This study 
pKT25 pSU40 derivative, lac promoter, allow 
in-frame fusion at C-terminal of T25,Km
R
 
Euromedex™ 
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pKNT25 pSU40 derivative, lac promoter, allow 
in-frame fusion at N-terminal of T25,Km
R
 
Euromedex™ 
pUT18 pUC19 derivative, lac promoter, allow 
in-frame fusion at N-terminal of T18, 
Amp
R
 
Euromedex™ 
pUT18C pUC19 derivative, lac promoter, allow 
in-frame fusion at C-terminal of T18, 
Amp
R
 
Euromedex™ 
pKT25-zip pKT25 derivative, leucine zipper of 
GCN4 fused at C-terminal of T25,Km
R
 
Euromedex™ 
pUT18C-zip pUT18C derivative, leucine zipper of 
GCN4 fused at C-terminal of T25,Km
R
 
Euromedex™ 
pKT25-exsA exsA cloned in-frame with pKT25 This study 
pKT25-exsC exsC cloned in-frame with pKT25 This study 
pKT25-exsD exsD cloned in-frame with pKT25 This study 
pKT25-exsE exsE cloned in-frame with pKT25 This study 
pKNT25-exsA exsA cloned in-frame with pKNT25 This study 
pKNT25-exsC exsC cloned in-frame with pKNT25 This study 
pKNT25-exsD exsD cloned in-frame with pKNT25 This study 
pKNT25-exsE exsE cloned in-frame with pKNT25 This study 
pUT18-exsA exsA cloned in-frame with pUT18 This study 
pUT18-exsC exsC cloned in-frame with pUT18 This study 
pUT18-exsD exsD cloned in-frame with pUT18 This study 
pUT18-exsE exsE cloned in-frame with pUT18 This study 
pUT18C-exsA exsA cloned in-frame with pUT18C This study 
pUT18C-exsC exsC cloned in-frame with pUT18C This study 
pUT18C-exsD exsD cloned in-frame with pUT18C This study 
pUT18C-exsE exsE cloned in-frame with pUT18C This study 
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Table 2.2 Plasmids used in this study. 
All plasmids were stored at -20°C and further stored in glycerol stock at -80°C after 
transformation into E. coli DH5α with the exception that suicide plasmids were 
transformed into E. coli CC118λpir. 
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Table 2.3. Antibiotics and other additives used in this study 
Antibiotics/Additives Working concentration Concentration made 
Kanamycin (Km) 50μg/ml 50mg/ml (dH2O) 
Streptomycin (Sm) 50μg/ml 50mg/ml (dH2O) 
Ampicillin (Amp) 100μg/ml 100mg/ml (dH2O) 
Rifampicin (Rif) 50μg/ml 50mg/ml (DMSO) 
Chloramphenicol (Cm) 50μg/ml 50mg/ml (Ethanol) 
Gentamycin (Gm) 50μg/ml 50mg/ml (dH2O) 
IPTG 0.3mM to 1mM 1M (dH2O) 
Table 2.3 Antibiotics and other supplements used in this study  
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2.2 Chromosomal DNA extraction 
Bacteria were cultured overnight in 10ml broth culture with appropriate 
antibiotics at its appropriate temperature. They were then harvested by 
centrifugation at 1600xg for 15 min at room temperature. The supernatant was 
discarded and the cell pellet was resuspended in 1ml Solution A (section 2.2.1), in 
which 20μl of lysozyme (100mg/ml) was added. The sample was incubated at 37°C 
for 20 min followed by freezing at -80°C for 5 min. Then 1.5ml of Solution B (section 
2.2.1) was added and mixed by inversion. The sample was incubated at 37°C for 5 
min until viscous. Then 10μl of RNAse (20mg/ml) was added followed by 20 min 
incubation at 37°C. Then 10μl proteinase K (10mg/ml) was added followed by 20 
min incubation at 37°C again. A volume of 0.5ml of buffered phenol pH7.4 (bottom 
layer) was added to 0.5ml of sample and mixed, followed by centrifugation at 
15,000xg for 10 min. The top aqueous layer was transferred into a fresh Eppendorf 
tube. This was repeated once with phenol and twice with phenol-chloroform.  
It was then followed by ethanol precipitation. A 1/10 volume of 3M sodium 
acetate and 2 times volume of 100% ethanol were added and mixed by inversion. 
The sample was centrifuged at 15,000xg for 5 min and the supernatant was 
discarded. A volume of 0.5ml of 70% ethanol was added carefully not to disturb the 
DNA pellet and was followed by centrifugation at 15,000xg for 5 min. The 
supernatant was discarded and the DNA pellet was left to dry. Finally the DNA pellet 
was dissolved in 200μl of dH2O. 
2.2.1 Buffer Preparation 
Solution A:  
10mM Tris-HCl pH7.2                            (78.8mg in 50ml of dH2O) 
150mM NaCl                                    (0.438g in 50ml of dH2O) 
100mM EDTA                                    (1.86g in 50ml of dH2O) 
Solution B: 
100mM Tris-HCl pH 8.8                           (0.78g in 50ml of dH2O) 
51 
1% (w/v) SDS                                   (2.5ml of 20% (w/v) SDS) 
100mM NaCl                                     (0.29g in 50ml of dH2O) 
 
2.3 Polymerase Chain Reaction (PCR)  
Reagents of PCR listed in 2.3.1 were mixed together to make a Master Mix, 
except the DNA template, which was added separately into each tube. The 
polymerases utilized in this study were KOD DNA polymerase (Toyobo Life 
Science™), Platinum® Pfx DNA polymerase (Invitrogen™), Phusion High-Fidelity 
DNA polymerase (New England Biolabs™) and Taq DNA polymerase (New England 
Biolabs™). The PCR samples were then put in the thermal cycler and the reaction 
was started under appropriate conditions listed in table 2.4. 
 
2.3.1 Normal PCR conditions 
10X Buffer                                                             5μl 
2mM dNTPs                                                            5μl 
25mM MgCl2                                                           4μl 
Primers                                                           1μl +1μl 
Polymerase                                                           0.5μl 
DNA                                                                   5μl 
Distilled H2O was added up to 50μl of total volume 
2.3.2 colony PCR screen condition 
10X Buffer                                                             5μl 
2mM dNTPs                                                            5μl 
50mM MgCl2                                                           2μl 
DMSO                                                                 2μl 
Primers                                                            1μl+1μl 
Taq Polymerase                                                       0.5μl 
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Distilled H2O was added up to 50μl of total volume. 
Bacterial colonies were picked up by sterilized tips and were transferred into each 
PCR tube independently. 
 
Table 2.4 PCR cycle conditions 
 Taq polymerase KOD polymerase Pfx 
polymerase 
Heated lid 105°C 105°C 105°C 
Denaturing 1 cycle 95°C    3 min 95°C     3 min 95°C   3 min 
Denaturing 30 cycles 95°C   40 sec 95°C    40 sec 95°C  40 sec 
Annealing 30 cycles 55°C   30 sec 60°C    30 sec 55°C  30 sec 
Extension 30 cycles 72°C  variable 70°C    variable 68°C variable 
Final 
extention 
1 cycle 72°C   2 min 70°C    2 min 68°C   2 min 
Hold Infinite 10°C 10°C 10°C 
Table 2.4 PCR conditions for different polymerase. Annealing temperature was 
altered according to different primers. A gradient of annealing temperature might be 
required for optimization. Annealing temperature was set to 55°C in the presence of 
5μl of 10X Enhancer Buffer provided for Pfx polymerase. Extension time was set up 
according to the length of the target fragment following the manufacturer’s 
instructions. The default extension rates for all polymerase were 1kb/min. 
2.4 Agarose Gel Electrophoresis 
2.4.1 Buffer Preparation 
Preparation of 50X TAE:                  6X Loading Buffer: 
Tris                  2M                Bromophenol Blue       0.25%(w/v) 
Glacial acetic acid     5.7% (v/v)          Xylene cyanole          0.25%(w/v) 
EDTA                0.3M              Glycerol                  50% (v/v) 
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1X TAE was made by diluting 20ml 50X TAE in 1000ml dH2O. 
2.4.2 Preparation of agarose gel 
To 100ml 1X TAE Buffer 0.8g-1.0g of agarose powder was added to make a 
0.8%-1.0% agarose gel. It was heated in the microwave untill the agarose was 
dissolved completely. When it cooled down to approximately 56°C, it was poured 
into a gel tray with a comb and sealed by tape. It was left for 20-30 min to solidify 
and put into a gel tank filled up with 1X TAE buffer. Then the DNA samples with 
loading dye (5:2) were loaded into the gel wells. The gel was usually run at 80V for 
75 min and stained with ethidium bromide (0.5μg/ml) for 15 min. Finally the gel 
photo was taken on an ultraviolet trans-illuminator. 
2.4.3 Gel extraction using QIAgen agarose gel extraction kit 
The desired DNA fragment could be excised from agarose gel with a sterile 
scalpel and transferred to a sterile pre-weighted Eppendorf tube. To 1 volume of the 
agarose gel (100mg~100μl), 3 volumes of Buffer QG was added. It was then 
incubated at 50°C for 10-15 min and mixed by inverting every 2-3 min until the gel 
slice was completely dissolved. Then 1 gel volume of isopropanol was added and 
mixed. The sample was transferred to a QIAquick spin column and centrifuged at 
14,000 xg for 1 min. The flow-through was discarded and 0.5ml of Buffer QG was 
added to the spin column to remove any residual agarose, followed by centrifugation 
for 1 min. The flow-through was discarded again and 0.75ml of Buffer PE was added 
to wash the sample. It was centrifuged for 1 min and the flow-through was discarded, 
followed by further centrifugation for 1 min to remove any further wash buffer. The 
spin column was then placed in a fresh Eppendorf tube and 50μl of Elution Buffer 
was added to the centre of the spin column, followed by centrifugation for 1 min to 
elute the desired DNA sample. 
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2.5 Restriction enzyme digestion 
All components were mixed together according to the manufacturer’s guidance. 
The sample was usually purified following the PCR purification protocol in 2.6. 
2.5.1 Standard reaction conditions: 
DNA samples          5μl-26μl (0.5-2μg) 
Restriction enzyme     1μl (10 units) 
10X Buffer             3μl 
dH2O was added up to 30ul of total volume. 
2.6 PCR purification using the QIAgen PCR purification kit 
Five volumes of Buffer PBI was added to the PCR sample and mixed by 
inversion. A QIAquick spin column was placed in a provided 2ml collection tube and 
the sample was applied to the QIAquick spin column, followed by centrifugation at 
15,000xg for 1 min. The flow-through was discarded and the column was placed 
back into the same collection tube. A volume of 0.75ml of Buffer PE was added to 
the column followed by centrifugation at 15,000xg for 1 min. The flow-through was 
discarded and the column was placed back into the collection tube followed by 
centrifugation for an additional 1 min. The column was placed in a sterile Eppendorf 
tube. A volume of 50μl of Buffer EB was added to the centre of the column 
membrane and it was left to stand for 1 min. To eluted DNA, the sample was 
centrifuged at 15,000xg for 1 min. 
 
2.7 Mini-preparation of plasmid DNA (using QIAgen plasmid extraction kit) 
Bacteria were cultured overnight in 10ml BHIB or LB broth with appropriate 
antibiotics at the appropriate temperature with shaking at 200 rpm. 
To harvest the cells, the samples were centrifuged at 1,600xg for 15 min to 
pellet the cells. The supernatant was discarded and the cell pellets were 
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resuspended in 250μl of Buffer P1. The sample was then transferred into a fresh 
Eppendorf tube and 250μl of Buffer P2 was added and mixed by inversion, 350μl of 
Buffer N3 was then added and gently mixed by inversion. 
The sample was centrifuged at 15,000xg for 10 min and a white pellet was 
formed at the bottom of the tube. The supernatant was transferred to the QIAprep 
spin column. To increase the concentration of the products, each spin column might 
contain supernatants from more than one tube (of the same sample). The sample 
was then centrifuged at 15,000xg for 1 min and the flow-through was discarded. A 
volume of 0.5ml of Buffer PB was added followed by centrifugation at 15,000xg for 1 
min and the flow-through was discarded. A volume of 0.75ml of Buffer PE was 
added followed by centrifugation at 15,000xg for 1 min and the flow-through was 
discarded. The sample was centrifuged for an additional 1 min to remove residual 
wash buffer. The QIAprep spin column was placed into a fresh Eppendorf tube, 50μl 
of Buffer EB (pre-warmed) was added to the centre of the column membrane and it 
was left to stand for 1 min. To elute plasmid DNA, the sample was centrifuged at 
15,000xg for 1 min. 
2.8 Ligation 
Purified PCR fragments and purified linearized plasmids with corresponding 
restriction sites on both ends can be ligated together using T4 DNA ligase according 
to the manufacturer’s guidance. A typical ligation reaction is shown in table 2.5. All 
samples and controls were incubated overnight at 15℃.  
Table 2.5 Ligation reaction and controls. 
 Ligation Reaction +Ligase Control No Ligase Control 
Linearized plasmid 100ng-200ng 100ng-200ng 100ng-200ng 
PCR fragment 50ng-100ng Null  Null 
Ligase Buffer 1.5μl 1.5μl 1.5μl 
T4 Ligase 1 unit 1 unit Null 
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dH2O Added up to 15μl of total volume 
Table 2.5 Ligation reaction conditions. T4 DNA ligase from Promega™ was used 
throughout the study. 
2.9 Preparation of competent cells 
E. coli strains (DH5α, CC118-λpir, etc.) were incubated overnight in 10ml broth 
culture with 200 rpm shaking at 37°C. 
1ml suspension of bacterial cells from the pre-culture was transferred into 
100ml of sterile fresh broth to make a 1:100 dilution. Then this culture was incubated 
at 37℃ with 200rpm shaking for approximately 2 hours until the OD600nm reached 
0.3 (approx. 4-7 x 10
7
 cfu/ml). The culture was collected into two 50ml plastic 
centrifuge tubes, chilled on ice for 15 min and it was then centrifuged at 1600xg for 
20 min at 4°C. The supernatant was discarded and the cell pellet was resuspended 
in 33ml (1/3 of the original volume) of RF1 solution. It was incubated on ice for 15 
min. The cell culture was then centrifuged at 1600xg for 20 min at 4°C.The cell pellet 
was then resuspended in 8ml (1/12.5 of the original volume) of RF2 solution and 
incubated on ice for 15 min. The cell suspension was then aliquoted (200μl or 400μl) 
into pre-chilled sterile Eppendorf tubes and stored at -80°C. 
2.12.1 Buffer Preparation 
RF1 solution 
100mM KCl                                0.745g of KCl in 100ml of dH2O 
50mM MnCl2                        0.99g of MnCl2·4H2O in 100ml of dH2O 
30mM Potassium acetate               0.295g of KCH3CO2in 100ml of dH2O 
10mM CaCl2                       0.147g of CaCl2·2H2O in 100ml of dH2O 
RF2 solution 
10mM MOPS                            0.21g of MOPS in 100ml of dH2O 
10mM KCl                                  75mg of KCl in 100ml of dH2O 
75mM CaCl2                        1.10g of CaCl2·2H2O in 100ml of dH2O 
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15% glycerol (v/v)                                 15ml in 100ml of dH2O 
2.10 Transformation 
A volume of 60-100μl of competent cells were added into sterile Eppendorf 
tubes, to each of which 200ng of plasmid DNA (or all 15μl of the ligation sample) 
was added and mixed by pipetting up and down. The sample was chilled on ice for 
30 min. It was then heat shocked in a 42°C water bath for 90 seconds. Then 1ml of 
sterile BHIB or LB broth was added into each tube and the sample was incubated at 
37°C for 60 min. Then 100μl of the sample was spread on LB agar plates with 
appropriate antibiotics and incubated overnight at 37°C. 
2.11 Bacterial conjugation 
Bacterial strains to be conjugated were pre-cultured overnight in 10ml broth 
culture with appropriate antibiotics at the appropriate temperature with shaking at 
200rpm. 
To harvest the cells, the samples were centrifuged at 1600xg for 15 min. The 
supernatants were discarded and the pellets were washed with 5ml sterile PBS. 
They were re-centrifuged and washed with 5ml PBS again. Then the samples were 
centrifuged at 1600xg for another 15 min and the supernatants were poured off. The 
cell pellets were resuspended in their own volume (supernatant left in the tube, 
around 0.3ml).The suspensions of the two conjugal bacterial strains (E. coli donor 
and A. hydrophila recipient) were mixed in a sterile Eppendorf tube. The mixed 
strains were pipetted onto a sterile 25mm diameter 0.45μm nitrocellulose filter disc 
placed on the CBA plate. 
The sample was incubated at 30°C for 6 hours. The filter disc was then 
removed and washed in a sterile universal tube with 3ml sterile PBS. Serial dilutions 
(10
-2
 and 10
-3
) were made and 100ul of each was spread onto LB agar plates with 
appropriate antibiotics. 
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2.11.1 Buffer preparation 
PBS  
Dissolve 5 PBS tablets (Sigma-Aldrich™) in 1L dH2O then autoclaved to sterilize, to 
generate 0.01M phosphate buffer (pH7.4), 0.0027M KCl and 0.137M NaCl. 
 
2.12 β-Galactosidase assay 
2.12.1 Buffer Preparation: 
Z-Buffer (final concentration of 1X) 
Na2HPO4 (0.06M)                                  16.1g of Na2PO4∙7H2O 
NaH2PO4 (0.04M)                                  5.5g of NaH2PO4∙H2O 
KCl (0.01M)                                                0.75g of KCl 
MgSO4 (0.001M)                                   0.24g of MgSO4∙7H2O 
dH2O                                               added up to 1000ml 
Final pH=7.0 
(β-Mercaptoethanol (0.05M), which is 270μl in 100ml of Z-Buffer, to be added 
on the day of experiment.) 
1L of Z-Buffer was made up and stored at 4°C. β-Mercaptoethanol was not 
added because it is very volatile and would evaporate upon storage at 4°C. 
 
1M Na2CO3                                                10.6g/100ml 
 
0.1% (w/v) SDS              Make up 1% (w/v) stock solution and dilute 10X 
 
Chloroform 
 
(5) ONPG (ortho-Nitrophenyl-β-galactoside)          4mg/ml in Z-Buffer with 
0.05M β-Mercaptoethanol, to be prepared on the day of experiment 
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2.12.2 Protocol of β-galactosidase assay: 
Bacterial strains containing the reporter plasmids in which the promoter of 
interest was fused to lacZ were incubated in 10ml broth culture overnight with 
appropriate antibiotics at appropriate temperature (for promoters that were thought 
to be activated on swarming agar, samples were cultured on swarming agar 
overnight first and then scraped into 1ml sterile PBS until the OD600nm was 0.3-0.7). 
Antibiotics with colour (e.g. Rifampicin) may not be added to avoid interference of 
absorbance reading. 
A 50μl suspension of the bacterial pre-culture was added into 5ml of BHI broth 
containing the appropriate antibiotics. For each strain, three tubes were prepared 
(cultured triplicate) and incubated in the shaker (200rpm) at the appropriate 
temperature. The OD was checked after approximately 3 hours at 600nm, every 15 
min, until they reached the OD600 0.3-0.7 for each tube. If any of them reached the 
OD before others, they were stored on ice to stop bacterial growth. 
In the meanwhile, ONPG solution containing the substrate of β-galactosidase 
was prepared. A volume of 54μl of mercaptoethanol was added to 20ml of Z-Buffer 
to make up a 0.05M solution, into 6ml of which, 24mg of ONPG was added to make 
a 4mg/ml ONPG solution. 
Two 13ml glass tubes (β-galactosidase assay tubes) were labelled for each 
sample and two controls contained only sterile broth culture with antibiotics (PBS 
only for bacteria that were cultured on swarming agar). Thus for one bacterial strain, 
there were 6 tubes, duplicates of the strains that had been grown in triplicates. 
A volume of 900μl of Z-Buffer containing Mercaptoethanol was added to each 
tube and then 30μl of chloroform was shot quickly into the buffer to make a dome at 
the bottom of the tube, to prevent quick evaporation of chloroform. Then 100μl of 
each bacterial culture that had reached the OD600 0.3-0.7 was added into each tube. 
The OD600 of the bacterial culture should be read again just before adding into the 
tubes. Then 30μl of 0.1% SDS was added to each tube and vortexed for 10 seconds 
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to permeabilize the cells. They were then incubated in the 30°C water bath for 15 
min and all the steps afterwards were carried out at 30°C. 
To each tube, 200μl of ONPG (4mg/ml) was added and vortexed for 3 seconds 
and each tube was treated the same in 30 sec intervals including the controls. A 
Timer was used to record the time when the substrate was added. 
When an appropriate yellow colour had developed, the reaction was stopped by 
adding 500μl of 1M Na2CO3 and mixed. The exact time of adding Na2CO3 was 
recorded as the stopping time. The stopping should be carried out in the same way 
as starting that all tubes were treated in 30 seconds intervals. 
The optical density of the samples were read at two wavelengths, 420nm and 
550nm.The two control tubes were used to set the reference for each of the two 
wavelengths. Absorbance at 420nm was the absorbance of the yellow 
O-nitrophenol. The absorbance at 550nm was the scatter of cell debris, when 
multiplied by 1.75; it approximated the scatter observed at 420nm. Thus OD550 was 
a light scattering factor for the contribution of the cells to the value at 420nm. The 
absorbance measured at 420nm should between 0.2-0.8 to be a significant value. 
Miller Unit was a standard to measure the activity of β-galactosidase in 
β-galactosidase assay. Miller Unit was calculated as: 
1 Miller Unit = 1000 x [OD420 - (1.75 x OD550)] / (Time x Volume x OD600) 
in which, time was the reaction time = (stopping time – starting time) in min. Volume 
was the volume of cells added into the glass test tubes in milliliters (i.e. 0.1ml). 
OD600 reflected the cell density. 
2.13 Oxidase test 
A small amount (around 1mg) of N,N,N’N,N-tetramethyl-p-phenylene diamine 
dihydrochloride was added to 1ml dH2O and pipetted onto a filter disc. Colonies 
were picked up by either a tip or a toothpick stick and then scratch on the filter disc. 
If the colony turned purple instantly (within 5 seconds), it indicated that this bacterial 
colony was oxidase positive (e.g. Aeromonas spp.). Otherwise it indicated that the 
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colony was oxidase negative (e.g. E. coli). 
 
2.14 Protein Overexpression 
The E. coli protein expression strain containing the plasmid of interest was 
incubated overnight in 10ml LB broth with appropriate antibiotics and 1% (w/v) filter 
sterilized glucose. On the next day, it was transferred into 1L of LB broth with 
appropriate antibiotics and 1% (w/v) filter-sterilized glucose. It was then incubated at 
37°C for approximately 2 hours until the OD600 was around 0.2. At this point, 
0.3mM-1mM IPTG was added to induce the protein expression. After 2-3 hours 
incubation, the cells were harvested by centrifugation at 8,000xg for 15 min at 4°C. 
The pellet was resuspended in Binding Buffer and frozen overnight at -20°C. It was 
then sonicated using Jencons Vibracell at 20 kHz (20% amplitude) for 8x 20sec with 
1 min intervals on ice. The sonicated sample was then centrifuged at 30,000xg for 
30 min at 4°C to separate soluble and insoluble proteins. After sonication, the 
supernatant that contained soluble proteins was transferred into a fresh universal 
tube while the pellet left in the centrifuge tube and both were stored at -20°C. 
2.14.1 Buffer Preparation 
Binding Buffer (1L) 
10mM Imidazole                         5ml of 2M imidazole stock solution 
500mM NaCl                                                      30g 
5% (v/v) Glycerol                                                  50ml 
20mM Phosphate Buffer                    200ml of 0.1M Phosphate Buffer 
 
Phosphate Buffer stock (1L) 
0.2M NaH2PO4·H2O                                     27.6g in 1L dH2O 
0.2M of Na2HPO4·7H2O                                 53.6g in 1L dH2O 
Mix 95ml of 0.2M NaH2PO4·H2O and 405ml of 0.2M of Na2HPO4·7H2O, and 
500ml dH2O was added to make 1L 0.1M Phosphate Buffer 
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1M IPTG stock                                     2.38g in 10ml of dH2O 
 
2.15 Polyacrylamide Gel Electrophoresis (PAGE) 
Table 2.6 SDS-PAGE Gel components. 
Resolving Gel (Pour first) 
%Gel Acrylamide 
(30% w/v) 
Lower Tris 
1.5M pH 8.8 
H2O TEMED AP (10% 
w/v) 
SDS (10% 
w/v) 
5 1.65ml 2.5ml 5.65ml 5µl 100µl 100µl 
10 3.3ml 2.5ml 4.0ml 5µl 100µl 100µl 
12 4.0ml 2.5ml 3.3ml 5µl 100µl 100µl 
14 4.66ml 2.5ml 2.64ml 5µl 100µl 100µl 
15 5.0ml 2.5ml 2.3ml 5µl 100µl 100µl 
 
Stacking Gel (Pour last) 
Acrylamide 
(30% w/v) 
Upper Tris 0.5M 
pH 6.8 
H2O TEMED AP (10% 
w/v) 
SDS (10% 
w/v) 
1.3ml 2.1ml 4.4ml 17 µl 100 µl 100µl 
Table 2.6 SDS-PAGE Gel components. The percentage of resolving gel used was 
dependent upon the expected size of the protein sample. The smaller the size of the 
protein, the higher percentage of resolving gel was used. 
 
The protein samples were prepared by boiling with 1X Laemmli Buffer at 100°C 
for 10 min, followed by chilling on ice for 2 min and centrifuged for 5 min. To each 
well of SDS-PAGE gel, 10-15µl of the sample was loaded. The gel was run at 160V 
for 100 min in 1X SDS Running Buffer. The gel was stained with Coomassie Blue 
Stain Solution overnight and then destained with Destain Solution until the bands 
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were visible. 
2.15.1 Buffer Preparation 
Upper Tris (0.5M pH 6.8)                           19.7g in 250ml of dH2O 
 
Lower Tris (1.5M pH 8.8)                          45.43g in 250ml of dH2O 
 
Laemmli Buffer 
62.5mM Tris (pH 6.8) 
2% (w/v) SDS 
5% (v/v) β-Mercaptoethanol 
10% (v/v) Glycerol 
0.02% (w/v) Bromophenol Blue 
 
10X SDS Running Buffer 
250mM Tris-Base                                       30.2g in 1L dH2O 
1.92M Glycine                                          144g in 1L dH2O 
1% (w/v) SDS                                            10g in 1L dH2O 
 
Coomassie Blue Stain Solution (1L) 
500ml Methanol 
2.5g Coomassie Blue 
100ml Acetic acid 
dH2O added up to 1L 
 
Destain Solution (1L) 
400ml Methanol 
100ml Acetic acid 
dH2O added up to 1L 
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2.16 Histidine-tagged Protein Purification Protocol  
2.16.1 Column Preparation 
The 1ml HisTrap HP Column (GE Healthcare™) was washed first with 5ml 
dH2O using the syringe with luer adaptor. Then the syringe was filled with 0.5ml of 
provided 0.1M nickel salt solution (NiSO4) and loaded onto the column. Finally the 
column was washed with 5ml dH2O again to remove any air trapped inside. 
2.16.2 Purification protocol 
Sonicated samples were taken out from the -20°C freezer, if the desired protein 
was insoluble, it was first dissolved in Binding Buffer supplied with 8M Urea. Then 
the sample was first prepared by filtration through a 0.45μm filter to remove any 
debris. 
When the column was prepared according to 2.16.1 column preparation, it was 
equilibrated with 10ml Binding Buffer using the syringe. Then the protein sample 
was loaded onto the column and the flow-through (FT) was collected. Any 
Histidine-tagged proteins should now be bound to the nickel ions in the column. The 
column was then washed with 10x column volumes of Binding Buffer and the wash 
fraction was collected as well.  
The His-tagged protein was then eluted with 5ml Binding Buffer with increasing 
imidazole concentration (20mM to 500mM) and the elutant was collected in 1ml 
fractions. All fractions were checked by SDS-PAGE, including the flow-through and 
the wash fractions. 
After the protein elution, the column was regenerated by washing with 10ml 
Binding Buffer and could be used to purify the same protein to avoid 
cross-contamination. 
2.16.3 Buffer Preparation 
8M Urea Buffer                              48g in 100ml of Binding Buffer 
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2M imidazole stock                 6.8g in 50ml dH2O and Buffered to pH7.8 
2.17 Protein Purification for MBP-tagged proteins 
The over-expression and purification of MBP-tagged proteins was performed 
according to the pMAL™ Protein Fusion and Purification System manual (New 
England BioLabs™). The IPTG induced cell culture was harvested follow 2.14 
protein expression protocol but resuspended in 25ml of Column Buffer instead. 
The 1ml MBPTrap HP columns supplied from GE Healthcare™ was first 
prepared by washing with 10 column volumes (10ml) of Column Buffer. When the 
MBP-tagged protein sample was sonicated and centrifuged, the supernatant which 
contained the fusion protein was loaded on the column and the flow-through (FT) 
was collected. The column was then washed with 15ml Column Buffer and the wash 
fraction was collected as well. Then the fusion protein was eluted with Column 
Buffer + 10mM maltose and 10 fractions of 1ml aliquots were collected. All fractions 
including the flow through and the wash were checked by SDS-PAGE. Finally the 
column was regenerated by washing with 10ml Column Buffer. 
2.17.1 Buffer Preparation 
Column Buffer (1L) 
20mM Tris-HCl (pH7.4)                           20ml of 1M Tri-HCl pH7.4 
200mM NaCl                                                     11.7g 
1mM EDTA                                           2ml of 0.5M EDTA 
1mM sodium azide                                1ml of 1M sodium azide 
10mM β-mercaptoethanol                                          0.7ml 
 
1M Tris-HCl pH7.4            31.52g in 200ml of dH2O and buffered to pH7.4 
 
0.5M EDTA                    3.72g in 20ml of dH2O and buffered to pH8.0 
 
1M sodium azide                                   0.65g in 10ml of dH2O 
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10mM Maltose                            0.36g in 100ml of Column Buffer 
 
2.18 Western Blot 
After SDS-PAGE, one of the two duplicate gel was stained with Coomassie as 
usual while the other one was soaked in 1X Transfer Buffer for 15 min in a square 
15cm petri dish with enough buffer to cover the gel, to remove any SDS left on the 
gel. Then the blotting cassette (Bio-Rad™) together with 4 filter paper and 1 
nitrocellulose membrane (Geneflow™ 0.45μm pore size) of similar size with the gel 
were soaked in 1X Transfer Buffer for 15 min as well. Then the blotting cassette was 
set up and any air bubble was removed. It was then put into a tank filled up with 1X 
Transfer Buffer and run at 10V overnight (or 60V for 1hour) with stirring. The 
cassette should be put in the direction that the electrons passed from the gel 
towards the membrane to allow blotting. 
On the next day, the membrane was taken out and the pre-stained ladder 
should have transferred onto the membrane. The membrane was then soaked in 
20ml of PBS + 5% (w/v) dry skimmed milk powder (Marvel™) for 1hour (or overnight) 
to block any non-specific binding sites. After blocking, the membrane was washed 
10 min in 20ml PBS Buffer with 0.1% v/v Tween20 (PBST). Then 10μl (1:2000) of 
primary antibody was added to 20ml of PBST + 5% milk, in which the membrane 
was soaked for 1 hour. After primary antibody binding, the membrane was washed 3 
times 10 min in 20ml PBST Buffer. Then the membrane was probed with 20ml PBST 
+ 5% milk with 5μl secondary antibody (1:4000) for 1 hour. After secondary antibody 
binding, the membrane was washed 3 times 10 min in 20ml PBST Buffer again and 
was ready for developing.  
Pierce™ ECL Western Blotting Substrate (Thermo Scientific™) was used to 
develop the membrane. 1ml of Solution I was mixed with 1ml of Solution II and 
poured evenly on the membrane. Then the western blot photo was taken using 
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Chemidoc™ XRS+ System (Bio-Rad™). 
2.18.1 Buffer Preparation 
10X Transfer Buffer (1L) 
Glycine                                                          144g 
Tris-Base                                                        30.2g 
dH2O added up to 1L 
 
PBST Buffer 
10mM PBS Buffer                                                   1L 
Tween 20                                                    0.1% (v/v) 
 
2.19 Far-Western Blot 
Far-Western blotting was based on Western Blot and used to investigate 
protein-protein interactions. After blocking, the membrane was probed with a 
non-antibody protein with a different fusion tag as the loaded proteins. The 
membrane was probed for 1 hour followed by 3 times 10 min wash with PBST Buffer. 
Then the membrane was then incubated with the primary antibody against the 
probing protein for 1 hour followed by 3 times 10 min wash with PBST Buffer. Then 
the secondary antibody binding and developing were carried out the same way as 
the standard Western Blot in 2.18. 
 
2.20 Bacterial Adenylate Cyclase Two-Hybrid (BACTH) Assay 
The BACTH Assay was carried out using the Euromedex™ BACTH System Kit. 
The target genes were first cloned into the BACTH plasmids in frame with either T25 
or T18 fragments of the cyaA gene at the 5’ or 3’ end of the gene of interest (See 
Table 2.2 plasmids used in this study), to allow co-expression of fusion proteins. 
Then one of the T25 derived plasmid constructs was co-transformed with a T18 
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derived plasmid construct into E. coli BTH101 reporter competent cells and 
incubated on MacConkey/maltose agar for 2 nights at 30°C.  
When the two proteins of interest interacted with each other, heterodimerization 
of the fusion proteins allowed the complementation of the T25 and T18 fragments to 
form a catalytic domain of adenylate cyclase (CyaA), thus cAMP was synthesized. 
Then the mal operon was activated by cAMP/CAP complex. Therefore the maltose 
metabolism pathway was switched on in the E. coli BTH101 reporter strain, which 
allowed the fermentation of maltose and the production of acid that turned the pH 
indicator in MacConkey agar pink. Therefore positive interaction colonies were 
pink/red in colour whereas negative colonies were white.  
2.20.1 Media Preparation 
MacConkey agar 
MacConkey agar base (Difco™)                            40g in 1L dH2O 
Dissolved and autoclave sterilized. Components below were added when it was 
cooled down to approximately 56°C. 
1% (w/v) maltose                               50ml of 20% (w/v) maltose 
0.5mM IPTG                                           0.5ml of 1M IPTG 
Ampicillin (100μg/ml)                          1ml of ampicillin (100mg/ml) 
Kanamycin (50μg/ml)                          1ml of kanamycin (50mg/ml) 
 
2.21 Isothermal Assembly (ISA) 
The ISA was used to assemble multiple DNA fragments into one plasmid vector 
in a single reaction. Each fragment assembled in this reaction should have an 
approximately 30bp adapter sequence overlapping each other. Then the fragments, 
which were equal-molar when added, were mixed together with ISA Buffer and three 
enzymes: T5 exonuclease, Phusion polymerase and Taq ligase. Then it was 
incubated at 50°C overnight and transformed into E. coli DH5α to select desired 
resistance. 
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2.21.1 5X ISA Buffer (1ml) 
1M Tris-HCl pH 7.5                                                500μl 
2M MgCl2·6H2O                                                   25μl 
100mM dATP                                                      10μl 
100mM dTTP                                                      10μl 
100mM dCTP                                                     10μl 
100mM dGTP                                                     10μl 
1M DTT                                                          50μl 
PEG-8000                                                      0.25gμl 
100mM NAD                                                      50μl 
dH2O                                                            335μl 
 
2.21.2 ISA reaction (5 tubes) 
5X ISA Buffer                                                      20μl 
Diluted (8X, 1μl to 7μl of 1X ISA Buffer) T5 exonuclease                0.5μl 
Phusion Polymerase                                              1.25μl 
Taq Ligase                                                        10μl 
dH2O                                                           43.3μl 
Then aliquot into 5x 15μl in each reaction 
 
2.22 Statistics 
The statistical analysis carried out in this study was using Microsoft™ Excel 2010 
and GraphPad™ Prism 5, in which Student’s t-test and One-way ANOVA were used 
to determine the significance of the data. 
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2.23 Software and website 
Apart from the statistical software, other software and websites were used in this 
study. For example, SnapGene® was used to illustrate DNA maps and design 
primers; FinchTV® was used to display DNA sequencing traces; BLAST® was used 
in sequencing and gene mapping; NEBcutter (V2.0) was used to determine 
restriction sites. 
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Chapter 3  
Regulation of Type III Secretion 
System 
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3.1 Introduction 
The Type III secretion system has been reported in many Gram-negative 
bacteria such as Yersinia spp., Pseudomonas spp., Vibrio spp., Salmonella spp. 
and Shigella spp. (Cornelis et al 1998, Cornelis & Van Gijsegem 2000, Galan & 
Collmer 1999, Park et al 2004, Yahr et al 1997). Unlike Type I, Type II or Type V 
secretion systems, T3SS is known to inject protein effectors across the plasma 
membrane directly into host cell cytosol or to secrete translocators that help effector 
proteins to get through (Cornelis & Van Gijsegem 2000). The T3SS was not reported 
in Aeromonas spp. until 2002, when Burr and colleagues first identified seven open 
reading frames that encoded homologues of Yersinia T3SS in Aeromonas 
salmonicida (Burr et al 2002). Later on, the T3SS was found to be present in more 
Aermonas species, in most of which the gene cluster that encoded T3SS was 
located on a single chromosomal region like in Pseudomonas spp., except for A. 
veronii which had two distant T3SS gene clusters on its single chromosome 
(Chacon et al 2004, Makino et al 2003, Yu et al 2004). 
 
Similar to P. aeruginosa, previous evidence has shown that the T3SS in A. 
hydrophila was also under control of the master regulator ExsA (Vilches et al 2009, 
Yahr & Wolfgang 2006). Moreover, ExsA in A. hydrophila shares 76% amino acid 
homology with ExsA in P. aeruginosa, both of which belong to AraC family of 
transcriptional activators (Frank & Iglewski 1991, Yahr & Frank 1994). Like ExsA in P. 
aeruginosa, ExsA in A. hydrophila is also thought to recognize a specific DNA 
sequence (TNAAAANA), which is shared in all promoter regions of the T3SS gene 
cluster (Vilches et al 2004). This consensus sequence that recruits ExsA is normally 
found 15 bp upstream of the -35 RNA polymerase binding site in P. aeruginosa 
(Hovey & Frank 1995). Similar strategies were utilized in this project to identify 
promoters of the T3SS in A. hydrophila. 
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Further evidence in P. aeruginosa has shown that the T3SS master regulator 
ExsA is controlled by a regulatory cascade of proteins ExsD, ExsC and ExsE 
(Dasgupta et al 2004, McCaw et al 2002, Rietsch et al 2005, Urbanowski et al 2005, 
Zheng et al 2007). ExsD is reported to be an anti-activator protein that negatively 
regulates the T3SS master regulator ExsA through direct protein-protein interaction 
(McCaw et al 2002). ExsC is an anti-anti-activator protein that binds to ExsD and 
stop it from inhibiting ExsA (Dasgupta et al 2004). Also, ExsC is reported to be the 
chaperone protein for the small secreted protein ExsE, which is found to be a 
negative regulator of the T3SS (Rietsch et al 2005). ExsE negatively regulates the 
T3SS via its physical interactions with ExsC, preventing ExsC from binding to ExsD, 
thus allowing ExsD to be free to bind and inhibit the transcriptional activation from 
ExsA (Urbanowski et al 2005). 
 
A previous study in our laboratory investigating the lateral flagella system of A. 
hydrophila discovered several mutants using a transposon library screen that were 
inhibited for swarming motility. Two of the non-swarming transposon mutants were 
discovered to be mutated in the exsD gene that encodes one of the regulators of the 
A. hydrophila T3SS. This finding correlated with the work of the Leung laboratory in 
Singapore who had suggested regulatory cross-talk between the aeromonad T3SS 
and the lateral flagella system (Yu et al 2007). As very little is known about the 
regulatory cascade of the aeromonad T3SS or indeed its potential role in regulating 
the lateral flagella system, this project was undertaken. 
 
3.2 Construction of an exsC mutant 
The aim of these experiments was to produce insertional knockouts of the 
potential regulatory components of the A. hydrophila T3SS. Since the exsA mutant 
had already been created in the lab previously (Shaw, unpublished), an exsC 
mutant was the first to be constructed. 
74 
In order to facilitate a knockout in the exsC gene, a selectable marker was 
inserted in the middle of the exsC gene. This is achieved by PCR amplification using 
Pfx DNA polymerase with exsC forward and reverse internal primers (Appendix 1) 
on the template pBBexsCEB plasmid, obtained from laboratory collection (Shaw, 
unpublished) (Figure 3.1 A). The size of exsCEB region was 1080bp and the two 
inverse primers were located adjacent to each other near the middle of the exsC 
gene, but pointing different orientations, to allow PCR amplification of the full 
plasmid (5964bp). After PCR amplification, the exsCEB region was divided into two 
parts centred within the exsC gene, one was 249bp while the other one was 831bp. 
Thus the plasmid was opened up to allow a blunt-end insertion (Figure 3.1 B). The 
PCR product was checked by agarose gel electrophoresis (Figure 3.2).  
 
In order to provide the kanamycin resistance cassette for the insertional 
mutagenesis, the plasmid pUC4KIXX was digested with the restriction enzyme 
SmaI. This resulted in a blunt end DNA fragment of 1.4kb that contained the 
kanamycin resistant cassette. This was separated on a 1% agarose gel from the 
plasmid backbone and purified by gel extraction (Figure 3.3).  
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Figure 3.1 Depiction of the inverse PCR of pBBexsCEB using primers exsC internal 
forward and exsC internal reverse. A, plasmid map of pBBexsCEB and the exsC 
internal primers (shown in purple) located near the middle of exsC gene. B, linearized 
pBBexsCEB with a blunt-end insertional site sitting internal of exsC to allow insertion of 
an antibiotic resistance selectable marker. Key features of the plasmid construct were 
shown in arrows. The exsC, exsE and exsB genes were shown in grey boxes. Created 
using SnapGene® software.  
A. 
B. 
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Figure 3.2 A 1% agarose gel showing the PCR product of pBBexsCEB with primers 
exsC internal forward and reverse, using Pfx DNA polymerase. Lane 1, Q-step 4 
quantitative DNA ladder (Yorkshire Bioscience). Lane 2 and 3, two independent PCR 
products of linearized pBBexsCEB (~6kb), amplified with exsC internal primers. 
Figure 3.3 A 1% agarose gel showing the 1.4kb gel extracted kanamycin resistance 
cassette from pUC4KIXX. Lane 1, Q-step 4 quantitative DNA ladder (Yorkshire 
Bioscience). Lane 2 and 3, two independent KmR cassettes (~1.4kb) obtained by 
digesting pUC4KIXX plasmid with SmaI restriction enzyme, followed by gel extraction. 
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As the pBBexsCEB PCR product had been amplified using Pfx DNA 
polymerase, that had resulted in the production of blunt ends, this allowed its 
ligation to the SmaI generated 1.4kb Km
R
 resistance cassette. The ligation was 
transformed into E. coli DH5α and a number of colonies were isolated that were 
kanamycin resistant from the Km
R 
cassette and Chloramphenicol resistant from the 
plasmid backbone. 
 
However it was essential to check the orientation of Km
R
 insertion in these 
potential clones as it should be the same orientation as the exsCEB operon to avoid 
polar effects. The constructed plasmid pBBexsCKm
R
 was sequenced and checked 
on agarose gel, which shows an expected band of 7.3kb (Figure 3.4).  
 
Then the exsCEB::Km
R
 fragment was excised from pBBexsCKm
R
 by digestion 
with the BamHI restriction enzyme, as BamHI sites were located upstream and 
downstream of the exsCEB fragment. This was subsequently ligated into 
BamHI-digested suicide plasmid pKNG101 to construct pKNGexsCKm
R
. The E. coli 
competent cell CC118-λpir was used to select the constructed suicide plasmid 
pKNGexsCKm
R
 (Figure 3.5). Then the constructed suicide plasmid was transformed 
into E. coli S17-1-λpir donor cells in order for conjugation with A. hydrophila AH3R 
strains to allow allele exchange. After conjugation, a double crossover event was 
selected by picking up colonies that were streptomycin sensitive and kanamycin 
resistant, since the streptomycin resistance gene was carried by the suicide plasmid 
backbone. The putative mutants were checked by PCR screening using exsC 
amplification primers (Appendix 1) and Taq DNA polymerase  (Figure 3.6). The 
expected size of the PCR screening product should be around 2kb, which was 
comprised of 1.4kb kanamycin resistance cassette and 600bp of exsC amplification 
product. The PCR screening products were sent for sequencing provided by Core 
Genomic Facility, University of Sheffield. The sequencing results were viewed using 
FinchTV and analysed using BLAST search to ensure correct orientation of Km
R
 
insertion and double crossover of the exsC knockout.  
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Figure 3.4 A 1% agarose gel showing plasmid construct of pBBexsCKmR. Lane 1, the 
plasmid construct of pBBexsCKmR (~7.3kb). Lane 2, Promega™ Supercoiled DNA 
Ladder (2-10kb).  
Figure 3.5 A 1% agarose gel showing plasmid construct of pKNGexsCKmR. Lane 1-3, 
independent isolations of plasmid pKNGexsCKmR (~9kb), while lane 3 was a possible 
dominant dimer of the plasmid; Lane 4, Promega™ Supercoiled DNA Ladder (2-10kb). 
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Figure 3.6 A 1% agarose gel showing PCR screening of potential exsC mutants. Lane 
1-4, PCR screening products exsC:KmR (~2kb), amplified from both pKNGexsCKmR 
positive control (lane1) and from potential exsC mutant chromosomal DNA (lane 2-4); 
Lane 5, Q-step 4 quantitative DNA ladder (Yorkshire Bioscience). 
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3.3 Construction of the exsD and exsE- mutants 
After the mutagenesis of exsC, the construction of exsD and exsE mutants 
were carried out following the same protocol but after several attempts no 
successful suicide vector constructs were obtained. Thereby another mutagenesis 
method, Isothermal Assembly (ISA), also known as Gibson assembly, was utilized 
to construct the exsD and exsE mutants. 
 
ISA required three DNA fragments and one digested plasmid for the assembly, 
in which exsD was amplified by PCR into two fragments using primers exsD F1 
forward/reverse and exsD F2 forward/reverse (Appendix 1), each containing 
adapter sequence overlapping with the plasmid or the kanamycin cassette (Figure 
3.7 and Figure 3.8). The kanamycin cassette was amplified by PCR from plasmid 
pJMK30 using Pfx DNA polymerase and primers Kan forward/reverse (Appendix 1), 
while the plasmid pGEM-3Zf(+) was digested with the restriction enzyme HincII 
(Figure 3.9). The fragments were then assembled together following the ISA 
protocol described in section 2.21. After transformation, ampicillin and kanamycin 
resistant E.coli DH5α colonies were selected to harvest the plasmid construct 
pGEMexsDKm
R
, while pGEMexsEKm
R
 was assembled in the meantime using the 
same method (Figure 3.10). The expected size of the exsD ISA products cloned in 
the plasmid was 5.4kb, which was comprised of 3.2kb pGEM-3Zf(+) plasmid vector, 
1.4kb of kanamycin resistance cassette and 800bp of both exsD fragments. Then 
the exsD::Km
R
 fragment was extracted from the pGEMexsDKm
R
 constructs by PCR 
using Pfx DNA polyermase with exsD_pGEM forward and exsD_pGEM reverse 
primers (Appendix 1) (Figure 3.11). A similar PCR amplification was carried out to 
obtain the exsE::Km
R
 fragment. Pfx DNA polymerase was used with primers 
exsE_pGEM forward and exsE_pGEM reverse primers on the plasmid construct 
pGEMexsEKm
R
 (Figure 3.11). Both PCR fragments of exsD::Km
R
 and exsE::Km
R
 
were blunt-end and were ready to ligate into SmaI-digested suicide plasmid 
pKNG101 (Figure 3.11).   
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Figure 3.7 Illustration of Isothermal Assembly to construct pGEMexsDKmR plasmid. 
PCR fragments of 460bp for 5’ exsD (fragment 1, amplified by exsD F1 forward/reverse 
primers), 350bp for 3’ exsD (fragment 2, amplified by exsD F2 forward/reverse primers) 
and 1.4kb of the kanamycin resistance cassette from pJMK30 were mixed together with 
the HincII-digested pGEM-3Zf(+) plasmid using Isothermal Assembly. Each fragment 
was designed to contain a 30bp adapter sequence overlapping each other. Key features 
of the plasmid were shown in arrows while primers were shown in purple. Created using 
SnapGene software.  
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Figure 3.8 A 1% agarose gel showing PCR amplification of exsD fragments and exsE 
fragments for ISA. Lane 1, Q-step 4 quantitative DNA ladder (Yorkshire Bioscience); 
Lane 2, 3’ fragment of exsD amplified by exsD F2 forward/reverse primers (360bp); 
Lane 3, 5’ fragment of exsD amplified by exsD F1 forward/reverse primers (460bp); 
Lane 4, 3’ fragments of exsE amplified by exsE F2 forward/reverse primers (600bp); 
Lane 5, 5’ fragment of exsE amplified by exsE F1 forward/reverse primers (500bp).  
Figure 3.9 A 1% agarose gel of kanamycin cassette and linearized pGEM-3Zf(+). A, 
kanamycin resistance cassette amplified from pJMK30 using Kan1 forward/reverse 
primers (1.4kb); B, linearized pGEM-3Zf(+) resulted from digestion with HincII restriction 
enzyme.  
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Figure 3.10 A 1% agarose gel of ISA constructs isolated after transformation and 
propagated in E. coli DH5α. Lane 1 and 2, two independent isolates of pGEMexsDKmR; 
Lane 3, Promega™ Supercoiled DNA Ladder (2-10kb); Lane 4 and 5, two independent 
isolates of pGEMexsEKmR. 
Figure 3.11 A 1% agarose gel of PCR fragments isolated after amplification from 
pGEMexsDKmR and from pGEMexsEKmR together with SmaI-digested pKNG101. Lane 
1 and 2, two independent PCR products of exsD:KmR from pGEMexsDKmR using 
primers exsD_pGEM forward and exsD_pGEM reverse (2.2kb); Lane 3 and 4, two 
independent PCR products of exsE:KmR from pGEMexsEKmR using primers 
exsE_pGEM forward and exsE_pGEM reverse (2.5kb); Lane 5, SmaI-digested 
pKNG101 (6.8kb). 
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After ligation, the samples were transformed into competent cells of E. coli 
CC118-λpir to select both kanamycin resistant and streptomycin resistant colonies, 
which was carried by the plasmid backbone. The plasmid constructs 
pKNGexsDKm
R
 and pKNGexsEKm
R
 were then harvested from those isolates by 
mini-prep (Figure 3.12). Once the suicide plasmids pKNGexsDKm
R
 and 
pKNGexsEKm
R
 were constructed, they were transformed into E. coli donor cell 
S17-1-λpir and then conjugated into A. hydrophila AH3R to allow allele exchange 
(Figure 3.13). After conjugation, the transconjugants were incubated on LB agar 
with rifampicin and kanamycin. Each colony was then patched onto replica plates, 
one with rifampicin and kanamycin, while the other one with kanamycin and 
streptomycin. The ones that were rifampicin and kanamycin resistant but 
streptomycin sensitive were potential exsD mutant or exsE mutant. 
 
The chromosomal DNA of these potential exsD mutants were then extracted 
and used as templates for PCR screening using Taq DNA polymerase with exsD F1 
forward and exsD F2 reverse primers. The expected size of the wild type was 
approximately 800bp, which was solely the size of the exsD fragment, while the 
expected size of a double crossover or allelic exchange mutant should be 2.2kb, 
with an extra 1.4kb of the kanamycin resistance cassette (Figure 3.14). The same 
PCR screening was carried out on potential exsE mutant chromosomal DNA using 
Taq DNA polymerase with exsE F1 forward and exsE F2 reverse primers. The 
expected size of the double crossover should be 2.5kb with additional kanamycin 
resistance cassette (Figure 3.15). The PCR screening of a single crossover might 
result in multiple bands due to the integration of the whole suicide plasmid construct 
into the A. hydrophila AH3R chromosome, however only the size of the exsD or 
exsE fragment by itself was normally shown due to the limit of elongation time 
during PCR screening. The PCR screening products of double crossovers were 
sent for sequencing provided by Core Genomic Facility, University of Sheffield. The 
sequencing results were analyzed by FinchTV and BLAST search to double check 
the insertional knockout of the exsD and exsE genes.  
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Figure 3.12 A 1% agarose gel showing suicide plasmid constructs pKNGexsDKmR and 
pKNGexsEKmR harvested from kanamycin and streptomycin resistant E. coli 
CC118-λpir cells. A. suicide plasmid construct pKNGexsDKmR (9kb), comprised of 
exsD:KmR (2.2kb) and SmaI-digested pKNG101 (6.8kb); B, suicide plasmid construct 
pKNGexsEKmR (9.3kb), comprised of exsE:KmR (2.5kb) and SmaI-digested pKNG101 
(6.8kb). 
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Figure 3.13 A diagrammatic representation of allelic exchange between the suicide 
vector construct pKNGexsDKmR and the exsD gene on the chromosome of A. 
hydrophila AH3R following conjugation of suicide plasmid from E. coli S17-1-λpir into 
the Aeromonas cells. Potential double crossover mutants were selected by replica 
plating. Each colony was patched on two LB agar plates, one with kanamycin and 
rifampicin and the other one with kanamycin and streptomycin. Those that were 
streptomycin sensitive were taken for further investigation. Key features of the plasmid 
vector were shown in red arrows, while the exsA gene, exsD gene and the KmR 
cassette were shown in grey arrows. The figure was created using SnapGene® 
software.   
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Figure 3.14 A 1% agarose gel showing PCR screening of potential exsD mutants. Lane 
1, the PCR screening product of an aeromonad trans-conjugant that has a potential 
double crossover. The size of the band consisted of the size of exsD fragment (800bp) 
and the kanamycin cassette (1.4kb); Lane 2, Q-step 4 quantitative DNA ladder 
(Yorkshire Bioscience); Lane 3, the PCR screening product of a potential single 
crossover, only the size of the exsD fragment was shown (800bp) due to the limit of 
elongation time during PCR screening. 
Figure 3.15 A 1% agarose gel showing PCR screening of potential exsE mutants. Lane 
1, the PCR screening product of an aeromonad trans-conjugant that has a potential 
single crossover, only the size of exsE fragment on its own was shown (1.1kb); Lane 2, 
the PCR screening product of an aeromonad trans-conjugant that has a potential 
double crossover with an additional 1.4kb of the kanamycin resistance cassette.   
88 
3.4 β-Galactosidase assays for the T3SS promoter activity 
The putative promoter regions of the T3SS from A. hydrophila AH3R were 
previously cloned into broad host range promoter probing plasmid pKAGb-2(-) to 
fuse with the promoter-less lacZ gene in order to measure the promoter activity by 
β-galactosidase assays (Shaw, unpublished). Some of the putative promoter 
regions were predicted by searching for the specific ExsA binding site TNAAAANA 
among the T3SS regulon (Hovey & Frank 1995, Vilches et al 2004). As a result, a 
total of 5 putative promoter regions of the A. hydrophila AH3R T3SS were cloned 
into the pKAGb2(-) and were conjugated independently into the constructed A. 
hydrophila exsA, exsC, exsD, exsE mutants and the AH3R wild type strain. Each 
promoter region cloned was 400-800bp in length and was named as PascN, PaopN, 
PexsC, PexsA and PexsD, after the first gene immediately downstream of the 
putative promoter (Figure 3.16). 
 
Once the individual reporter plasmids were conjugated into A. hydrophila AH3R 
cells, the promoter activities were measured through the β-galactosidase assay for 
each strain. Before measuring the β-galactosidase activities of the A. hydrophila 
T3SS promoters in different mutant backgrounds, the conditions in which the 
bacteria were cultured were optimized in the A. hydrophila AH3R wild type strain. It 
was suggested by Vilches and colleagues that the addition of 20mM MgCl2 and 
10mM EGTA to the media was the optimal inducing condition for the expression of A. 
hydrophila T3SS (Vilches et al 2009). However, in order to determine the effect of 
MgCl2 and EGTA on the A. hydrophila T3SS promoter activities, the promoter 
activities were still measured in both inducing and non-inducing conditions, to which 
no MgCl2 or EGTA was added (Figure 3.17). 
 
The β-galactosidase activity of PascN in A. hydrophila AH3R wild type strain 
grown in non-inducing conditions was 808 MU while the activity was 2098 MU when 
grown with additional MgCl2 and EGTA. The promoter activity of PascN in inducing 
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condition was a significant increase compared to the activity in non-inducing 
condition (p<0.001) (Figure 3.17). However, when promoter PaopN was assayed, 
the β-galactosidase activities for non-inducing condition and inducing condition were 
2357 MU and 1470 MU respectively. The promoter activity of PaopN assayed in 
inducing condition was significantly lower than in non-inducing condition (p<0.01). A 
similar discovery was found for promoter PexsA, of which the promoter activity 
assayed in inducing condition was significantly lower than in non-inducing condition 
(p<0.001). The promoter activity of PexsA in non-inducing condition was 10066 MU 
while the activity was 7377 MU in inducing condition (Figure 3.17). However, the 
promoters PexsC and PexsD showed no significant difference when assayed in 
either inducing condition or non-inducing condition (Figure 3.17). The promoter 
activity of PexsC was 352 MU in non-inducing condition while it was 418 MU in 
inducing condition. The activity of PexsD in non-inducing condition was 494 MU 
while in inducing condition the promoter was 649 MU (Figure 3.17).  
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Figure 3.16 Illustration of the T3SS regulon in A. hydrophila AH3R. The putative promoter regions were shown in bent arrows and named as 
PascN, PaopN, PexsC, PexsA and PexsD after the name of first gene downstream. Each promoter region was amplified by PCR and cloned into 
lacZ-fusion plasmid pKAGb-2(-) to measure the activity in different mutant backgrounds. This figure is adapted from Vilches, et al. (2004).  
 
91 
 
Figure 3.17 β-galactosidase activities of A. hydrophila AH3R T3SS promoters assayed 
in non-inducing and inducing conditions. All of the promoter activities were measured in 
A. hydrophila AH3R wild type strains, which were grown in LB broth to log phase at 
30°C with shaking at 200rpm. Additional 20mM MgCl2 and 10mM EGTA were added in 
inducing condition. Only PascN showed increased promoter activity in inducing 
condition, while promoter activities of PaopN and PexsA were significantly decreased 
with addition MgCl2 and EGTA. The promoter activity of PexsC and PexsD showed no 
significant difference in non-inducing condition or inducing condition. Each bar 
represents each strain grown in triplicate with duplicate samples. The experiment was 
repeated at least three times for each bar. The error bars showed Standard Error of the 
Mean (SEM). The graph was created using GraphPad™ Prism 5. The significance was 
determined using Student’s t-test (p*<0.05, p**<0.01, p***<0.001). 
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The activities of A. hydrophila T3SS promoters were then measured in different 
mutant backgrounds using non-inducing conditions to avoid more variations. The 
promoter activity of PascN in the A. hydrophila AH3R wild type was 808 MU, but the 
promoter activity was almost completely suppressed in the A. hydrophila exsA 
mutant, in which the promoter activity was down to approximately 15 MU (Figure 
3.18). In the exsD mutant, the PascN promoter activity increased to 1551 MU, which 
was significantly different from the activities in both A. hydrophila AH3R wild type 
and exsA mutant strains (p<0.001). The PascN promoter activity was repressed, but 
not completely shut down, to 444 MU in the A. hydrophila exsC mutant (Figure 3.18). 
While in the A. hydrophila exsE mutant strain, the promoter activity was further 
increased to 2059 MU, which was a significant increase compared to the activities in 
the A. hydrophila exsA and exsC mutants (p<0.001). 
 
The other aeromonad T3SS promoters such as PexsC and PexsD showed 
similar trend of activities as in PascN promoter in different backgrounds. (Figure 
3.19 and Figure 3.20). The β-galactosidase activity of PexsC in the A. hydrophila 
AH3R wild type was 352 MU, while it was almost completely switched off in the A. 
hydrophila exsA mutant. When exsD was knocked out, the promoter activity of 
PexsC increased to 1424 MU, which was significantly higher than the activities 
measured in both the wild type and the exsA mutant strains (p<0.001). In A. 
hydrophila exsC mutant, the promoter activity of PexsC decreased to 347 MU but 
remained at a similar level to the A. hydrophila AH3R wild type. While in the A. 
hydrophila exsE mutant, the PexsC promoter activity showed an increase to 604 MU, 
which was significantly differently from which measured in the wild type, exsA 
mutant and exsC mutant (p<0.001) (Figure 3.19) 
 
The promoter activity of PexsD in A. hydrophila wild type strain was 494 MU 
and it was significantly reduced to 121 MU when exsA gene was knocked out 
(p<0.001) (Figure 3.20). In the A. hydrophila exsD mutant, the promoter activity of 
PexsD increased to 744 MU, which is significantly higher than the promoter activity 
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measured in the wild type strain (p<0.05). While in exsC mutant the promoter 
activity was reduced to 413 MU, which was close to the wild-type value but 
significantly lower than in the exsD mutant strain (p<0.001). When exsE was absent, 
the promoter activity of PexsD reached 1109 MU, which was a significant increase 
compared to the activities in all other backgrounds (p<0.01) (Figure 3.20). 
 
The promoter activity of PaopN in the wild type strain A. hydrophila AH3R was 
2357 MU, which was significantly higher than the promoter activities of PascN, 
PexsC and PexsD in the wild type strain (p<0.001). When the master regulator ExsA 
was knocked out, the activity of PaopN promoter was reduced down to 43 MU. 
However, the promoter activity of PaopN in the exsD mutant was 1067 MU, which 
was significantly lower than the activity in the wild type strain but higher than the 
activity in the exsA mutant (p<0.01) (Figure 3.21). Unlike PascN, PexsC and PexsD, 
the promoter activity of PaopN was not reduced in the exsC mutant or increased in 
the exsE mutant. The β-galactosidase activity of PaopN was 1708 MU in exsC 
mutant, which was significantly higher than in the exsD mutant but lower than in the 
wild type (p<0.05). In the exsE mutant, the PaopN promoter activity was 609 MU, 
which was significantly lower than the activities measured in the wild type (p<0.001), 
exsD mutant (p<0.05) and exsC mutant strains (p<0.001) (Figure 3.21) 
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Figure 3.18 β-galactosidase activities of promoter PascN in A. hydrophila AH3R wild 
type and mutant backgrounds. The promoter activities were measured when each strain 
was grown in LB broth to log phase at 30°C with shaking at 200rpm without adding any 
CaCl2 or EGTA. The promoter activity of PascN was significantly decreased in the exsA 
mutant and exsC mutant when compared to the promoter activities in exsD mutant and 
exsE mutant (p<0.001). Also, the promoter activities in the wild type strain was 
significantly lower than both the exsD mutant and the exsE mutant strains (p<0.001). 
Each bar represents each strain grown in triplicate with duplicate samples. The 
experiment was repeated at least three times for each bar. The error bars showed 
Standard Error of the Mean (SEM). The graph was created using GraphPad™ Prism 5. 
The significance was determined using Student’s t-test (p*<0.05, p**<0.01, p***<0.001). 
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Figure 3.19 β-galactosidase activities of promoter PexsC in A. hydrophila AH3R wild 
type and mutant backgrounds. The promoter activities were measured when each strain 
was grown in LB broth to log phase at 30°C with shaking at 200rpm without adding any 
CaCl2 or EGTA. The promoter activity of PexsC was significantly decreased in exsA 
mutant and exsC mutant when compared to the promoter activities in exsD mutant and 
exsE mutant (p<0.001). The promoter activity of PexsC in the exsD mutant was 
significantly higher than in the wild type strain (p<0.001) while the promoter activity in 
the exsC mutant remained at a similar level to the wild type strain. Each bar represents 
each strain grown in triplicate with duplicate samples. The experiment was repeated at 
least three times for each bar. The error bars showed Standard Error of the Mean (SEM). 
The graph was created using GraphPad™ Prism 5. The significance was determined 
using Student’s t-test (p*<0.05, p**<0.01, p***<0.001). 
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Figure 3.20 β-galactosidase activities of promoter PexsD in A. hydrophila AH3R wild 
type and mutant backgrounds. The promoter activities were measured when each strain 
was grown in LB broth to log phase at 30°C with shaking at 200rpm without adding any 
CaCl2 or EGTA. The promoter activity of PexsD was significantly decreased in exsA 
mutant and exsC mutant when compared to the promoter activities in exsD mutant and 
exsE mutant (p<0.001). The promoter activity in the exsD mutant was a significant 
increase when compared to the wild type strain (p<0.05). However, the promoter activity 
of PexsD in the exsC mutant remained at a similar level to the wild type strain. In the 
exsE mutant, the promoter activity was significantly increased compared to the exsC 
mutant (p<0..001), exsD mutant (p<0.01), exsA mutant (p<0.001) and the wild type 
strains (p<0.001). Each bar represents each strain grown in triplicate with duplicate 
samples. The experiment was repeated at least three times for each bar. The error bars 
showed Standard Error of the Mean (SEM). The graph was created using GraphPad™ 
Prism 5. The significance was determined using Student’s t-test (p*<0.05, p**<0.01, 
p***<0.001).  
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Figure 3.21 β-galactosidase activities of promoter PaopN in A. hydrophila AH3R wild 
type and mutant backgrounds. The promoter activities were measured when each strain 
was grown in LB broth to log phase at 30°C with shaking at 200rpm without adding any 
CaCl2 or EGTA. The promoter activity of PaopN was significantly decreased in exsA 
mutant when compared to the promoter activities in the other backgrounds (p<0.001). 
Surprisingly the promoter activity of PaopN in exsD mutant was significantly lower than 
both the wild type strain and the exsC mutant strain (p<0.01). However, the promoter 
activity of PaopN in the exsC mutant was significantly lower than in the wild type strain 
(p<0.05). In exsE mutant, the promoter activity of PaopN was significantly lower than 
the activities measured in the exsC mutant (p<0.001), exsD mutant (p<0.05) and the 
wild type strain (p<0.001). Each bar represents each strain grown in triplicate with 
duplicate samples. The experiment was repeated at least three times for each bar. The 
error bars showed Standard Error of the Mean (SEM). The graph was created using 
GraphPad™ Prism 5. The significance was determined using Student’s t-test (p*<0.05, 
p**<0.01, p***<0.001).   
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As for the promoter PexsA, which was responsible for the expression of the 
putative T3SS master regulator ExsA in A. hydrophila, the promoter activity was 
much higher than the other promoters of T3SS. In A. hydrophila wild type strain 
AH3R, the β-galactosidase activity of the promoter PexsA was 10,066 MU. Unlike 
the other promoters of T3SS, all of which were repressed when exsA was knocked 
out, the promoter activity of PexsA was not suppressed but demonstrated a 
significant increase in activity in the exsA mutant to 15,546 MU (p<0.001) (Figure 
3.22). More surprisingly, the promoter activity of PexsA decreased to 5,030 MU in 
the exsD mutant background, which was significantly lower than the promoter 
activities of both the wild type and the exsA mutant strains (p<0.001). In the exsC 
mutant, the promoter activity of PexsA increased to 12,826 MU, which was 
significantly higher than both the activities in the wild type (p<0.05) and in the exsD 
mutant strains (p<0.001), but not significantly different from the promoter activity in 
the exsA mutant. The promoter activity of PexsA in the exsE mutant was 7,860 MU, 
which was significantly lower than both the activities in the exsA mutant (p<0.001) 
and in the exsD mutant strains (p<0.01) (Figure 3.22). 
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Figure 3.22 β-galactosidase activities of promoter PexsA in A. hydrophila AH3R wild 
type and mutant backgrounds. The promoter activities were measured when each strain 
was grown in LB broth to log phase at 30°C with shaking at 200rpm without adding any 
CaCl2 or EGTA. Unlike the other promoters of the T3SS, the promoter activity of PexsA 
demonstrated a significant increase in the exsA mutant and exsC mutant backgrounds 
when compared to the promoter activities measured in the exsD mutant and exsE 
mutant backgrounds (p<0.01). The promoter activity in the exsD mutant was a 
significant decrease when compared to the wild type strain (p<0.001). Each bar 
represents each strain grown in triplicate with duplicate samples. The experiment was 
repeated at least three times for each bar. The error bars showed Standard Error of the 
Mean (SEM). The graph was created using GraphPad™ Prism 5. The significance was 
determined using Student’s t-test (p*<0.05, p**<0.01, p***<0.001). 
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3.5 Re-constitution of T3SS regulation in Escherichia coli 
Due to the unexpected results of the PexsA promoter activities in different A. 
hydrophila backgrounds, another approach was required to investigate the 
regulation of the T3SS. Thereby, E. coli was utilized to re-constitute T3SS regulation 
by co-transforming two plasmids into this cell background (Figure 3.23). The 
reporter plasmid pKAGb-2(-) contains a promoter-less lacZ gene and a 
chloramphenicol resistant gene. When the T3SS promoter was fused upstream of 
the promoter-less lacZ gene, the β-galactosidase activity of the promoter could then 
be measured in the same way it was measured in A. hydrohphila backgrounds. In 
the meantime, the gene encoding the master regulator of the A. hydrophila T3SS, 
exsA was cloned into the broad host range pBBR1MCS-5 plasmid by digesting both 
the exsA fragment and the plasmid with restriction enzyme HindIII and ligating using 
T4 DNA ligase (Figure 3.24). The orientation of the cloning was checked by 
sequencing to ensure the expression of exsA gene in-trans. Once both plasmids 
were ready, they were co-transformed into E. coli DH5α cells. Then chloramphenicol 
and gentamycin resistant colonies were selected to perform β-galactosidase 
assays. 
 
Each of the T3SS promoter activities was measured in the presence or 
absence of exsA in E. coli cells by co-transforming the promoter-fused pKAGb-2(-) 
reporter plasmid with pBBR5exsA plasmid construct or pBBR1MCS-5 empty 
plasmid respectively (Figure 3.25). All of the T3SS promoters, except for promoter 
PexsA, had no activity or very low activity in E. coli DH5α cells, whether or not exsA 
was present in-trans. When the promoter activity of PexsA was measured with 
empty pBBR1MCS-5, the β-galactosidase activity was approximately 2,806 MU, but 
when measured with pBBR5exsA construct, the promoter activity of PexsA was 
decreased significantly to approximately 1,962 MU (p<0.001) (Figure 3.25). This 
suggested that the master regulator ExsA might negatively regulate its own 
promoter PexsA, which agreed with our findings of PexsA promoter activities in A. 
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hydrophila wild type and mutant backgrounds.   
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Figure 3.23 Re-constitution of T3SS regulation in E. coli DH5α. 
The promoters (P) of T3SS were cloned into reporter plasmid pKAGb-2(-) and fused 
upstream of a promoter-less lacZ gene. The A. hydrohphila AH3R exsA gene was 
cloned into pBBR1MCS-5 plasmid and co-transformed into E. coli DH5α with 
pKAGb-2(-) reporter plasmid constructs. The T3SS promoter on the reporter 
plasmid could then be regulated by the exsA in-trans. β-galactosidase assay was 
carried out to measure the promoter activity in the presence or absence of exsA 
in-trans. 
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Figure 3.24 A 1% agarose gel showing cloning of exsA into pBBR1MCS-5. Lane 1, 
HindIII-digested exsA fragment (~1kb); Lane 2, Q-step 4 quantitative DNA ladder 
(Yorkshire Bioscience); Lane 3, Promega™ Supercoiled DNA Ladder (2-10kb); Lane 4, 
Undigested pBBR1MCS-5 plasmid (~4.7kb); Lane 5, HindIII-digested pBBR1MCS-5 
(~4.7kb); Lane 6, Q-step 4 quantitative DNA ladder (Yorkshire Bioscience); Lane 7, 
Promega™ Supercoiled DNA Ladder (2-10kb); Lane 8, ligated plasmid construct 
pBBR5exsA (~5.7kb).  
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Figure 3.25 β-galactosidase activities of T3SS promoters in the E. coli re-constitution 
system. The promoter activities were measured when each strain was grown in LB 
broth to log phase at 37°C with shaking at 200rpm without adding any CaCl2 or EGTA. 
Each T3SS promoter activity was measured in the presence of exsA (+exsA) or 
absence of exsA (control) in-trans. Negative control was measured using promoter-less 
pKAGb-2(-) plasmid. All of the A. hydrophila T3SS promoters had no or very low 
activities in the E. coli re-constitution system except for the promoter PexsA. The 
promoter activity of PexsA was significantly higher in the absence of exsA rather than in 
the presence of exsA in-trans (p<0.001). The experiment was repeated at least three 
times for each bar. The error bars showed Standard Error of the Mean (SEM). The 
graph was created using GraphPad™ Prism 5. The significance was determined using 
Student’s t-test (p*<0.05, p**<0.01, p***<0.001).  
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3.6 Discussion 
The aim of this study was to investigate the role of each exs gene in the 
regulation of the T3SS in A. hydrophila and find out if the regulatory cascade is 
present in A. hydrophila AH3R through knocking out the exs genes and measuring 
the activities of putative T3SS promoters in the wild type and mutant backgrounds. 
 
Before measuring the activities of A. hydrophila T3SS promoters in the mutant 
backgrounds, the assay condition was optimized first, as there was evidence 
showing that the expression of the A. hydrophila T3SS was induced significantly 
with additional 20mM MgCl2 and 10mM EGTA. Vilches and colleagues 
demonstrated that the expression level of two T3SS mediated genes aopN and 
aexT was up-regulated with additional MgCl2 and EGTA using gfp-fusions (Vilches 
et al 2009). However in this study, the β-galactosidase activities of PaopN and 
PexsA were decreased in the inducing condition, in which additional MgCl2 and 
EGTA were added. Moreover, no significant difference of promoter activity between 
inducing condition and non-inducing condition was found for promoters PexsC and 
PexsD (Figure 3.17).  
 
The reason why the findings in this study were contradictory to Vilches’ was 
unknown but there were limitations in the methods used in both this project and the 
Vilches’ study. In this study, as the putative T3SS promoters were cloned in the 
multi-copy lacZ-fusion plasmid pKAGb-2(-), the β-galactosidase assay carried out 
was possibly influenced by the transcriptional factor titration effect. The potential 
repressors might be ‘outnumbered’ by the high copy number of the promoter, which 
was supposed to be repressed but still showing activities during the assay (Brewster 
et al 2014, Guido et al 2006).  
 
As in Vilches’ study, the activity of the PaopN promoter was obtained by 
measuring the expression level of gfp-fusion. The gfp reporter gene was integrated 
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into the A. hydrophila AH-3 chromosomal DNA downstream of the PaopN promoter 
and upstream of the aopN gene. The integration of gfp gene might affect the 
expression of the downstream operon, in which at least three genes, acrR, acrG and 
acrV were possibly involved in the low-Ca
2+
 response as their homologues had 
similar activities in Y. pestis, P. aeruginosa or A. salmonicida (Table 1.2). What was 
not indicated in Table 1.2 was that not only AcrR was involved in low-Ca2+ response 
as its homologues LcrR in Y.pestis, but also the homologues of AcrG and AcrV were 
reported to be involved in calcium response in A. salmonicida as well as in Y. pestis 
(Barve & Straley 1990, Burr et al 2003, Matson & Nilles 2001). 
 
Furthermore, the promoter activity of PaopN measured later on in mutant 
backgrounds also suggested potential secondary regulations on some of the T3SS 
promoters. The genes in the operon downstream of PaopN will be dicussed in more 
detail when investigating the promoter activity of PaopN in mutant backgrounds. To 
avoid more variations, the β-galactosidase activities of the T3SS promoters 
measured afterwards in the mutant backgrounds were all assayed in non-inducing 
conditions. 
 
As shown in figure 3.18, the promoter activity of PascN was repressed down to 
15 MU in the exsA mutant, suggesting that the promoter was not activated in the 
absence of ExsA. While in the exsD mutant, the promoter activity was boosted up to 
1551 MU, which was significantly increased when compared to the activities in both 
exsA mutant and the wild type (p<0.001). This suggested that PascN promoter 
activity was increased in the absence of ExsD, which was proposed to be the 
anti-activator of the T3SS in this study. Then the promoter activity was suppressed 
down to 444 MU in the exsC mutant, which was a significant decrease compared to 
the wild type or the exsD mutant strains (p<0.01). In the exsE mutant, the promoter 
activity was increased up to 2059 MU, indicating that the promoter was activated in 
the absence of ExsE.  
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The patterns of the PascN, PexsC and PexsD promoter activities in different 
mutant backgrounds were in consensus with the hypothesis that ExsA was the 
master regulator of the T3SS. Therefore, in the exsA mutant, the promoters were 
not activated due to the absence of the master regulator. While in the exsD mutant, 
the absence of the anti-activator ExsD allowed the activator ExsA to switch on the 
promoters, thus the promoter activities of PascN, PexsC and PexsD were increased 
significantly compared to in the wild type or in the exsA mutant strains.  
 
In the exsC mutant, the hypothesis proposed that the absence of ExsC allowed 
ExsD to bind ExsA, thus the promoter should be suppressed. However, the 
β-galactosidase activities of PascN, PexsC and PexsD promoters in the exsC 
mutant strain remained at similar levels of activity to the wild type strain, indicating 
that there was likely to be secondary regulation. One of the possible reasons is that 
the anti-activator ExsD may self-associate, which prevents the inhibitory function of 
ExsD on ExsA. As reported in P. aeruginosa, the ExsD trimerized at 30°C and was 
unable to inhibit ExsA until the trimerization was disrupted at 37°C. Moreover, the 
presence of ExsC protein overcomes the ExsD trimerization, suggesting a higher 
binding affinity of ExsC-ExsD than ExsD self-association (Bernhards et al 2013). In 
this case, the self-association of ExsD could explain the similar promoter activities of 
PascN, PexsC and PexsD when measured in the exsC mutant and the wild type 
strains. Hence in the absence of ExsC, the ExsD self-association competed with the 
inhibition of ExsA, thus the promoter activities of PascN, PexsC and PexsD were 
reduced when compared to the activities measured in the exsD mutant but 
remained at a similar level to the activities in the wild type strain.  
 
However, the fact that P. aeruginosa grows optimally at 37°C while the optimal 
growth temperature for A. hydrophila AH-3 is 30°C, makes the temperature- 
sensitive self-association activity of ExsD unclear in A. hydrophila AH-3 strains. 
There was evidence from previous studies showing that many other factors were 
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also involved in the regulation of the T3SS, including quorum sensing system, 
environmental factors like Mg
2+
 or Ca
2+
 concentration, σ54 factor RpoN and the 
translocation regulator AopN and AcrR (Hendrickson et al 2000, Vilches et al 2009, 
Yu et al 2007, Yu et al 2004). The complete picture of all factors that affects the 
regulation of A. hydrophila T3SS still remains unknown. 
 
In the exsE mutant, the absence of ExsE allowed the chaperone protein ExsC 
to bind ExsD, thus ExsA was released to switch on the promoter, hence the activity 
of PascN and PexsD was further increased. In the environment, when the bacteria 
such as A.salmonicida or P.aeruginosa, were in contact with the host cells and the 
effector proteins were secreted, in this case ExsE, the T3SS regulon was then 
further activated to inject more toxins into the host cells (Rietsch et al 2005, 
Urbanowski et al 2007, Urbanowski et al 2005, Vanden Bergh & Frey 2013).  
 
The promoter activity of PexsC was not elevated in the absence of ExsE, and 
was much lower than the promoter activity of PexsD. It possibly suggests that when 
ExsE is absent, more ExsD was made in contrast with ExsC due to higher promoter 
activity. The increase in the pool of ExsD proteins provide the bacteria with another 
level of regulation for ExsA activation. Moreover, as it was recently reported in P. 
aeruginosa that the ExsD could only bind to ExsA when they were synthesized at 
the same time as folding intermediates, the ExsD protein released from ExsC 
binding could not re-bind the ExsA protein (Bernhards et al 2013). Thereby, it was 
not surprising that ExsD was required to be synthesized at a higher level than ExsC. 
In fact, the expression of ExsD was also driven by the PexsA promoter, as both the 
exsA-ascL and exsD-ascL operons share the same terminator, to allow 
simultaneous expression of ExsD and ExsA.  
 
The promoter activity of PaopN in the wild type was around 2357 MU, which 
was higher than the activities of PascN, PexsC and PexsD, suggesting that PaopN 
is a stronger promoter. Although the activity of PaopN was completely suppressed in 
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the exsA mutant, the absence of ExsD and ExsE did not increase the promoter 
activity compared to the wild type while the absence of ExsC did not repress the 
promoter activity like it did to PascN, PexsC and PexsD.  
 
The reason why this promoter was regulated differently from the others is 
unknown but it is possibly related to the genes in the operon downstream of PaopN. 
The first gene of the operon that was regulated by PaopN was aopN and the 
function of its protein product AopN was known to be similar to its homologue YopN 
in Yersinia spp., which functions as a valve to form a protein complex that blocks 
Yop secretion from a cytosolic location of the Type III secretome (Ferracci et al 2005, 
Vilches et al 2008). The other genes downstream in the same operon were also 
reported to be involved in the regulation of the T3SS, such as acrR, acrG and acrV. 
 
The homologues of AcrG and AcrV in Y. pestis, LcrG and LcrV were reported to 
be involved in the secretion of the T3SS. The LcrG protein functions as a negative 
regulator of T3SS similar to YopN that block the T3SS secretion but from the 
cytoplasmic side of the secretion apparatus on the inner membrane. It also functions 
as the cognate chaperone protein for the needle-tip secreted protein LcrV. When the 
T3SS is not activated in Y. pestis, the intracellular level of LcrV is low thus allowing 
the chaperone protein LcrG to block the secretion apparatus. But when the T3SS is 
triggered, the level of LcrV is increased to titrate out the LcrG protein from secretion 
apparatus thus allowing secretion (Matson & Nilles 2001). The homologues of acrG 
and acrV in A. salmonicida were also involved in the regulation of the T3SS in 
response to calcium as discussed before in introduction (Burr et al 2003).  
 
Like the homologue of AcrR in Y. pestis, LcrR is a bifunctional transcriptional 
factors that down-regulates the expression of LcrG in the presence of Ca
2+
, while it 
is necessary for LcrG expression in the absence of Ca
2+
 (Barve & Straley 1990). All 
three gene products of acrG, acrV and acrR are possibly involved in the regulation 
of T3SS, thus It is likely that there are secondary regulations affecting the activity of 
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PaopN promoter.  
 
The promoter activity of PascN, PaopN, PexsC and PexsD suggested that they 
were not strong promoters when compared to PexsA, which was responsible for the 
transcription of the T3SS master regulator ExsA. The promoter activity of PexsA 
was significantly increased when exsA was knocked out, suggesting that the master 
regulator ExsA might negatively regulate its own promoter PexsA.  
 
In 1976, AraC was reported to repress the expression of its own gene araC by 
binding to its own promoter region and blocking the recruitment of the RNA 
polymerase (Casadaban 1976, Hahn & Schleif 1983). As a member of AraC family 
proteins, there has been no report of ExsA that it can repress its own transcription 
so far. However, many members of the AraC family proteins share this feature that 
repress their own expression, such as XylR, one of the regulators for xylene 
metabolism in Pseudomonas putida and YbtA, a pesticin receptor regulator in 
Yersinia pestis (Fetherston et al 1996, Inouye et al 1987).  
 
The observations of PexsA activities in the exsD, exsC and exsE mutant strains 
further contributed to the hypothesis that ExsA was under control of a regulatory 
cascade. When exsD was knocked out, ExsA was freely allowed to repress its own 
promoter PexsA, thus a decrease of the PexsA promoter activity in the exsD mutant 
strain (Figure 3.22). In the exsC mutant, the promoter activity of PexsA was 
increased significantly when compared to the promoter activities in the wild type and 
the exsD mutant strains, but to a similar extent as the activity measured in exsA 
mutant (Figure 3.22). This was consistent with our hypothesis that in the absence of 
ExsC, ExsD was free to bind ExsA, which was then unable to repress the promoter 
PexsA, thus similar phenotypes were observed in the exsC mutant and the exsA 
mutant strains. Similarly, in the exsE mutant, the absence of the effector protein 
ExsE allowed its chaperone protein ExsC to bind to the de-activator ExsD thus 
allowing the activator protein ExsA to repress its own promoter PexsA, thereby the 
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promoter activity of PexsA was decreased significantly in the exsE mutant (Figure 
3.22). 
Due to the lack of T3SS in E. coli DH5α re-constitution system, all of the T3SS 
promoters, except for PexsA, had similar β-galactosidase activity as the negative 
control, suggesting that these promoters required certain T3SS-specific factors 
other than ExsA to be activated. This contributed to the previous suspicion that there 
might be secondary regulation or regulators other than the master regulator ExsA. 
 
However, the promoter PexsA was still highly active in E. coli DH5α cells in the 
absence of exsA in-trans, suggesting that this promoter was likely to be activated by 
housekeeping sigma factor σ70 in E. coli. While in the E. coli DH5α cells with induced 
exsA expression, the promoter activity of PexsA was down-regulated significantly. 
This confirmed our previous suspicion that ExsA might negative regulate its own 
promoter PexsA. Given all the results obtained so far, it was suggested that PexsA 
was constantly activated but under a negative feedback control of the master 
regulator ExsA, which was also constitutively expressed. Therefore, it could be 
deduced that the bacteria A. hydrophila AH3R maintained a minimal level of T3SS 
expression in the environment due to the constitutive expression of ExsA. When the 
bacteria encountered host cells, according to our hypothesis, ExsE was secreted 
out and ExsC was free to bind to ExsD that released abundant ExsA to further 
activate the T3SS in A. hydrophila AH3R.  
 
The inhibition of ExsA on its own promoter PexsA provided another level of the 
T3SS regulation. As the exsA-ascL and exsD-ascL operons share the same 
terminator, the only gene different is the exsA gene, which is under control of PexsA 
but not PexsD promoter (Figure 3.16). The fact that the activation of PexsD 
promoter requires the T3SS master regulator ExsA may suggest a scenario where 
the bacteria switch off the T3SS and release from the host cell. In this situation, the 
accumulation of ExsA restrains the expression of itself by inhibiting its own promoter 
as well as synthesizing more anti-activator ExsD, reducing the expression of the 
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T3SS overall, which results in the closure of the injectisome and detaching from the 
host cells. It also makes sense as the closure of the T3SS channel leads to the 
accumulation of the secreted protein ExsE, which sequester the chaperone protein 
ExsC from binding the anti-activator ExsD.  
 
3.7 Conclusion 
 The T3SS of A. hydrophila is regulated by a cascade of regulators that involves 
ExsA, ExsD, ExsC and ExsE.  
 The T3SS master regulator ExsA is inhibited by ExsD, which is repressed by 
ExsC while ExsC is inhibited by ExsE. 
 The T3SS master regulator ExsA also has a negative feedback that represses 
its own promoter PexsA. 
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Chapter 4  
Interactions Studies of T3SS 
Regulators 
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4.1 Introduction 
The hypothesis in this study that the master regulator ExsA of the A. hydrophila 
T3SS was under control of a cascade of proteins was largely based on the 
well-described T3SS regulatory cascade in Pseudomonas aeruginosa, in which 
ExsA, ExsD, ExsC and ExsE interact with each other through direct protein-protein 
interactions. 
 
ExsA was first identified in P. aeruginosa and was deduced to be a 
transcriptional factor due to its extensive homology shared with VirF in Yersinia 
enterocolitica, which was an AraC family transcriptional activator (Frank & Iglewski 
1991). As in most AraC/XylS family proteins, P. aeruginosa ExsA consists of a 
carboxyl-terminal helix-turn-helix DNA-binding motif and an amino-terminal 
oligomerization and ligand binding domain (Brutinel et al 2009, Martin & Rosner 
2001). As the transcriptional activation of ExsA was required for the expression of 
the T3SS secretion apparatus, translocation machinery and secreted effectors, 
ExsA was described as the master regulator of the P. aeruginosa T3SS (Hovey & 
Frank 1995, Yahr et al 1995).  
 
It was then reported in 2002 that the master regulator ExsA was negatively 
regulated by another protein named ExsD in P. aeruginosa through direct 
protein-protein interaction using bacterial LexA two-hybrid assay (McCaw et al 
2002). Later on, Brutinel and Yahr’s group demonstrated that the C-terminal domain 
of P.aeruginosa ExsA is incapable of cooperative DNA-binding and unaffected by 
the inhibition of ExsD, suggesting that the N-terminal domain of ExsA is required for 
interactions between ExsD and ExsA. (Brutinel et al 2009). 
 
Meanwhile, ExsC was found to be an anti-anti-activator in P. aeruginosa by 
Dasgupta and Yahr’s group in 2004. Mutagenesis and complementation 
experiments have suggested that ExsC functions in de-repression of the T3SS, 
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while Bacterial LexA two-hybrid assay and co-purification assays have suggested 
that ExsC interacts with ExsD through direct protein-protein interactions (Dasgupta 
et al 2004). They have also suggested that ExsC is a potential T3SS-specific 
chaperone protein due to the low molecular weight, the acidic isoelectric point and 
the putative C-terminal amphipathic α-helix (Dasgupta et al 2004). 
 
Later in 2005, the same group discovered that the secreted protein ExsE sat at 
the top of the signalling cascade by inhibiting its chaperone protein ExsC through 
direct protein-protein interactions (Urbanowski et al 2005). Therefore, the regulatory 
cascade of the P. aeruginosa T3SS is fully uncovered, that the T3SS-secreted 
protein ExsE binds to the chaperone protein ExsC, which antagonizes the 
anti-activation activity of ExsD on the master regulator ExsA. 
 
Moreover, the T3SS was reported in clinical Aeromonas isolates including A. 
hydrophila, A. caviae and A. veronii in 2004, by the identification of the T3SS genes 
ascF and ascG (Chacon et al 2004). In the same year, the complete T3SS that 
consisted of 35 genes in A. hydrophila AH-3 was sequenced but the regulation of 
the T3SS in A. hydrophila still remained unknown (Vilches et al 2004). It was then 
reported by Chopra’s group in 2007 that Exs proteins in A. hydrophila SSU strain, 
like in P. aeruginosa, had similar effect on the regulation of the T3SS using 
mutagenesis and over-expression assays (Sha et al 2007). In the meantime, 
Leung’s group demonstrated similar anti-activation activity of ExsD on ExsA in A. 
hydrophila AH-1 strain using mutagenesis assays (Yu et al 2007). 
 
There was no evidence of direct protein-protein interactions in the putative 
regulatory cascade of T3SS in A. hydrophila AH3R. Thus in this study, direct 
protein-protein interactions between each of the Exs proteins were investigated 
using Bacterial Adenylate Cyclase Two-Hybrid System (BACTH) and Far-Western 
Blot. 
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4.2 Cloning of the T3SS regulatory components (exs genes) into the 
BACTH system 
The Bacterial Adenylate Cyclase Two Hybrid (BACTH) assay was carried out 
using the Euromedex™ BACTH System Kit (Section 2.20). The target genes were 
first cloned into the BACTH plasmids in frame with either T25 or T18 fragments of 
the cyaA gene at the 5’ or 3’ end of the gene of interest (Table 2.2 plasmids used in 
this study), to allow co-expression of fusion proteins. There were 4 different BACTH 
plasmids allowing the target genes to fuse in different orientations, for instance, 
exsA was cloned into pKT25 and pKNT25 for both C-terminal and N-terminal fusion 
with the T25 fragment respectively. 
 
For cloning into pKT25 plasmid, the exsA gene was amplified from the A. 
hydrophila AH3R chromosomal DNA using exsA_pKT25 forward and exsA_pKT25 
reverse primers (Appendix 1) with Platinum Pfx DNA polymerase, introducing an 
XbaI restriction site at the 5’ end and an EcoRI restriction site at the 3’ end for 
directional cloning (Figure 4.1). In order to insert the exsA gene in frame with the 
T25 fragment, there was a 6bp spacer, designed in the exsA_pKT_forward primer, 
located in between the 3’ end of T25 fragment and the 5’ end of the exsA gene 
(Figure 4.2).The plasmid pKT25 and the amplified exsA gene were then digested 
with both XbaI and EcoRI restriction enzymes to allow ligation with T4 DNA ligase. 
After ligation, it was transformed into E. coli DH5α cells and kanamycin resistant 
colonies were selected for screening using colony PCR screen (section 2.3.2). The 
screening primers pKT25_screen forward and pKT25_screen reverse (Appendix 1) 
were used together with Taq DNA polymerase and the colony PCR screening 
products were checked by agarose gel electrophoresis (Figure 4.3). Potential 
successful constructs were sequenced by Core Genomic Facility, University of 
Sheffield. The sequencing results were analysed using FinchTV and BLAST search 
to ensure the in-frame insertion.  
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Figure 4.1 Illustration of the plasmid construct pKT25-exsA. The exsA gene was 
amplified using Platinum Pfx DNA polymerase with exsA_pKT_forward primer, which 
introduced an XbaI site at 5’ end, and exsA_pKT_reverse primer, which introduced an 
EcoRI site at 3’ end. The pKT25 plasmid and the amplified exsA fragment were digested 
with both of the restriction enzymes and ligated together with T4 ligase. A successful 
insert was screened by colony PCR screen using pKT25_screen forward and 
pKT25_screen reverse primers with Taq polymerase. The exsA gene was inserted in 
frame with the T25 fragement at 3’ end, allowing the ExsA protein fused to the 
C-terminal of the T25 fragment. Key features of the plasmid construct were shown in 
arrows while primers were shown in purple. Created using SnapGene software. 
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Figure 4.2 Demonstration of the in-frame insertion of the exsA gene into the pKT25 
plasmid. The XbaI restriction site (TCTAGA) was located at the 3’ end of the T25 
fragment but the first nucleotide of the XbaI restriction site (T) overlapped with the last 
nucleotide of the T25 fragment. In order to insert exsA in frame with the T25 fragment, 
the spacer in between must be multiples of 3 (number of codons). Thereby an extra G 
was designed downstream of the XbaI site in the exsA_pKT_forward primer to make a 
6bp spacer in between thus allowing in-frame insertion of the exsA gene into the pKT25 
plasmid. Generated using SnapGene software. 
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Figure 4.3 A 1% agarose gel showing colony PCR screen of pKT25-exsA. There was 
an approximately 300bp distance between the pKT25_screen forward and 
pKT25_screen reverse primers, thus the screening of successful constructs should be 
1.1kb, which comprised of 300bp and the size of the inserted exsA gene (800bp). Lane 
1, Highranger 1kb DNA ladder (Norgen Biotek); Lane 3-5 and 7-9, empty pKT25 
plasmid with no insert; Lane 2 and 6, potential successful pKT25-exsA plasmid 
construct. 
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A similar approach was used to clone each of the exsA, exsD, exsC and exsE 
genes into each of pKT25, pKNT25, pUT18 and pUT18C plasmids to obtain 16 
plasmid constructs in total. Examples of pKNT25-exsC, pUT18-exsD and 
pUT18C-exsD were shown to illustrate different orientation of the T25/T18 fusion 
provided by different BACTH plasmids (Figure 4.4, Figure 4.5, and Figure 4.6). 
 
Once all 16 of the BACTH plasmid constructs were obtained, then one of the 
T25 derived plasmid constructs was co-transformed with a T18 derived plasmid 
construct into E. coli BTH101 reporter competent cells and incubated on 
MacConkey/maltose agar for 2 nights at 30°C.  
 
When the two proteins of interest interacted with each other, heterodimerization 
of the fusion proteins allowed the complementation of the T25 and T18 fragments to 
form a catalytic domain of adenylate cyclase (CyaA), thus cAMP was synthesized. 
Then the mal operon was activated by cAMP/CAP complex. Therefore the maltose 
metabolism pathway was switched on in the E. coli BTH101 reporter strain, which 
allowed the fermentation of maltose and the production of acid that turned the pH 
indicator in MacConkey agar pink. Therefore positive interaction colonies were 
pink/red in colour whereas negative colonies were white. Control plasmids 
pKT25-zip and pUT18C-zip, which expressed T25-zip and T18-zip fusion proteins 
with leucine zipper motifs, were co-transformed into E.coli BTH101 reporter strain to 
present a positive control of the interaction, while plasmid pKT25 and pUT18 were 
co-transformed into E.coli BTH101 as a negative control (Figure 4.7). 
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Figure 4.4 Illustration of the plasmid construct pKNT25-exsC. The exsC gene was 
amplified using Platinum Pfx DNA polymerase with exsC_pKNT_forward and 
exsC_pKNT_reverse primers. The exsC gene was inserted in frame at 5’ end of the T25 
fragment, allowing ExsC protein fused to the N-terminal of the T25 fragment. Key 
features of the plasmid construct were shown in thick arrows while ORFs were shown in 
thin arrows. Primers were shown in purple. Created using SnapGene software. 
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Figure 4.5 Illustration of the plasmid construct pUT18-exsD. The exsD gene was 
amplified using Platinum Pfx DNA polymerase with exsD_pUT_forward and 
exsD_pUT_reverse primers. The exsD gene was inserted in frame at 5’ end of the T18 
fragment, allowing ExsD protein fused to the N-terminal of the T18 fragment. Key 
features of the plasmid construct were shown in thick arrows while ORFs were shown in 
thin arrows. Primers were shown in purple. Created using SnapGene software. 
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Figure 4.6 Illustration of the plasmid construct pUT18C-exsD. The exsD gene was 
amplified using Platinum Pfx DNA polymerase with exsD_pUT18C_forward and 
exsD_pUT18C_reverse primers. The exsD gene was inserted in frame at 3’ end of the 
T18 fragment, allowing ExsD protein fused to the C-terminal of the T18 fragment. Key 
features of the plasmid construct were shown in thick arrows while ORFs were shown in 
thin arrows. Primers were shown in purple. Created using SnapGene software 
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Figure 4.7 Illustration of the BACTH controls. A. Plasmid pKT25-zip and pUT18C-zip 
expressed fusion proteins T25-zip and T18-zip that interacted with each other through 
leucine zipper motifs, allowing complementation of T25 and T18 fragment to form a 
catalytic domain of adenylate cyclase (CyaA), thus cAMP was synthesized from ATP. 
When E.coli BTH101 containing these plasmids was grown on MacConkey-maltose 
agar for 2 days at 30°C, the MacConkey agar turned pink/red as the result of the 
activation of the mal operon. B. Plasmid pKT25 and pUT18 were co-transformed into 
E.coli BTH101 reporter strain as a negative control. T25 and T18 fragments were apart 
from each thus no complementation of the adenylate cyclase. Therefore the colonies 
and the MacConkey Agar remained white. 
  
125 
4.3 Investigation of the interactions between Exs proteins using BACTH 
As the hypothesis suggested, the master regulator of the T3SS in the A. 
hydrophila AH3R strain was ExsA. It is thought to be able to self-interact for 
cooperative activation of the T3SS promoters as well as interacting with the 
anti-activator ExsD, while not interacting with ExsC or ExsE. When co-transforming 
pKT25-exsA with pUT18-exsA or pUT18C-exsA, strong interactions were shown in 
both cases. Moreover, when co-transforming pKNT25-exsA with pUT18-exsA or 
pUT18C-exsA, the interactions were very strong as well. Thereby only one figure of 
exsA-exsA self-interaction was shown here (Figure 4.8). The interactions between 
ExsA and ExsD were as strong as the self-interaction of ExsA. Each of the 
exsA-fused BACTH plasmid constructs showed positive interaction when 
co-transformed with each of the exsD-fused BACTH plasmid constructs, except for 
exsD-pKT25, which showed no interaction with either pUT18-exsA or pUT18C-exsA 
(Figure 4.9). Only pKT25-exsA with pUT18C-exsD is shown as an example in 
Figure 4.8. On the other hand, ExsA showed no interaction with ExsC in any case; 
the co-transformation of pUT18-exsA with pKNT25-exsC is shown as an example 
(Figure 4.8). Similarly, ExsA showed no interaction with ExsE in any case; 
pUT18C-exsA with pKNT25-exsE is shown as an example (Figure 4.8). 
 
ExsD which had been shown to interact with ExsA, showed no evidence of 
ExsD-ExsD self-interaction when co-transforming pKT25-exsD or pKNT25-exsD 
with either pUT18-exsD or pUT18C-exsD. Only pUT18-exsD with pKT25-exsD is 
shown here as an example (Figure 4.10). However, ExsD was shown to interact with 
ExsC in every combination. Thus pUT18C-exsD with pKT25-exsC is shown as an 
example of strong ExsD-ExsC interaction (Figure 4.10). In contrast no evidence of 
ExsD-ExsE interaction was found in any case, as shown in co-transformation of 
pUT18C-exsD with pKNT25-exsE (Figure 4.10).  
.  
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Figure 4.8 Illustration of BACTH interactions between ExsA and each of the Exs 
proteins. Plasmid combinations were co-transformed into E. coli BTH101 and grown on 
MacConkey-maltose agar for 2 days at 30°C. A, pKT25-exsA with pUT18C-exsA 
showing strong ExsA-ExsA self-interaction B, pKT25-exsA with pUT18C-exsD showing 
strong ExsA-ExsD interaction; C, pUT18-exsA with pKNT25-exsC showing no 
interaction between ExsA and ExsC; D, pUT18C-exsA with pKNT25-exsE showing no 
interaction between ExsA and ExsE. The BACTH assay was carried out three times for 
each combination.  
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Figure 4.9 Illustration of BACTH interactions between ExsA and ExsD. Plasmid 
combinations were co-transformed into E. coli BTH101 and grown on 
MacConkey-maltose agar for 2 days at 30°C. A, pUT18C-exsA with pKNT25-exsD 
showed strong ExsA-ExsD interaction; B, pKT25-exsA with pUT18C-exsD showed 
strong ExsA-ExsD interaction as well; C and D, pKT25-exsD plasmid construct showed 
no ExsA-ExsD interaction when co-transformed with either pUT18-exsA or 
pUT18C-exsA plasmid construct. The BACTH assay was carried out three times for 
each combination.  
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Figure 4.10 Illustration of BACTH interactions between ExsD and each of the Exs 
proteins. Plasmid combinations were co-transformed into E. coli BTH101 and grown on 
MacConkey-maltose agar for 2 days at 30°C. A, pUT18C-exsD with pKT25-exsA 
showed strong ExsD-ExsA interaction; B, pUT18-exsD with pKT25-exsD showed no 
ExsD-ExsD self-interaction; C, pUT18C-exsD with pKT25-exsC showed strong 
ExsD-ExsC interaction; D, pUT18C-exsD with pKNT25-exsE showed no evidence of 
ExsD-ExsE interaction. The BACTH assay was carried out three times for each 
combination.  
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Moreover, ExsC protein was shown not to interact with the ExsA protein in any 
combination of BACTH plasmid constructs. Co-transformation of pKT25-exsC with 
pUT18-exsA is shown here as an example of negative interaction (Figure 4.11). 
Strong ExsC-ExsD interaction was shown in every case; hereby pUT18-exsC with 
pKNT25-exsD is shown as an example (Figure 4.11). Although pKT25-exsC and 
pKNT25-exsC were shown to interact with pUT18-exsC and pUT18C-exsC, the 
pink/red colouration of MacConkey Agar in ExsC-ExsC self-interaction was much 
weaker compared to the colouration in ExsC-ExsD or ExsC-ExsE. The 
co-transformation of pUT18C-exsC with pKNT25-exsC into the E. coli BTH101 
reporter strain is shown as an example (Figure 4.11). Very strong ExsC-ExsE 
interaction was observed in every combination of exsC-fused BACTH plasmid 
constructs with exsE-fused BACTH plasmid constructs. pKT25-exsC with 
pUT18C-exsE is shown as an example (Figure 4.11). 
 
As for ExsE protein, which was shown to interact with ExsC protein only, the 
exsE-fused BACTH plasmid constructs showed no positive interaction when 
co-transformed with exsA-fused or exsD-fused BACTH plasmid constructs. The 
co-transformation of pUT18C-exsE with pKT25-exsA and pKNT25-exsE with 
pUT18C-exsD showed negative interaction in ExsE-ExsA and ExsE-ExsD (Figure 
4.12). On the other hand, as demonstrated in ExsC interactions, ExsE-ExsC 
interaction was very strong in every case, as shown in pUT18-exsE with 
pKNT25-exsC co-transformation (Figure 4.12). However, ExsE-ExsE self-interaction 
was shown to be very weak, as no interaction was observed in co-transformation of 
pKT25-exsE with pUT18-exsE or pUT18C-exsE, while weak interaction was 
observed in co-transformation was observed in co-transformation of pKNT25-exsE 
with pUT18-exsE or pUT18C-exsE (Figure 4.12 and Figure 4.13). 
 
A summary of the overall interactions between each two of the T3SS regulatory 
components (Exs proteins) are shown in Table 4.1. Strong interactions were 
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observed between ExsA-ExsA, ExsA-ExsD, ExsD-ExsC and ExsC-ExsE, which 
agreed with the hypothesis that ExsA-ExsD-ExsC-ExsE regulatory cascade was 
based on direct protein-protein interactions.  
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Figure 4.11 Illustration of BACTH interactions between ExsC and each of the Exs 
proteins. Plasmid combinations were co-transformed into E. coli BTH101 and grown on 
MacConkey-maltose agar for 2 days at 30°C. A, pKT25-exsC with pUT18-exsA showed 
no ExsC-ExsA interaction; B, pUT18-exsC with pKNT25-exsD showed strong 
ExsC-ExsD interaction; C, weak ExsC-ExsC self-interaction was shown as in 
pUT18C-exsC with pKNT25-exsC co-transformation; D, pKT25-exsC with 
pUT18C-exsE showed very strong ExsC-ExsE interaction. The BACTH assay was 
carried out three times for each combination.  
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Figure 4.12 Illustration of BACTH interaction between ExsE and each of the Exs 
proteins. Plasmid combinations were co-transformed into E. coli BTH101 and grown on 
MacConkey-maltose agar for 2 days at 30°C. A, pUT18C-exsE with pKT25-exsA 
showed no ExsE-ExsA interaction; B, no ExsE-ExsD interaction was shown as in 
pKNT25-exsE with pUT18C-exsD; C, very strong ExsE-ExsC was shown as in 
pUT18-exsE with pKNT25-exsC; D, weak ExsE-ExsE self-interaction was shown as in 
pKNT25-exsE with pUT18C-exsE. The BACTH assay was carried out three times for 
each combination.   
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Figure 4.13 Illustration of BACTH assay of ExsE-ExsE self-interaction. Plasmid 
combinations were co-transformed into E. coli BTH101 and grown on 
MacConkey-maltose agar for 2 days at 30°C. A and B, no interaction was observed in 
co-transformation of pKT25-exsE with pUT18-exsE or pUT18C-exsE; C and D, weak 
ExsE-ExsE self-interaction was shown in co-transformation of pKNT25-exsE with 
pUT18-exsE or pUT18C-exsE. The BACTH assay was carried out three times for each 
combination. 
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Table 4.1 Investigation of the interactions between each two of the Exs proteins using BACTH system. Positive interactions were shown in ‘+’ 
while negatives were shown in ‘-‘, weak interactions were shown in ‘+/-‘. The orientation (from N-terminal to C-terminal) of the T25/T18 fusion 
was shown in green boxes. Positive interactions were observed in ExsA-ExsA, ExsA-ExsD, ExsD-ExsC and ExsC-ExsE, which agreed with the 
hypothesis of ExsA-ExsD-ExsC-ExsE regulatory cascade of the T3SS in A. hydrophila AH3R. 
135 
 
4.4 Overexpression of Exs proteins using the pET system 
Apart from the BACTH assay, the in-vitro investigation of the protein-protein 
interactions in the regulatory cascade of the T3SS in A. hydrophila AH3R requires 
the overexpression of the Exs proteins.  
 
The over-expression vector pET28a was used to over-express Exs proteins. 
Since a pET28exsA plasmid construct had already been created in the lab (Shaw, 
unpublished), only the plasmid construct pET28exsD, pET28exsC and pET28exsE 
were required. To begin with, the T3SS regulatory genes exsD, exsC and exsE, 
were amplified independently by PCR from the A. hydrophila AH3R chromosomal 
DNA using Platinun Pfx DNA polymerase. The primers used to amplify these genes 
(Appendix 1) introduced a start codon and a stop codon at either end of each gene 
allowing in-frame cloning into the pET28a vector to ensure an N-terminal His-tag. 
The PCR products of the exs genes were then digested by NdeI and HindIII (NdeI 
and EcoRI for exsE) and ligated with the pET28a plasmids digested by the same 
pair of restriction enzymes (Figure 4.14). The ligations were transformed into E.coli 
DH5α competent cells and kanamycin resistant colonies were screened by colony 
PCR screen using T7 promoter (forward) and T7 terminator (reverse) primers 
(Appendix 1). Plasmid constructs pET28exsC, pET28exsD and pET28exsE 
screened with successful inserts were extracted from the E. coli DH5α cells (Figure 
4.15). 
 
As all exs genes were cloned into the pET28a plasmids, they were then 
sequenced using T7 promoter (forward) and T7 terminator (reverse) primers to 
ensure the in-frame insertion, the orientation of the inserts and that no mutation was 
present in the inserts. After examination with sequencing and BLAST search, all 
plasmids were then transformed into E. coli over-expression strains to overexpress 
the Histidine-tagged Exs proteins.  
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Figure 4.14 A 1% agarose gel showing the double-digested exsC, exsE, exsD and 
pET28a. Lane 1, Q-step 4 quantitative DNA ladder (Yorkshire Bioscience); Lane 2, NdeI 
and HindIII digested exsC fragment (~450bp); Lane 3, NdeI and EcoRI digested exsE 
fragment (~250bp); Lane 4, NdeI and HindIII digested exsD fragment (~800bp); Lane 5, 
NdeI and HindIII digested pET28a plasmid vector (~5.4kb); Lane 6, NdeI and EcoRI 
digested pET28a plasmid vector (~5.4kb). 
Figure 4.15 A 1% agarose gel showing the plasmid constructs of pET28exsA, 
pET28exsC, pET28exsD and pET28exsE. Lane 1, Promega™ Supercoiled DNA 
Ladder; Lane 2, plasmid construct pET28exsA (~6.2kb), which was possibly dimerized; 
Lane 3, plasmid construct pET28exsC (~5.8kb); Lane 4, plasmid construct pET28exsD 
(~6.2kb); Lane 5, plasmid construct pET28exsE (~5.6kb); Lane 6, Q-step 4 quantitative 
DNA ladder (Yorkshire Bioscience); Lane 7, empty pET28a vector linearized by HindIII 
digestion (~5.4kb); Lane 8, HindIII-digested plasmid construct pET28exsA (~6.2kb).  
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Because the over-expression of His-tagged Exs proteins was unstable in E.coli 
BL21(DE3) and C41(DE3) strains, the E.coli BL21Star™ (DE3) strain was used for 
stable overexpression of the Exs proteins. Due to the mutation in the RNaseE gene 
(rne131) of the E.coli BL21Star™ (DE3) strain, mRNA stability was increased and 
protein overexpression was enhanced. 
 
The His-tagged Exs protein over-expression was carried out following the 
methods in section 2.14. After sonication, both the soluble fraction and the insoluble 
fraction were loaded on SDS-PAGE gel to determine the solubility of the His-tagged 
Exs proteins (Figure 4.16). However, all of the His-tagged Exs proteins were present 
in the insoluble fraction. Several approaches were tried to solubilize the His-tagged 
Exs proteins, such as inclusion body preparation, but after dialyzing out the 
guanidine HCl or Urea, the proteins precipitated again and were not soluble until at 
least 3.2M Urea was added. Thereby 3.2M Urea was added to the Binding Buffer to 
solubilize the His-tagged Exs proteins for protein purification by affinity 
chromatography (section 2.16). After solubilizing the His-tagged Exs proteins in 
3.2M Urea, the samples were centrifuged at 30,000xg for 30min at 4°C to obtain the 
supernatant crude extracts, which were then loaded on HisTrap HP Column (GE 
Healthcare™) for protein purification. 
 
During protein purification of the His-tagged Exs proteins from the nickel 
column, the samples were collected at each point, such as crude extract, 
flow-through, wash fraction and elutions with different concentration of 
imidazole-added Binding Buffer (imidazole-BB). Then 10μl of each sample was 
loaded on a 12% SDS-PAGE gel (section 2.15) together with 1X Laemmli Buffer to 
determine the purified His-tagged Exs proteins (Figure 4.17, Figure 4.18, Figure 
4.19 and Figure 4.20). 
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Figure 4.16 A 12% SDS-PAGE gel showing the solubility of the His-tagged Exs proteins. 
Lane 1, BLUeye Prestained Protein Ladder (Geneflow); Lane 2, soluble fraction of 
HisExsA overexpression; Lane 3, insoluble fraction of HisExsA overexpression (~33kDa); 
Lane 4, soluble fraction of HisExsC overexpression; Lane 5, insoluble fraction of HisExsC 
overexpression (~18.5kDa); Lane 6, soluble fraction of HisExsD overexpression; Lane 7, 
insoluble fraction of His ExsDoverexpression (~33kDa); Lane 8, soluble fraction of 
HisExsE overexpression; Lane 9, insoluble fraction of HisExsE overexpression (~11kDa). 
All of the His-tagged Exs proteins were present in the insoluble fraction. The HisExsC 
was hardly visible on this gel, but present later on after protein purification. 
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Figure 4.17 A 12% SDS-PAGE gel showing the purification of HisExsA protein. Lane 1, 
the crude extract of HisExsA; Lane 2, the flow-through collected when loading crude 
extract; Lane 3, the wash fraction collected when washing the nickel column with 
Binding Buffer (BB); Lane 4, elution with 100mM imidazole-BB; Lane 5, elution with 
150mM imidazole-BB; Lane 6, elution with 200mM imidazole-BB; Lane 7, elution with 
300mM imidazole-BB; Lane 8, elution with 400mM imidazole-BB; Lane 9, elution with 
500mM imidazole-BB. The purified HisExsA (~33kDa) was obtained from lane 7, 8 and 9.  
Figure 4.18 A 12% SDS-PAGE gel showing the purification of HisExsC protein. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, the crude extract of HisExsC; 
Lane 3, the flow-through collected when loading crude extract; Lane 4, the wash fraction 
collected when washing the nickel column with Binding Buffer (BB); Lane 5, elution with 
100mM imidazole-BB; Lane 6, elution with 200mM imidazole-BB; Lane 7, elution with 
300mM imidazole-BB; Lane 8, elution with 400mM imidazole-BB; Lane 9, elution with 
500mM imidazole-BB. The purified HisExsC (~18.5kDa) was obtained from lane 7, 8 and 
9.   
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Figure 4.19 A 12% SDS-PAGE gel showing the purification of HisExsD protein. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, the crude extract of HisExsD; 
Lane 3, the flow-through collected when loading crude extract; Lane 4, the wash fraction 
collected when washing the nickel column with Binding Buffer (BB); Lane 5, elution with 
100mM imidazole-BB; Lane 6, elution with 150mM imidazole-BB; Lane 7, elution with 
200mM imidazole-BB; Lane 8, elution with 300mM imidazole-BB; Lane 9, elution with 
400mM imidazole-BB; Lane 10, elution with 500mM imidazole-BB. The purified HisExsD 
(~33kDa) was obtained from lane 9 and 10. 
Figure 4.20 A 12% SDS-PAGE gel showing the purification of HisExsE protein. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2 and 3, the crude extract of 
HisExsD; Lane 4, the flow-through collected when loading crude extract; Lane 5, the 
wash fraction collected when washing the nickel column with Binding Buffer (BB); Lane 
6, elution with 100mM imidazole-BB; Lane 7, elution with 150mM imidazole-BB; Lane 8, 
elution with 200mM imidazole-BB; Lane 9, elution with 300mM imidazole-BB; Lane 10, 
elution with 400mM imidazole-BB; Lane 11, elution with 500mM imidazole-BB. The 
purified HisExsE (~11kDa) was obtained from lane 9, 10 and 11.  
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4.5 Overexpression of Exs proteins using the pMAL™ system 
In order to determine the protein-protein interactions, the proteins were needed 
to be tagged with another detectable domain that could also possibly enhance the 
protein solubility. Therefore the maltose-binding protein (MBP) tag was chosen. 
 
To overexpress MBP-fused Exs proteins using pMAL™ Protein Fusion and 
Purification System, the genes encoding the Exs proteins were required to be 
cloned into the pMAL-c5X plasmid. Since the exs genes had already been inserted 
in-frame with the pET28a plasmids vector, it was easier to cut out the exs inserts 
from the pET28exs plasmid constructs and then ligated into digested pMAL-c5X, 
where they would be inserted in-frame to create an N-terminal MBP-fusion protein. 
The plasmid constructs pET28exsA, pET28exsC, pET28exsD and pET28exsE were 
digested with NdeI and EcoRI, then the inserts were gel extracted (section 2.4.3) to 
obtain double-digested exs fragments. In the meantime, the pMAL-c5X plasmid 
vector was digest with NdeI and EcoRI as well to allow ligation with the 
double-digested exs fragments. After ligation, ampicillin resistant colonies were 
screened by colony PCR screen using pMAL screening primers (Appendix 1) with 
Taq DNA polymerase (Figure 4.21). Once all exs genes were cloned into the 
pMAL-c5X plasmid vector, they were then sequenced using pMAL screening 
primers to ensure the in-frame insertion, the orientation of the inserts and no 
mutation in the inserts. After examination with sequencing and BLAST search, all 
plasmids were then transformed into E. coli ER2523 (NEB Express) for the 
over-expression of the MBP-fused Exs proteins. 
 
Once transformed, The E. coli expression strain ER2523 was induced with 
0.3mM IPTG for 2 hours at 37°C. The cells were harvested and sonicated followed 
by centrifugation to separate soluble and insoluble fractions. The whole-cell extracts, 
soluble fractions and insoluble fractions were loaded on a 12% SDS-PAGE gel to 
find out the solubility of the MBP-fused Exs proteins. The solubility was double 
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checked with Western Blot using murine anti-MBP antibody and HRP-conjugated 
goat anti-mouse IgG (Figure 4.22). Most of the MBP-fused Exs proteins were 
present in the soluble fraction while only MBP5 protein, which was expressed by the 
MBP-encoding gene on the pMAL-c5X plasmids, was present in the insoluble 
fractions (Figure 4.22). 
 
The soluble MBP-fused Exs proteins were then purified by affinity 
chromatography using MBPTrap HP columns supplied from GE Healthcare™ 
(section 2.17). The MBP-Exs fusion proteins were eluted from the MBPTrap HP 
columns by 10mM maltose and each fraction of the elution was collected together 
with the flow-through and the wash fraction. Then 10μl of each sample was mixed 
with 1X Laemmli Buffer to be loaded on SDS-PAGE gels (Figure 4.23, Figure 4.24, 
Figure 4.25 and Figure 4.26).  
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Figure 4.21 A 1% agarose gel showing the colony PCR screen of the pMALexs plasmid 
constructs. Lane 1-4, colony PCR screen of pMALexsA, in which lane 3 and 4 were 
potential positive constructs with an extra 900bp of the exsA inserts; Lane 5-8, colony 
PCR screen of pMALexsC, in which lane 5 and 6 were potential positive constructs with 
an extra 500bp of the exsC inserts; Lane 9-11, colony PCR screen of pMALexsD, in 
which all lanes were potential positive constructs with an extra 800bp of the exsD 
inserts; Lane 12-14, colony PCR screen of pMALexsE, in which lane 12 and 13 were 
potential positive constructs with an extra 200bp of the exsE inserts. 
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Figure 4.22 Western Blot using murine anti-MBP antibody to show the solubility of the 
MBP-fused Exs proteins. Lane 1, BLUeye Prestained Protein Ladder (Geneflow); Lane 
2, whole-cell extract of MBP-ExsA from NEB express; Lane 3, soluble fraction of 
MBP-ExsA, the expected size was 75kDa, which comprised of the size of ExsA (~33kDa) 
and MBP5 (~42kDa); Lane 4, insoluble fraction of MBP-ExsA; Lane 5, whole-cell extract 
of MBP-ExsC; Lane 6, soluble fraction of MBP-ExsC (~61kDa, 19kDa+42kDa); Lane 7, 
insoluble fraction of MBP-ExsC; Lane 8, whole-cell extract of MBP-ExsD; Lane 9, 
soluble fraction of MBP-ExsD (~75kDa, 33kDa+42kDa); Lane 10, insoluble fraction of 
MBP-ExsC; Lane 11, BLUeye Prestained Protein Ladder (Geneflow); Lane 12, 
whole-cell extract of MBP-ExsE; Lane 13, soluble fraction of MBP-ExsE (~53kDa, 
11kDa+42kDa); Lane 14, insoluble fraction of MBP-ExsE. The sizes of MBP-ExsA and 
MBP-ExsD were smaller than expected, which might be because the exact size of a 
fusion protein was not equal to the sum of its protein components.  
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Figure 4.23 A 10% SDS-PAGE gel showing the purification of MBP-ExsA fusion protein. 
Lane 1, BLUeye Prestained Protein Ladder (Geneflow); Lane 2, crude extract of 
MBP-ExsA before purification; Lane 3 and 4, the flow-through collected when loading 
crude extract; Lane 5, the wash fraction collected when wash the column with Column 
Buffer (section 2.17.1); Lane 6-10, elution with 10mM maltose. Purified MBP-ExsA  
fusion protein (~75kDa) was obtained from lane 8, 9 and 10. 
Figure 4.24 A 10% SDS-PAGE gel showing the purification of MBP-ExsC fusion protein. 
Lane 1, PageRuler Unstained Protein Ladder (Thermo Scientific); Lane 2, crude extract 
of MBP-ExsA before purification; Lane 3, the flow-through collected when loading crude 
extract; Lane 4, the wash fraction collected when wash the column with Column Buffer; 
Lane 5-12, elution with 10mM maltose. Purified MBP-ExsC fusion protein (~61kDa) was 
obtained from lane 6-12. 
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Figure 4.25 A 10% SDS-PAGE gel showing the purification of MBP-ExsD fusion protein. 
Lane 1, BLUeye Prestained Protein Ladder (Geneflow); Lane 2, crude extract of 
MBP-ExsD before purification; Lane 3 and 4, the flow-through collected when loading 
crude extract; Lane 5, the wash fraction collected when wash the column with Column 
Buffer; Lane 6-10, elution with 10mM maltose. Purified MBP-ExsD fusion protein 
(~75kDa) was obtained from lane 8, 9 and 10. 
Figure 4.26 A 10% SDS-PAGE gel showing the purification of MBP-ExsE fusion protein. 
Lane 1, Precision Plus Protein™ Unstained standards (Bio-Rad); Lane 2, the 
flow-through collected when loading crude extract; Lane 3, the wash fraction collected 
when wash the column with Column Buffer; Lane 4-8, elution with 10mM maltose. 
Purified MBP-ExsE fusion protein (~53kDa) was obtained from lane 4-6. 
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4.6 Investigation of the Exs protein interactions using Far-Western Blot 
As both the His-tagged and MBP-fused Exs proteins were obtained, the 
interactions between each of the Exs proteins were determined using Far-Western 
Blot (section 2.19). In Far-Western Blot, the target proteins were transferred from 
the SDS-PAGE gel onto a nitrocellulose membrane. Then the target proteins were 
probed with a putative interacting protein, which had a different tag with the target 
proteins on the nitrocellulose membrane. The interactions between two proteins 
could then be detected by Western Blot using antibodies against the tagged putative 
interacting protein.  
 
In this case, the purified His-tagged Exs proteins were loaded on an 
SDS-PAGE gel together with a MBP-fused Exs protein as a positive control (Figure 
4.27). They were then transferred onto a nitrocellulose membrane, which was 
probed with the MBP5 protein without Exs fusion as a negative control. The 
over-expression and purification of the MBP5 protein were carried out following the 
exact methods used for preparation of MBP-fused Exs proteins (Figure 4.28). Once 
the nitrocellulose membrane was probed with the MBP5 protein, the murine 
anti-MBP antibody was used followed by HRP-conjugated goat anti-mouse IgG to 
allow the detection of the MBP fusions (Figure 4.29). Only the positive control 
MBP-ExsC fusion protein was detected by anti-MBP antibody when probed with 
MBP5 protein, suggesting that the His-tagged Exs proteins were unable to interact 
with MBP5 protein without Exs fusions. 
 
Then the nitrocellulose membrane with His-tagged Exs proteins was probed 
with MBP-ExsA fusion protein to investigate the interactions between ExsA and 
each of the Exs proteins (Figure 4.30). The HisExsD protein was detected in the 
Far-Western Blot when probed with MBP-ExsA, indicating the interaction between 
ExsA and ExsD, although the interaction appeared weak. No interaction with ExsC 
or ExsE was seen. Furthermore, no self interaction with ExsA was observed.   
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Figure 4.27 A 12% SDS-PAGE gel showing the purified Exs proteins and a MBP-fused 
Exs protein as positive control for Far-Western Blot. Lane 1, BLUeye Prestained Protein 
Ladder (Geneflow); Lane 2, purified HisExsA protein (~33kDa); Lane 3, purified HisExsC 
protein (~18.5kDa); Lane 4, purified HisExsD protein (~33kDa); Lane 5, purified HisExsE 
protein (~11kDa); Lane 6, purified MBP-ExsC protein (~61kDa). The proteins on this 
SDS-PAGE gel were then transferred onto a nitrocellulose membrane for Far-Western 
Blot. 
Figure 4.28 A 10% SDS-PAGE gel showing the purification of the MBP5 protein. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, the flow-through collected when 
loading crude extract; Lane 3, the wash fraction collected when wash the column with 
Column Buffer; Lane 4-8, elutions with 10mM maltose. Purified MBP5 protein 
(~42.5kDa) without Exs fusion was obtained from lane 4-6.  
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Figure 4.29 Far-Western Blot of MBP5 probing His-tagged Exs proteins. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, purified HisExsA protein 
(~33kDa); Lane 3, purified HisExsC protein (~18.5kDa); Lane 4, purified HisExsD protein 
(~33kDa); Lane 5, purified HisExsE protein (~11kDa); Lane 6, purified MBP-ExsC protein 
(~61kDa) as a positive control. Only MBP-ExsC was observed after blotting with murine 
anti-MBP antibody, suggesting that MBP5 protein without Exs fusions was unable to 
interact with His-tagged Exs proteins.  
Figure 4.30 Far-Western Blot of MBP-ExsA probing His-tagged Exs proteins. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, purified HisExsA protein 
(~33kDa); Lane 3, purified HisExsC protein (~18.5kDa); Lane 4, purified HisExsD protein 
(~33kDa); Lane 5, purified HisExsE protein (~11kDa); Lane 6, purified MBP-ExsC protein 
(61kDa) as a positive control. The HisExsD protein was detected, suggesting ExsA-ExsD 
interaction.  
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When probing the His-tagged Exs proteins with MBP-ExsC in the Far-Western 
Blot, the HisExsD and HisExsE were detected by murine anti-MBP antibody and 
HRP-conjugated goat anti-mouse IgG (Figure 4.31). There were two bands of 
different sizes detected for HisExsD, one was the size of the HisExsD (~33kDa) while 
the other one was possibly the size of dimerized HisExsD (~66kDa). Apart from 
HisExsD, HisExsE was also detected when probed with MBP-ExsC, suggesting 
ExsC-ExsD interaction and ExsC-ExsE interaction. No interaction was seen for 
ExsA or self-interaction with ExsC. 
 
However, when MBP-ExsD was used to probe His-tagged Exs proteins, nothing 
was detected except for the positive control. Thereby, the Far-Western Blot was 
carried out reversely, using HisExsD to probe the MBP-fused Exs proteins. Thus 
MBP-fused Exs proteins were loaded on the SDS-PAGE gel and transferred onto 
the nitrocellulose membrane, which was probed with HisExsD followed by detection 
using mouse anti-His antibody and HRP-conjugated goat anti-mouse IgG (Figure 
4.32). Only MBP-ExsC protein was detected apart from the positive control, showing 
the interaction between ExsD and ExsC. 
 
In the meantime, the Far-Western Blot of MBP-ExsE probing His-tagged Exs 
proteins was carried out, in which the HisExsC and the HisExsE proteins were 
detected by anti-MBP antibody and HRP-conjugated goat anti-mouse IgG (Figure 
4.33). The presence of HisExsC and the HisExsE proteins in the Far-Western Blot 
probed with MBP-ExsE protein suggested the interactions between ExsE and ExsC 
as well as the ExsE-ExsE self-interaction. 
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Figure 4.31 Far-Western Blot of MBP-ExsC probing His-tagged Exs proteins. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, purified HisExsA protein 
(~33kDa); Lane 3, purified HisExsC protein (~18.5kDa); Lane 4, purified HisExsD protein 
(~33kDa); Lane 5, purified HisExsE protein (~11kDa); Lane 6, purified MBP-ExsC protein 
(~61kDa) as a positive control. The HisExsD and HisExsE proteins were detected, 
suggesting ExsC-ExsD and ExsC-ExsE interactions. The upper band showing in lane 4 
was possibly the size of a dimerized HisExsD (~66kDa), implying possible dimerization of 
ExsD protein in the presence of ExsC. 
Figure 4.32 Far-Western Blot of HisExsD probing MBP-fused Exs proteins. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, purified MBP-ExsA protein 
(~75kDa); Lane 3, purified MBP-ExsC protein (~61kDa); Lane 4, purified MBP-ExsD 
protein (~75kDa); Lane 5, purified MBP-ExsE protein (~53kDa); Lane 6, purified HisExsD 
protein (~61kDa) as a positive control. Only MBP-ExsC was detected when probed with 
HisExsD protein.  
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Figure 4.33 Far-Western Blot of MBP-ExsE probing His-tagged Exs proteins. Lane 1, 
BLUeye Prestained Protein Ladder (Geneflow); Lane 2, purified HisExsA protein 
(~33kDa); Lane 3, purified HisExsC protein (~18.5kDa); Lane 4, purified HisExsD protein 
(~33kDa); Lane 5, purified HisExsE protein (~11kDa); Lane 6, purified MBP-ExsC protein 
(~61kDa) as a positive control. The HisExsC and HisExsE were detected when probed 
with MBP-ExsE, suggesting ExsE-ExsC interaction and ExsE-ExsE self-interaction. 
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4.7 Discussion 
The protein-protein interactions among the Exs proteins were investigated both 
in-vivo and in-vitro through BACTH assay and Far-Western Blot respectively. The 
overall results of the interaction studies agreed with the hypothesis that 
ExsA-ExsD-ExsC-ExsE regulatory cascade was based on direct protein-protein 
interactions. 
 
The evidence in P. aeruginosa has suggested that the C-terminal domain of 
ExsA has two helix-turn-helix DNA binding motifs but lacks the ability to self-interact 
for cooperative binding of the DNA (Brutinel et al 2009). Furthermore, in P. 
aeruginosa, ExsD was shown to inhibit the DNA-binding ability of ExsA by 
interacting with the N-terminal domain of ExsA, which is involved in the ExsA-ExsA 
self-interaction (Brutinel et al 2010). However in this study, the C-terminal domain of 
the ExsA protein was shown to interact with both N-terminal and C-terminal domain 
of itself in the BACTH assay (Figure 4.8A). Rather than over-expressing only 120 
amino acid of C-terminal domain of ExsA (278 amino acids in total) in Brutinel’s 
study, the T25/T18 fusion to the N-terminal domain of ExsA might not be sufficient to 
block the interactions between ExsA and ExsD or ExsA-ExsA self-interaction.  
 
The reason why pKT25-exsD showed no ExsA-ExsD interaction when 
co-transformed with either pUT18-exsA or pUT18C-exsA was unclear, since 
C-terminal domain of ExsD showed strong interaction with either C-terminal or 
N-terminal domain of ExsA when co-transforming pUT18C-exsD with either 
pKT25-exsA or pKNT25-exsA (Figure 4.9). Also the T25 fragment was unlikely to be 
the reason of no interaction because pKNT25-exsD showed strong interaction with 
both pUT18-exsA and pUT18C-exsA (Figure 4.9).  
 
In Far-Western Blot, when MBP-ExsA was used to probe His-tagged Exs 
proteins, only HisExsD was detected although the interaction seemed weak. This 
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correlates with the recent findings in P. aeruginosa that ExsD is found to bind ExsA 
only as folding intermediate when these two proteins were synthesized together 
(Bernhards et al 2013). Thereby, strong interactions between ExsD and ExsA were 
observed in vivo using BACTH assay when they were co-expressed whereas weak 
interactions were shown in vitro using Far-Western Blot. 
 
However, in Far-Western Blot, when MBP-ExsD was used to probe His-tagged 
Exs proteins, no evidence of an interaction with any Exs protein was observed 
(Figure not shown), but when HisExsD was used to probe MBP-fused Exs proteins in 
Far-Western Blot, the interaction between ExsD and ExsC was observed (Figure 
4.32). As shown in Figure 4.1, in pKT25-exsD plasmid construct, the T25 fragment 
was fused to the N-terminal of the ExsD protein that allowed the C-terminal of ExsD 
to interact with other proteins. It might indicate that when large subunits such as T25 
fragment or MBP5 protein was fused to the N-terminal of ExsD protein, the 
interactions between ExsD and other Exs proteins were disabled, suggesting that 
the N-terminal domain of ExsD was required for protein-protein interactions. 
 
Furthermore, the BACTH assay showed no evidence of ExsD-ExsD 
self-interaction, which was also observed in the Far-Western Blot. However, when 
the HisExsD protein was probed with MBP-ExsC protein in Far-Western Blot, 
possible ExsD dimerization was observed, suggesting that ExsD dimerization might 
require the involvement of ExsC proteins. As it was reported in P. aeruginosa, the 
size of the ExsC-ExsD complex consisted of two molecules of both ExsC and ExsD 
proteins using Gel Filtration Chromatography and Analytical Ultracentrifugation, 
together with the Isothermal Titration Calorimetry data, which indicated an equal 
molar binding ratio of ExsC and ExsD, suggesting a heterotetramer complex of 
ExsC-ExsD at 2:2 ratio with a binding affinity of 18nM (Zheng et al 2007). However, 
the finding in this study does not correlate with the work of Berhards and collegues, 
who suggested the formation of ExsD homotrimer at 30°C in P. aeruginosa 
(Bernhards et al 2013). It might be because that the self-association requires 
155 
full-length of ExsD and both His-tagged and MBP-fused proteins were 
over-expressed in E. coli at 37°C. But the assay was not carried out at 37°C. 
 
The interactions of ExsC with each of the Exs proteins shown in BACTH assay 
revealed a potential hierarchy of ExsC interactions based on the binding affinity. The 
potential strongest interaction was observed in ExsC-ExsE, which was a typical 
T3SS chaperone-effector interaction described in P. aeruginosa (Dasgupta et al 
2004, Urbanowski et al 2005, Vogelaar et al 2010). Although in this study the 
binding kinetics was not yet carried out, the ExsC-ExsD interaction was thought to 
be weaker than the ExsC-ExsE interaction but stronger than the ExsC-ExsC 
self-interaction from the observation of the BACTH assay. This finding corresponds 
to the Isothermal Titration Calorimetry studies carried out by Zheng’s group, who 
has determined the binding affinities for ExsC-ExsD (18nM) and ExsC-ExsE (1nM) 
in P. aeruginosa (Zheng et al 2007). This suggests that the ExsC chaperone protein 
prefers to bind to the effector protein ExsE rather than the anti-activator ExsD. When 
the concentration of ExsE decreases, the abundant ExsC proteins bind to ExsD and 
antagonize the inhibition of ExsD on ExsA. Thereby the concentration of the effector 
protein ExsE plays a crucial role in the regulation of the ExsA transcriptional 
activation. 
 
However, quantitative assays are required to determine how strong the 
interactions are between ExsC and ExsD or between ExsC and ExsE in A. 
hydrophila. The BioLayer Interferometry (BLI) was carried out trying to investigate 
the binding kinetics of the Exs proteins using ForteBio BLItz™ system (Data not 
shown). The BLI assay utilizes glass-fibre based biosensors that immobilize protein 
X, which is able to bind protein Y. The protein binding in each case changes the 
wavelength of the reflection light that can be measured to calculate the binding 
affinity of the protein X to protein Y. However, in this study the binding of the second 
protein to the first protein was unsuccessful, thus the binding affinity between the 
Exs proteins remained unknown. The reason why BLItz assay failed was unclear but 
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it might be due to the insolubility of some of the His-tagged Exs proteins, which had 
to be dissolved in at least 3.2M Urea, hence an interference of the BLItz assay. 
 
The ExsC-ExsC self-interaction was shown to be the weakest in the BACTH 
assays while no evidence of the ExsC self-interaction was found using Far-Western 
Blots, suggesting that the self-interaction of ExsC was likely to be based on the 
interaction of ExsC with other Exs proteins. Both ExsD and ExsE were reported to 
bind to dimerized ExsC in P. aeruginosa, in which the ExsC-ExsD forms a 2:2 
heterotetramer while ExsC binds to ExsE in a 2:1 form (Vogelaar et al 2010, Zheng 
et al 2007). 
 
ExsE-ExsE self-interaction was shown to be very weak in BACTH assays, as 
pKT25-exsE showed no interaction with neither pUT18-exsE nor pUT18C-exsE 
while pKNT-exsE showed weak interaction with pUT18-exsE and pUT18C-exsE 
(Figure 4.13). It was hard to determine whether ExsE-ExsE self-interaction presents 
until the Far-Western Blot showed clear ExsE-ExsE interaction when HisExsE protein 
was detect by ExsE-MBP probing. 
 
The interactions that was shown in BACTH assay but not shown in Far-Western 
Blot were ExsA-ExsA, ExsD-ExsA and ExsC-ExsC. There were several possible 
reasons why these interactions were not present in Far-Western Blot. First of all, 
Far-Western Blot is an in-vitro method to investigate protein-protein interactions, 
thus some of the interactions may require the in-vivo environment to take place. 
Also, the size of MBP5 fusion protein is approximately 42.5kDa, which is fused to 
the N-terminal of the Exs protein and is much larger than the sizes of both T25 and 
T18 fragment of CyaA protein. Thus the interactions that involved N-terminal 
domains of the Exs proteins, especially for ExsA and ExsD proteins, were possibly 
blocked by the MBP-fusion. Although there were approaches that utilized factor Xa 
to cleave the MBP proteins off the MBP-fused Exs proteins, this was not feasible 
due to the stability and solubility of the Exs proteins.  
157 
 
The reason why the His-tagged Exs proteins were insoluble was unknown. It 
was not because of pH of the Binding Buffer, as the isoelectric points (pI) of the Exs 
proteins (6.53 for HisExsA, 5.44 for HisExsC, 6.13 for HisExsD and 11.54 for HisExsE) 
were not close to the pH of the Binding Buffer (pH 7.9). If the pI of the proteins were 
close to the pH of the Binding Buffer, the net charges of the proteins were close to 
zero, thereby rather than interacting with the buffer to become solubilized, the 
proteins preferred to interact with each other to precipitate. However, as several of 
the proteins appear to be chaperones, a co-expression approach using pET-Duet 
should be attempted. This should allow observation of direct protein-protein 
interactions in pull-down assays. 
 
4.8 Conclusion 
 Direct protein-protein intections were found between ExsA-ExsA, ExsA-ExsD, 
ExsD-ExsC and ExsC-ExsE using BACTH system  
 His-tagged and MBP-fused Exs proteins were overexpressed and purified for 
Far-Western Blot. 
 Direct protein-protein interactions were found between ExsA-ExsD, ExsD-ExsC, 
ExsC-ExsE and ExsE-ExsE using Far-Western Blot. 
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 Chapter 5.  
Regulation of Lateral Flagella 
System 
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5.1 Introduction 
The flagellated Gram-negative bacteria A. hydrophila consists of two distinct 
flagella system, polar flagella and lateral flagella systems, in which the polar flagella 
system allows the bacteria to swim in liquid environments while the lateral flagella 
system allows the bacteria to swarm over the solid surfaces. Both flagella systems 
provide the bacteria with the ability to move towards more promising environments 
or away from less favourable conditions. Early in 1985, a Japanese group observed 
peritrichous lateral flagella in A. caviae and A. hydrophila by electron microscopy 
(Shimada et al 1985). Later in 2002, it was found that more than half of the 
mesophilic Aeromonas spp. possessed both flagella systems. Among these species, 
A. caviae and A. hydrophila are the most clinically isolated strains (Kirov et al 2002). 
However the lateral flagella system was described to be involved in the pathogenic 
association with host cells in E.coli and Salmonella typhimurium in 1994 (Harshey 
1994). This led to a rapid progress in understanding the function of the lateral 
flagella system in Gram-negative bacteria including Aeromonas species, in which 
the lateral flagella system was reported to be involved in host cell adherence and 
biofilm formation (Gavin et al 2002, Kirov 2003). 
 
It was reported that the lateral flagella gene clusters of A. hydrophila are 
comprised of 38 genes, located in a single chromosomal region rather than two 
distinct chromosomal regions as is seen in V. parahaemolyticus (Canals et al 2006a, 
Kirov 2003). The regulation of the lateral flagella system is mediated by the master 
regulator LafK and is dependent upon many other factors, such as T3SS and 
c-di-GMP levels (Gavin et al 2002, Merino et al 2006, Tamayo et al 2007, Yu et al 
2007).  
 
Unlike V. parahaemolyticus, in which the mutations in polar flagellum result in 
constitutive expression of lateral flagella, mutagenesis of polar flagellum production 
in Aeromonas does not affect the expression of the lateral flagella (Gavin et al 2002, 
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Merino et al 2006). However the intracellular c-di-GMP level has been shown to play 
a role in the regulation of the lateral flagella system in Vibrio and in Aeromonas, in 
both of which high intracellular c-di-GMP concentration represses the expression of 
the lateral flagella while low c-di-GMP level enhance the swarming motility caused 
by increased lateral flagella expression (Tamayo et al 2007). 
 
It was also reported in the A. hydrophila AH-1 strain that the expression levels 
of two tandem lateral flagellin genes lafA1 and lafA2 were decreased drastically 
when exsD or aopN genes were knocked out (Yu et al 2007). Similar findings were 
discovered in a previous study of the A. hydrophila AH-3 strain in our laboratory, 
where two of the non-swarming transposon mutants were found to be mutated in the 
exsD gene (Shaw unpublished). As it was indicated before, the exsD gene encoded 
an anti-activator protein ExsD that inhibited the T3SS master regulator ExsA. Thus 
the mutation in exsD gene resulted in activation of the T3SS, suggesting potential 
cross-talk between the lateral flagella system and the T3SS in A. hydrophila. 
 
In this study, the potential cross-talk between the two systems was investigated 
by swarming assays of different mutants and measurement of the lateral flagella 
promoters in various backgrounds. 
  
161 
5.2 Swarming assays of A. hydrophila AH3R wild type and different 
mutants 
Different strains of A. hydrophila AH3R including the exsA mutant, exsC mutant, 
exsD mutant, exsE mutant and a previously constructed lafK mutant were plated on 
the swarming agar (section 2.1.4) together with the A. hydrophila AH3R wild type 
(Figure 5.1). The wild type strain of A. hydrophila AH3R was able to swarm on the 
surface of the 0.6% (w/v) semi-solid agar, but when the major regulator of the 
Aeromonas lateral flagella system was knocked out in the lafK mutant, the swarming 
motility was completely lost. On the other hand, the swarming motility was not 
affected in the exsA mutant and exsC mutant as the mutant strains were able to 
swarm as much as in wild type strain. However, when the exsD gene or exsE gene 
was knocked out, the swarming motility was repressed as it was in the lafK mutant 
(Figure 5.1). 
 
The phenotypes of the swarming assays were quantified by measuring the 
swarming diameters of each strain on the swarming agar after overnight incubation 
at 30°C (Figure 5.2). The average swarming diameter of the A. hydrophila AH3R 
wild type strain was 6.9cm while it was significantly decreased to 1.1cm in the lafK 
mutant strain (p<0.001). The swarming motility of exsA mutant and exsC mutant 
strains were not significantly different from the wild type strain, with an average 
swarming diameter of 5.7cm and 6.3cm respectively (p>0.05). Moreover the 
swarming motility was significantly repressed in exsD mutant and exsE mutant 
strains when compared to the wild type strain, the exsA mutant and exsC mutant 
strains (p<0.001). The average swarming diameters of exsD mutant and exsE 
mutant strains were 2.7cm and 2.6cm respectively. The swarming diameters were 
measured at least 15 times for each strain and each time the different strains were 
plated on the same 220mm x 220mm square petri dishes with swarming agar to 
minimize the variations.  
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Figure 5.1 Swarming assays of different mutant strains of A. hydrophila AH3R. The 
exsA mutant and exsC mutant had similar swarming motility as the A. hydrophila AH3R 
wild type, while the swarming motility was repressed in the lafK mutant, exsD mutant 
and exsE mutant on the surface of 0.6% (w/v) swarming agar. Bacteria were incubated 
on the swarming agar at 30°C overnight. The experiment was repeated at least 15 
times.  
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Figure 5.2 Quantification of the swarming assays of A. hydrophila AH3R wild type and 
mutant strains. The swarming diameter of each strain was measured on the swarming 
agar after overnight incubation at 30°C. The swarming diameters were significantly 
lower in the lafK mutant when compared to the A. hydrophila AH3R wild type 
(p***<0.001), while there was no significant difference of swarming diameters among 
the wild type strain, the exsA mutant and exsD mutant (p>0.05). However, the swarming 
diameters of exsD mutant and exsE mutant was significant decreased when compared 
to the exsA mutant and exsC mutant (p***<0.001). The swarming diameters were 
measured at least 15 times for each strain. The error bars showed Standard Error of the 
Mean (SEM). The significance was determined using Student’s t-test.  
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5.3 Construction of lacZ-fusion vector with lateral flagella promoters 
In order to measure the changes of lateral flagella promoter activities in 
different mutant backgrounds, the putative promoters of lateral flagella system were 
cloned with a promoter-less lacZ gene on the reporter plasmid vector pKAGb-2(-). 
 
First of all, the putative promoter regions of the lateral flagella system were 
identified according to the designation of the open reading frames (ORFs) reported 
in A. hydrophila AH3. A total number of 9 putative promoters of the lateral flagella 
system were proposed according to the homology with other bacteria and confirmed 
by RT-PCR of the ORFs in previous studies (Canals et al 2006a, Gavin et al 2002). 
Each putative promoter region was 400-800bp in length and was named as PfliM, 
PlafK, PflgM, PflgA, PflgB, Pmaf, PlafA, PlafB and PlafX, after the first gene 
immediately downstream of the putative promoters (Figure 5.3). 
 
The construction of the plasmids pKAG-PfliM pKAG-PlafK, pKAG-PflgM, 
pKAG-PflgA, pKAG-PflgB, pKAG-Pmaf, pKAG-PlafA, pKAG-PlafB and pKAG-PlafX 
(pKAG-PLF constructs) were achieved by the fusion of the lateral flagella promoter 
regions with the promter-less lacZ gene in the reporter plasmid vector pKAGb-2(-) 
(Figure 5.4). First, the putative promoter regions were amplified by PCR from the A. 
hydrophila AH3R chromosomal DNA using amplification primers for each promoter 
regions (Appendix 1) together with Platinum Pfx DNA polymerase (Figure 5.5). The 
forward amplification primer of each promoter regions introduced a HindIII restriction 
site at 5’ end of the PCR product while the reverse primers introduced a BamHI 
restriction site at 3’ end. The PCR products of each lateral flagella promoter regions 
were then digested with HindIII and BamHI in order to ligate with the HindIII and 
BamHI double-digested pKAGb2(-) plasmid vector (Figure 5.5).  
 
The ligated samples were transformed into E. coli DH5α competent cells and 
successful constructs were selected by colony PCR screen using the pKAGb2(-) 
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screening primers (bla forward and lacZ reverse, Appendix 1) and Taq DNA 
polymerase. The screen of the pKAG-PlafX construct was shown as an example of 
successful colony PCR screen (Figure 5.6).  
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Figure 5.3 Illustration of the lateral flagella gene region in A. hydrophila AH3R. The putative promoter regions were shown in bent arrows and 
named as PfliM, PlafK, PflgM, PflgA, PflgB, Pmaf, PlafA, PlafB and PlafX after the name of first gene downstream. Each promoter region was 
400-800bp in length and were amplified by PCR and cloned into lacZ-fusion plasmid pKAGb-2(-) to measure the activity in different backgrounds. 
The figure is adapted from Canals, et al. (2006). 
 
167 
 
Figure 5.4 Illustration of the lateral flagella promoter regions cloning with a 
promoter-less lacZ gene in the reporter plasmid vector pKAGb-2(-). The insertion of the 
lateral flagella promoter regions were represented by the triangle. Both the lateral 
flagella promoter inserts and the pKAGb-2(-) plasmid vector were digested with HindIII 
and BamHI restriction enzymes. The putative promoter was inserted upstream of a 
promoter-less lacZ gene in order to measure the promoter activity by β-galactosidase 
assay. The plasmid carried a chloramphenicol resistance gene which was used to select 
successful transformants or conjugants. Key features of the plasmid were shown in 
large arrows. This figure was created using SnapGene software. 
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Figure 5.5 A 1% agarose gel picture showing the PCR products of lateral flagella 
putative promoters. Lane 1, Q-step 4 quantitative DNA ladder (Yorkshire Bioscience); 
Lane 2, PCR product of PfliM region (~400bp); Lane 3, PCR product of PlafK region 
(~800bp); Lane 4, PCR product of PflgM region (~800bp); Lane 5, PCR product of PflgA 
region (~600bp); Lane 6, PCR product of PflgB region (~800bp); Lane 7, PCR product 
of PlafA region (~800bp); Lane 8, PCR product of PlafB region (~700bp); Lane 9, PCR 
product of PlafX region (~600bp); Lane 10, PCR product of Pmaf region (~800bp); Lane 
11, HindIII and BamHI double digested pKAGb-2(-) plasmid vector (~9kb). 
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Figure 5.6 A 1% agarose gel showing the colony PCR screen pKAG-PLF constructs. 
Lane 1, Q-step 4 quantitative DNA ladder (Yorkshire Bioscience); Lane 2, colony PCR 
screen of the pKAG-PfliM construct, Lane 3, colony PCR screen of the pKAG-PflgM 
construct ; Lane 4, colony PCR screen of the pKAG-PflgB construct ; Lane 5, colony 
PCR screen of the pKAG-Pmaf construct ; Lane 6, colony PCR screen of the 
pKAG-PlafA construct ; Lane 7, colony PCR screen of the pKAG-PlafB construct ; Lane 
8, colony PCR screen of the pKAG-PlafX construct ; Lane 9, colony PCR screen of the 
pKAGb-2(-) plasmid control. Only pKAG-PlafX screen was a successful construct with 
an extra 600bp of the PlafX insertion. 
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5.4 β-Galactosidase assay of the lateral flagella promoters 
The successful constructs were extracted from the E. coli DH5α cells (Figure 
5.7) and were sequenced using the pKAGb-2(-) screening primers (bla and lacZ) by 
Core Genomic Facility, University of Sheffield. The sequencing results were 
analysed using FinchTV and BLAST search to ensure the insertion of the lateral 
flagella promoter regions into the lacZ-fusion plasmid vector pKAGb-2(-). 
 
The pKAG-PLF plasmid constructs were then transformed into E. coli S17-λpir 
cells in order for conjugation into A. hydrophila AH3R. Followed by conjugation, the 
chloramphenicol resistant A. hydrophila AH3R colonies were selected, which 
possessed the pKAG-PLF plasmid constructs independently. Then the 
β-galactosidase activities of the lateral flagella promoters were measured either in 
liquid conditions, in which the bacteria were grown in LB broth at 30°C with 200rpm 
shaking overnight, or in solid conditions, in which the bacteria were grown on 
swarming agar at 30°C overnight and the edge of the swarmer cells were 
resuspended in sterile PBS for β-galactosidase assay (Figure 5.8). 
 
The β-galactosidase activity of promoter PflgM was significantly increased from 
54 MU to 436 MU on swarming agar when compared to broth culture (p<0.001). 
Same pattern was also found for promoter PflgB, the β-galactosidase activity of 
which was 375 MU in liquid conditions but significantly increased to 970 MU when 
grown in solid conditions (p<0.001). The promoter activity of PlafA when grown in 
broth culture was 318 MU and it was significantly increased to 976 MU when grown 
on swarming agar (p<0.001). Furthermore, the promoter activity of PlafX was 
significantly increased from 145 MU in liquid condition to 349 MU in solid conditions 
(p<0.001) (Figure 5.8). 
 
However, there was no significant difference of the promoter activities when 
grown in liquid or solid conditions for promoters PfliM, PflgA, Pmaf and PlafB 
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(p>0.05). The β-galactosidase activity of promoter PfliM was 190 MU when grown in 
broth culture while it was 247 MU when grown on swarming agar (p>0.05). The 
β-galactosidase activity of promoter PflgA was 358 MU when grown in broth culture 
while it was 297 MU when grown on swarming agar. The promoter activity of Pmaf 
was 118 MU in liquid condition while it was 90 MU in solid condition and the 
promoter activity of PlafB was 41 MU in liquid condition while it was 59 MU in solid 
condition (Figure 5.8). 
 
Only the promoter activity of PlafK was significantly decreased when grown on 
swarming agar compared to grown in broth culture (p<0.001). The β-galactosidase 
activity of PlafK in liquid conditions was 139 MU while it was decreased to 26 MU in 
solid condition, which was almost completely suppressed (Figure 5.8). 
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Figure 5.7 A 1% agarose gel showing successful pKAG-PLF plasmid constructs. Lane 1, 
plasmid construct of pKAG-PfliM (~9.5kb); Lane 2, plasmid construct of pKAG-PlafK 
(~9.5kb); Lane 3, plasmid construct of pKAG-PflgM (~9.5kb); Lane 4, plasmid construct 
of pKAG-PflgA (~9.5kb); Lane 5, plasmid construct of pKAG-PflgB (~9.5kb); Lane 6, 
Promega™ Supercoiled DNA Ladder (2-10kb); Lane 7, plasmid construct of 
pKAG-Pmaf (~9.5kb); Lane 8, plasmid construct of pKAG-PlafA (~9.5kb); Lane 9, 
plasmid construct of pKAG-PlafB (~9.5kb); Lane 10, plasmid construct of pKAG-PlafX 
(~9.5kb). 
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Figure 5.8 β-galactosidase activities of lateral flagella promoters measured in liquid 
condition (in LB broth) or in solid condition (on swarming agar) in A. hydrophila AH3R 
wild type. The β-galactosidase activities of promoters PflgM, PflgB, PlafA and PlafX 
were increased significantly when grown on swarming agar compared to grown in LB 
broth (p***<0.001), while there was no significant difference of the promoter activities 
when grown in broth culture or on swarming agar for PfliM, PflgA, Pmaf and PlafB 
promoters (p>0.05). Only the promoter activity of PlafK was significantly decreased 
when grown on swarming agar (p<0.001). The experiment was repeated at least three 
times for each bar. The error bars showed Standard Error of the Mean (SEM). The 
graph was created using GraphPad™ Prism 5. The significance was determined using 
Student’s t-test. 
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Among the putative promoters, PfliM, PflgB and PlafA were further analysed to 
investigate the potential cross-talk between the lateral flagella system and the T3SS 
by measuring the β-galactosidase activities of these promoters in different mutant 
backgrounds, including the lafK mutant and all of the exs mutants. 
 
The plasmid constructs pKAG-PfliM, pKAG-PflgB and pKAG-lafA were 
conjugated into the exsA mutant, exsD mutant, exsC mutant and exsE mutant and 
chloramphenicol resistant mutant strains were selected. The mutant strains that 
carried pKAG-PLF constructs were then incubated at 30°C overnight on the 
swarming agar in order for the β-galactosidase assay. 
 
The β-galactosidase activity of promoter PfliM measured in the A. hydrophila 
AH3R wild type strain was 247 MU while it was significantly decreased to 22 MU in 
the lafK mutant (p<0.001). The promoter activity of PfliM was 215 MU in the exsA 
mutant but significantly decreased to 88 MU when measured in the exsD mutant 
strain (p<0.001). Similarly, in the exsC mutant strain, the promoter activity of PfliM 
was 225 MU while decreased significantly to 143 MU in the exsE mutant strain 
(p<0.001). There was no significant difference of the promoter activities among the 
exsA mutant, the exsC mutant and the wild type strains (p>0.05). However, the 
promoter activity in the exsD mutant was significantly higher than in the lafK mutant 
while it was significantly lower than in the exsE mutant (p<0.001) (Figure 5.9).  
 
The β-galactosidase activity of promoter PflgB in the A. hydrophila AH3R wild 
type strain was 970 MU while significantly decreased to 20 MU in the lafK mutant 
(p<0.001). The promoter activity was 684 MU in the exsA mutant strain, which was 
not significantly different with the promoter activities in the wild type and the exsC 
mutant strain (p>0.05) while it was significantly higher than the promoter activities in 
the lafK mutant, exsD mutant and exsE mutant strains (p<0.001). The promoter 
activity of PflgB was 105 MU in the exsD mutant while it was significantly increased 
to 665 MU in the exsC mutant strain (p<0.001). The β-galactosidase activity of 
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promoter PflgB was 435 MU in the exsE mutant, which was significantly lower than 
in the wild type, the exsA mutant and the exsC mutant strains but significantly higher 
than in the lafK mutant and exsD mutant strains (p<0.001) (Figure 5.10).  
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Figure 5.9 β-galactosidase activities of promoter PfliM in A. hydrophila AH3R wild type 
and mutant backgrounds. The promoter activities were measured when each strain was 
grown on swarming agar at 30°C overnight. Compared to the wild type strain, the 
promoter activity of PfliM was significantly decreased when the lateral flagella major 
regulator lafK was knocked out (p***<0.001), but there was no significant difference 
between the promoter activities in exsA mutant and the wild type strain (p>0.05). The 
promoter activity of PfliM was significantly decreased in the exsD mutant when 
compared to the exsA mutant (p***<0.001). Smiliarly in the exsE mutant, the promoter 
activity of PfliM was a significant decreased compared to the exsC mutant (p***<0.001). 
There was no significant difference of the promoter activities between the exsA mutant 
and the exsC mutant (p>0.05). The promoter activity of PfliM was significantly higher in 
the exsD mutant than in the lafK mutant, moreover, the promoter activity was 
significantly higher in the exsE mutant than in the exsD mutant (p***<0.001). The 
experiment was repeated at least three times for each bar. The error bars showed 
Standard Error of the Mean (SEM). The graph was created using GraphPad™ Prism 5. 
The significance was determined using Student’s t-test. 
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Figure 5.10 β-galactosidase activities of promoter PflgB in A. hydrophila AH3R wild 
type and mutant backgrounds. The promoter activities were measured when each strain 
was grown on swarming agar at 30°C overnight. Compared to the wild type strain, the 
promoter activity of PflgB was significantly decreased when the lateral flagella major 
regulator lafK was knocked out (p***<0.001), but there was no significant difference 
between the promoter activities in exsA mutant and the wild type strains (p>0.05). The 
promoter activity of PflgB was significantly decreased in the exsD mutant when 
compared to the exsA mutant or exsC mutant strains (p***<0.001). In the exsE mutant, 
there was a significant decrease of the promoter activity of PfliM when compared to the 
exsC mutant or the exsA mutant strains (p***<0.001). There was no significant 
difference of the promoter activities between exsA mutant and exsC mutant strains 
(p>0.05). The promoter activity of PflgB was significantly higher in the exsD mutant than 
in the lafK mutant, moreover, the promoter activity was significantly higher in the exsE 
mutant than in the exsD mutant (p***<0.001). The experiment was repeated at least 
three times for each bar. The error bars showed Standard Error of the Mean (SEM). The 
graph was created using GraphPad™ Prism 5. The significance was determined using 
Student’s t-test.  
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The pattern of the β-galactosidase activity of promoter PlafA was similar to 
PfliM and PflgB. In the A. hydrophila AH3R wild type strain, the promoter activity of 
PlafA was 976 MU while it was decreased significantly to 22 MU in the lafK mutant 
strain (Figure 5.11). The promoter activity of PlafA in the exsA mutant was 771 MU, 
which was significantly lower than in the wild type (p<0.05), but significantly higher 
than in the lafK mutant (p<0.001), exsD mutant (p<0.001) and exsE mutant strains 
(p<0.01). The promoter activity in the exsD mutant was 240 MU, which was 
approximately 4-fold lower than in the wild type strain and 3-fold lower than in the 
exsA mutant strain. The β-galactosidase activity of PlafA was 734 MU in the exsC 
mutant strain, which was not significantly different with the promoter activity in the 
exsA mutant (p>0.05) but significantly lower than in the wild type strain (p<0.01). 
Unlike PfliM and PflgB, the promoter activity of PlafA in the exsE mutant strain was 
638 MU, which was not significantly different with the promoter activity measured in 
the exsC mutant (p>0.05) but significantly lower than the exsA mutant (p<0.01). The 
promoter activity of PlafA in the exsE mutant was also significantly higher than in the 
exsD mutant (p<0.001), which was approximately 2.5-fold higher (Figure 5.11). 
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Figure 5.11 β-galactosidase activities of promoter PlafA in A. hydrophila AH3R wild type 
and mutant backgrounds. The promoter activities were measured when each strain was 
grown on swarming agar at 30°C overnight. Compared to the wild type strain, the 
promoter activity of PlafA was significantly decreased in the lafK mutant (p***<0.001), in 
the exsA mutant (p*<0.05) and in the exsC mutant (p**<0.01). The promoter activity of 
PflgB was significantly decreased in the exsD mutant when compared to the exsA 
mutant or exsC mutant strains (p***<0.001). In exsE mutant, the promoter activity of 
PlafA was a significant decrease when compared to the the exsA mutant strains 
(p**<0.01), but not significantly different from the promoter activity in exsC mutant 
(p>0.05). There was no significant difference of the promoter activities between exsA 
mutant and exsC mutant strains (p>0.05). The promoter activity of PlafA in the exsD 
mutant was significantly higher than in the lafK mutant, but significantly lower than in the 
exsE mutant (p***<0.001). The experiment was repeated at least three times for each 
bar. The error bars showed Standard Error of the Mean (SEM). The graph was created 
using GraphPad™ Prism 5. The significance was determined using Student’s t-test. 
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5.5 Discussion 
It was not surprising that the swarming motility was completely repressed in the 
lafK mutant as shown in the swarming assay, since lafK is responsible for encoding 
the major regulator of the A. hydrophila lateral flagella system, LafK. Moreover, the 
significant decrease of swarming motility was also observed in the exsD insertional 
knockout as well as in the exsE insertional knockout. It was in consensus with the 
hypothesis that there was potential cross-talk between the T3SS and the lateral 
flagella system of A. hydrophila. When the anti-activator ExsD was knocked out, the 
decrease of swarming motility suggested that the T3SS master regulator ExsA 
might play a negative regulatory role on the lateral flagella system. Thereby the 
swarming motility was de-repressed in the exsC mutant strains, in which the ExsA 
protein was inhibited by the abundant anti-activator ExsD. However, in the absence 
of ExsE, the effector-chaperone interaction was abolished so that the chaperone 
protein ExsC was bound to the anti-activator ExsD, thus allowing abundant ExsA to 
repress the lateral flagella system. This finding agrees with the previous study of 
transposon library screen, in which the exsD gene was mutated in two of the 
non-swarming transposon mutants. It also correlates to the findings of Leung’s 
group, who has demonstrated decreased expression and secretion level of the 
lateral flagellins LafA1 and LafA2 in the absence of ExsD protein in A. hydrophila 
AH-1 strain (Yu et al 2007).  
 
It was reported in many bacteria including V. parahaemolyticus and A. 
hydrophila that the lateral flagella system is hierarchically controlled at three levels 
(Wilhelms et al 2013) (Figure 5.12). The Class I promoters, including PfliM, PlafK 
and PflgA, were σ70-dependent and responsible for the transcription of the foremost 
genes, encoding the major regulator LafK and structural components such as C ring 
and P ring (Figure 5.12). The enhancer-binding protein LafK together with an 
alternative sigma factor RpoN (σ54) were required for the activation of the Class II 
promoters, including PflgB and PlafX, which were responsible for the transcription of 
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the lateral flagella-specific sigma factor LafS (σ28) and the other structural 
components forming the rod and the hook (Figure 5.12). Class III promoters, 
including PflgM, Pmaf, PlafA and PlafB, were LafS (σ28)-dependent and were 
involved in the transcription of the cognate anti-σ28 factor FlgM and the flagellin 
proteins (Canals et al 2006a) (Figure 5.12).  
 
When compared to the β-galactosidase activities of lateral flagella promoters 
measured in either liquid conditions or solid conditions, 4 out of 9 putative lateral 
flagella promoters (PflgM, PflgB, PlafA and PlafX) were significantly more active 
when grown on swarming agar compared to growth in LB broth (p***<0.001) (Figure 
5.8). This finding suggested that the promoters of the lateral flagella system were 
regulated in response to the growth conditions of the bacteria and were more active 
when grown on solid surfaces. It correlates with the polymorphic lifestyle of the A. 
hydrophila, which utilizes the polar flagella to swim in the liquid environment and 
expresses lateral flagella to swarm over the solid surfaces. On the other hand, there 
was no significant difference of the promoter activities when grown in broth culture 
or on swarming agar for PfliM, PflgA, Pmaf and PlafB promoters (p>0.05) (Figure 
5.8), suggesting that these promoters were possibly not responding to the 
environmental signal when the bacteria changing its lifestyle. The promoter PlafK 
was the only promoter showed significantly higher activity in the broth culture than 
on the swarming agar, suggesting possible negative feedback on the major 
regulator LafK. This also supports the findings of Wilhelms’ and collegues, who have 
demonstrated that a number of lateral flagella promoters, such as PlafK and PflgA 
are transcribed and are active in liquid conditions (Wilhelms et al 2013). 
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Figure 5.12 The transcriptional hierarchy of the lateral flagella system in Aeromonas 
species. The operon comprised of fliMNPQRflhAB genes is regulated by the promoter 
PfliM. The flgA-flgN operon is under control of the PflgA promoter. The operon of 
lafK-fliJ is regulated by the promoter PlafK. These 3 promoters are σ70-dependent and 
categorized as Class I promoters. The lateral flagella system major regulator LafK is 
expressed under control of the Class I promoters. Together with RpoN (σ54), LafK is 
required to activate the σ54-dependent promoters. The promoter PflgB that regulates the 
operon flgB-flgL and the promoter PlafX that regulates the operon lafX-lafU are 
σ54-dependent and categorized as Class II promoters. The promoter PlafX is 
responsible for the expression of the LafS (σ28), which is required for the activation of 
σ28-dependent promoters. The promoter PflgM that regulates flgMN genes, Pmaf that 
regulates maf-5 gene, PlafA that regulates the lafA gene and PlafB that regulates lafBC 
genes are σ28-dependent and categorized as Class III promoters. This figure was 
adapted from Wilhelms, et al. (2013) 
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The promoters PfliM, PflgA, Pmaf and PlafB that were not elevated in solid 
conditions were responsible for the activation of the genes encoding the structural 
components or involved in the assembly of the flagella. Among these four promoters, 
PfliM and PflgA were Class I promoters, which were σ70-dependent and are 
constitutively activated. A total of 8 genes were under control of these two promoters, 
fliM, fliN, fliP, fliQ, fliR, flhB and flhA which were regulated by promoter PfliM; flgA under 
control of PflgA. Based on homology studies to V.parahaemolyticus, the genes in 
the operon fliM-flhB that were regulated by the promoter PfliM were reported to 
encode either structural components of the C-ring (fliM and fliN) or involved in the 
export and assembly of the flagella (flip, fliQ, fliR and flhB) while FlgA that was 
encoded by flgA was a P-ring structural protein (Canals et al 2006a). Thereby the 
expression of the lateral flagella system when the bacteria were grown on the 
swarming agar did not affect the promoter activities of PfliM and PflgA. 
 
As for the Pmaf promoter, it is responsible for the transcription of the maf-5 
gene, which encodes the Maf-5 (modification accessory factor) protein (Wilhelms et 
al 2012). As Maf-5 is a lateral flagella glycosyl-transferase it is involved in the 
glycosylation of the flagellin protein LafA with pseudamic acid. It was also reported 
recently that the glycosylation by Maf proteins was required for full function of the 
polar flagellin in A. caviae (Parker et al 2012, Parker et al 2014). Therefore, the 
protein product of maf-5 was possibly required when the bacteria were grown in the 
broth culture as well, thus no significant difference of the Pmaf promoter activity was 
observed in between liquid or solid conditions. 
 
On the other hand, the promoter PlafB, which was not elevated in solid 
conditions, was responsible for the expression of LafB protein. LafB was reported to 
be a HAP2 flagella capping protein and mutation in lafB repressed the swarming 
motility of A. hydrophila while not affecting the polar flagella (Gavin et al 2002). The 
reason why the promoter activity of PlafB was not increased when grown on 
swarming agar was unclear, but the promoter activities PlafB was significantly lower 
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than the other lateral flagella promoters when grown in solid conditions (except for 
PlafK), suggesting that the putative promoter regions of PlafB cloned into the 
lacZ-fusion plasmid vector might not include the intact promoter sequence.  
 
As for the the other Class I promoter PlafK, which was responsible for the 
expression of the lateral flagella major regulator LafK, the promoter activity of PlafK 
was not increased but significantly decreased when grown on swarming agar 
(p<0.001). This pattern was similar to what was found earlier for PexsA promoter, 
which was responsible for the transcription of the T3SS master regulator ExsA. It 
was possible that the lateral flagella major regulator LafK was under control of a 
negative feedback loop similar to ExsA, that the expression of which was repressed 
by itself. This speculation can be tested by measuring the promoter activity of PlafK 
while over-expressing the lafK gene from an IPTG-inducible plasmid vector, such as 
pBBR1MCS-5 or pSRKGm, in A. hydrophila AH3R, using an empty plasmid vector 
as a negative control. 
 
One promoter was picked up from each of the Class I (PfliM), Class II (PflgB) 
and Class III (PlafA) promoters and the promoter activities were measured in the 
wild type, the lafK mutant and the exs mutant strains in order to investigate the 
potential cross-talk between the lateral flagella system and the T3SS. The promoter 
activities of PfliM, PflgB and PlafA measured in the exs mutants correlated with the 
phenotypes observed in the swarming assay. The patterns of the promoter activities 
were similar to the patterns of the swarming diameters of different mutant strains. It 
supported the hypothesis that there was potential cross-talk between the T3SS and 
the lateral flagella system. The lateral flagella promoter activities were significantly 
repressed when exsD and exsE genes were knocked out, while not affected in the 
absence of exsA and exsC genes. It suggests that the T3SS master regulator ExsA 
functions as a negative regulator of the lateral flagella system. When the 
anti-activator ExsD is missing, the abundant ExsA protein suppresses the 
expression of the lateral flagella system. Similarly, when ExsE is absent, the 
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chaperone protein ExsC binds to the anti-activator ExsD thus allowing ExsA to 
repress the lateral flagella system. 
 
Although this potential negative cross-talk between the T3SS and the lateral 
flagella system has not been reported in A. hydrophila AH-3 before, it has been 
described in P. aeruginosa and Y. enterocolitica (Bleves et al 2002, Soscia et al 
2007, Vilches et al 2009). It was reported in Y. enterocolitica by Bleves and 
collegues that the mutation in the flhDC operon, which was the master regulatory 
operon of the flagellum, resulted in the up-regulation of the the Yop secretion 
(Bleves et al 2002). Similar negative cross-talk between the T3SS and the lateral 
flagella system was determined later in P. aeruginosa as well. Soscia and collegues 
demonstrated that the T3SS expression, secretion and cytotoxicity of the bacterial 
strain were increased when flagellar assembly and/or mobility were compromised. 
Furthermore, in the same study, the flagella gene expression and motility were 
repressed when over-producing the T3SS master regulator ExsA in P. aeruginosa 
(Soscia et al 2007). 
 
It was suprising to observe that the promoter activity of PfliM was 
down-regulated in the lafK mutant, since the promoter PfliM was categorized as 
Class I promoter, the activation of which was in-dependent of the major regulator 
LafK (Figure 5.12) (Wilhelms et al 2013). However, when the promoter activity of 
PfliM was measure in the lafK mutant in broth culture, the promoter activity was 
restored to 225MU (Figure not shown) at a similar level as measured in the wild type 
strain on swarming agar (247 MU) or in broth culture (190 MU) (p>0.05). It indicates 
that the promoter PfliM is indeed in-dependent of the lateral flagella major regulator 
LafK in the broth culture but requires LafK for the activation on swarming agar, 
suggesting a dual function of the promoter PfliM. As the bacteria were unable to 
swim on the swarming agar, the promoter PfliM was possibly involved in the 
expression of the polar flagella system. 
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However, all three lateral flagella promoter activities were significantly higher in 
the exsD mutant when compared to the lafK mutant, in which the promoter activities 
were completely repressed. It suggests that the ExsA protein was not sufficient to 
completely shutdown the expression of the lateral flagella system. Furthermore, the 
lateral flagella promoter activities were significantly increased in the exsE mutant 
when compared to the exsD mutant, suggesting possible secondary regulation 
involved in the inhibition of the lateral flagella system. This correlated with the 
findings of T3SS promoter activities (e.g. PaopN), the pattern of which also 
indicated possible secondary regulations on the ExsA-ExsD-ExsC-ExsE cascade. 
 
The overall results also correlates with the findings in V. parahaemolyticus, 
which possesses the lateral flagella system and two T3SSs (T3SS1 and T3SS2). It 
was reported by Gode-Prtratz and collegues that the expression level of the lateral 
flagella gene flgBL was significantly repressed when over-expressing ExsA, and the 
swarming motility of V. parahaemolyticus was inhibited by exsA induction in vivo 
(Gode-Potratz et al 2010). The same study also suggested that the lateral flagella 
major regulator LafK was required for the regulation of the T3SS1 in response to 
calcium. Unlike P. aeruginosa or Yersinia spp., in which the T3SS is induced by the 
absence of calcium, the T3SS1 of V. parahaemolyticus has been shown to be 
induced by the presence of calcium or EGTA, in which the effect of EGTA induction 
has been shown to be the result of iron-chelating (Gode-Potratz et al 2010).  
 
However, it is still unclear how ExsA represses the expression of the lateral 
flagella system, since the lateral flagella promoter activities were decreased in the 
absence of ExsD despite the promoter class. The Class I promoter PfliM, the Class 
II promoter PflgB and the Class III promoter PlafA were all affected by the absence 
of ExsD and ExsE. The fact that the Class I promoter is affected suggests that the 
ExsA protein represses the expression of the lateral flagella system prior to the 
lateral flagella major regulator LafK. 
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It is also unknown whether the ExsA protein regulates the lateral flagella system 
directly or indirect. As the ExsA protein has already been over-expressed using the 
pET system and the pMAL system, the direct protein-DNA interaction can be 
investigated using electrophoretic mobility shift assays (EMSA) to determine 
whether ExsA binds to the lateral flagella promoters in a direct protein-DNA 
interaction manner. Moreover, the interactions between LafK and Exs proteins can 
be carried out to determine whether there is a protein-protein level of regulation.  
 
5.6 Conclusion 
 The swarming ability was shown to be significantly repressed in the lafK mutant, 
exsD mutant and exsE mutant when compared to the A. hydrophila AH3R wild 
type, exsA mutant and exsC mutant using swarming assays. 
 In A. hydrophila AH3R wild type, the activities of Class II and Class III lateral 
flagellar promoters were up-regulated when grown in solid conditions, except for 
PlafB and Pmaf. The activities of Class I promoters were not affected whether 
grown in liquid or solid conditions. 
 The activities of lateral flagellar promoters were repressed in the lafK mutant, 
exsD mutant and exsE mutant when compared to the A. hydrophila AH3R wild 
type, exsA mutant and exsC mutant. 
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Chapter 6.  
Conclusions 
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The results of this study suggest that the regulatory cascade of the T3SS which 
involves the ExsA, ExsD, ExsC and ExsE proteins in A. hydrophila AH-3 is similar to 
the T3SS regulatory cascade in P. aeruginosa. The transcriptional activator ExsA 
functions as the master regulator of the T3SS in A. hydrophila AH-3. The 
anti-activator protein ExsD inhibits the master regulator ExsA through direct 
protein-protein interactions. The chaperone protein ExsC is able to sequester the 
anti-activator ExsD from ExsA by direct binding to ExsD. While the effector protein 
ExsE binds to its cognate chaperone protein ExsC directly thus releasing ExsD to 
inhibit ExsA. The Exs regulatory cascade is also shown to be involved in the 
regulation of the lateral flagella system, in which ExsA possibly functions in 
down-regulating the lateral flagella promoter activities and suppressing the 
swarming motility.  
 
Five promoter sequences, PascN, PaopN, PexsC, PexsA and PexsD were 
identied in the T3SS regulon and four of them were shown to have no activity in the 
absence of ExsA, except for PexsA, which was responsible for the expression of the 
master regulator ExsA itself. The promoter activity of PexsA was up-regulated in the 
exsA mutant while in the E. coli reconstitution system the PexsA promoter activity 
was down-regulated with exsA in-trans. This finding indicates that the master 
regulator ExsA is under control of a negative feedback by inhibiting its own 
promoter.  
 
It was noted that the promoter activity of PexsC was not elevated and was 
much lower than the promoter activity of PexsD in the absence of ExsE. It possibly 
suggests that when ExsE is absent (secreted), more ExsD was made in contrast 
with ExsC due to higher promoter activity. The increase in the pool of ExsD proteins 
provide the bacteria with another level of regulation for ExsA activation. Moreover, 
as it was recently reported in P. aeruginosa that ExsD could only bind to ExsA when 
they were synthesized at the same time as folding intermediates, the ExsD protein 
released from ExsC binding could not re-bind the ExsA protein (Bernhards et al 
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2013). Thereby, it was not surprising that more ExsD was required to be synthesized 
than ExsC. In fact, the expression of ExsD was also driven by the PexsA promoter, 
as both the exsA-ascL and exsD-ascL operons share the same terminator, to allow 
simultaneous expression of ExsD and ExsA (Figure 3.16) (Bernhards et al 2013).  
 
Therefore, the intracellular concentrations of the ExsA, ExsD, ExsC and ExsE 
proteins play a vital role in the regulation of the T3SS as the pools of ExsA, ExsD, 
ExsC and ExsE proteins are changing in response to the environmental signals. 
When the T3SS is trigged, the effector protein ExsE is thought to be secreted out 
from the cell thus the intracellular concentration of ExsE is decreased, resulting in 
the increase of a free ExsC pool due to the releases of the chaperone protein ExsC 
from ExsE. The increase of the free ExsC pool results in the capture of more ExsD 
protein, leading to the decrease of the intracellular concentration of free ExsD. 
Thereby more of the master regulator ExsA are released to up-regulate the 
expression of the T3SS.  
 
The fact that the activation of PexsD promoter requires the T3SS master 
regulator ExsA may suggest a scenario where the bacteria switch off the T3SS and 
detach from the host cells. In this situation, the accumulation of ExsA suppresses 
the expression of itself by inhibiting its own promoter and synthesizing more 
anti-activator ExsD, reducing the expression of the T3SS overall. The increase of 
the ExsD pool results in the titration of the chaperone protein ExsC, thus the ExsC 
proteins are ‘outnumbered’ by ExsD, which results in the repression of the T3SS 
expression and the closure of the injectisome. It also makes sense as the closure of 
the T3SS channel leads to the accumulation of the secreted protein ExsE, which 
sequester the chaperone protein ExsC from binding the anti-activator ExsD. 
 
However, the promoter activity of PaopN does not fit into the pattern. The 
promoter activity of PaopN is significantly decreased in every exs mutant strain 
when compared to the promoter activity measured in the wild type strain. As the 
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operon aopN-aopD regulated by PaopN involves at least three genes acrR, acrG 
and acrV which are possibly related to the T3SS regulation in response to calcium, it 
may suggest possible secondary regulation involved in the T3SS expression.  
Both the BACTH assay and the Far-Western Blot indicate strong interactions in 
between ExsA-ExsD, ExsD-ExsC and ExsC-ExsE, supporting the hypothesis of the 
ExsA-ExsD-ExsC-ExsE regulatory cascade. Moreover, the self-interaction of ExsA 
protein was observed from BACTH assay while the self-interaction of ExsE protein 
was observed from Far-Western Blot. However, the self-association of ExsD and 
ExsC reported in P. aeruginosa was not observed in this study. As it has been 
reported in P. aeruginosa, ExsC dimerises to form a 2:2 heterotetramer with ExsD 
while bind to ExsE at a 2:1 ratio (Bernhards et al 2013, Zheng et al 2007). This 
might be due to the fusion of T25/T18, His6 or MBP onto the N-terminal of these 
proteins during over-expression or because the self-association of ExsC and ExsD 
required the presence of chaperones.  
 
Moreover, the regulatory components of the T3SS (Exs proteins) has been 
shown to be involved in the regulation of the lateral flagella system. The swarming 
assay of the exs mutants has shown reduced swarming motility in exsD mutant and 
exsE mutant strains similar to the lafK mutant strain. It suggests that the T3SS 
master regulator ExsA functions in repressing the expression of the lateral flagella 
system in A. hydrophila AH-3. It correlates with the findings in V. parahaemolyticus, 
which possess lateral flagella system as well as two T3SSs. The expression level of 
the lateral flagella gene flgBL was significantly repressed when over-expressing 
ExsA and the swarming motility of V. parahaemolyticus was inhibited by exsA 
induction in vivo (Gode-Potratz et al 2010). 
 
The lateral flagella promoter activities measured in liquid conditions and solid 
conditions correlate with the lateral flagellar gene transcriptional hierarchy proposed 
by Wilhelms and collegues, who has classified the lateral flagella promoters into 
three classes (Wilhelms et al 2013). In general, Class I promoters, including PfliM, 
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PlafK and PflgA, have shown no significant difference of activities or even 
down-regulated when measured on swarming agar compared to in broth culture. In 
contrast, the activities of Class II and Class III promoters were up-regulated when 
measured on swarming agar compared to be measured in broth culture, except for 
Pmaf and PlafB promoters. The reason why these two promoters failed to fit into the 
pattern is unclear. The Pmaf promoter, which is reported to be a Class III promoter 
in the lateral flagella system and is required for the expression of the Maf-5 protein 
(Wilhelms et al 2013). As Maf-5 is a glycosyl-transferase, it is involved in the 
glycosylation of the lateral flagellin protein LafA with pseudamic acid. (Wilhelms et al 
2012). However, Maf proteins may also be required for the polar flagella system as it 
is reported that Maf proteins are required for full function of the polar flagellin in A. 
caviae (Parker et al 2012, Parker et al 2014). As for PlafB, The activity of PlafB 
promoter was too low to be considered as an intact promoter. 
 
The patterns of the promoter activities (PfliM, PflgB and PlafA) measured in the 
exs mutant backgrounds were similar to the patterns of the swarming diameters of 
different mutant strains. It indicates that the lateral flagella promoter activities are 
significantly repressed in the absence of ExsD and ExsE, while not affected in the 
absence of ExsA and ExsC, supporting the hypothesis that the T3SS master 
regulator ExsA functions as a repressor of the lateral flagella system. When the 
anti-activator ExsD is absent, the abundant ExsA proteins suppress the expression 
of the lateral flagella system. Similarly, when ExsE is absent, the chaperone protein 
ExsC binds to the anti-activator ExsD thus allowing ExsA to repress the lateral 
flagella system. Although this potential negative cross-talk between the T3SS and 
the lateral flagella system has not been reported in A. hydrophila AH-3 before, there 
was evidence of cross-talk between the T3SS and the flagella system in 
P.aeruginosa and Y. enterocolitica (Bleves et al 2002, Soscia et al 2007, Vilches et 
al 2009). 
 
 
193 
An overview of the genetic regulation between the T3SS and the lateral flagella 
system is shown in Figure 6.1. The T3SS master regulator ExsA activates the 
transcription of the T3SS by inducing the T3SS promoter activities, except that ExsA 
negative regulates its own promoter PexsA. The master regulator ExsA is controlled 
by a cascade of proteins including ExsD, ExsC and ExsE. The de-activator ExsD 
inhibits ExsA by direct binding. ExsC inhibits ExsD and ExsE inhibits ExsC via direct 
protein-protein interactions as well. ExsA was also shown to negatively regulate the 
lateral flagella system since the absence of ExsD or ExsE represses the swarming 
ability and the activities of lateral flagellar promoters. 
 
It was only shown in this study that the regulatory components of the T3SS 
were involved in the regulation of the lateral flagella system in A. hydrophila AH-3. 
Whether the lateral flagella system affects the T3SS in A. hydrophila AH-3 is still 
unknown, although there was evidence showing that the lateral flagella major 
regulator LafK was required for T3SS1 expression in V. parahaemolyticus 
(Gode-Potratz et al 2010).  
 
Given the tools prepared in this study so far, the T3SS promoter activities can 
be measured in the lafK mutant background in the presence of Ca
2+
 and/or EGTA. 
Moreover, the effect of iron in correlation to the T3SS and the lateral flagella system 
can also be investigated in A. hydrophila AH-3. As for the Exs proteins, a pETDUET 
system may be utilitzed to co-express two proteins in the same time as most of them 
are chaperones of the others (e.g. ExsA-ExsD, ExsD-ExsC and ExsC-ExsE). 
Thereby, more protein assays such as Pull-down assay can be used to investigate 
direct protein-protein interactions between Exs proteins. Also, EMSA can be used to 
inviestigate the interactions between ExsA and promoter sequences of both T3SS 
and lateral flagella system. 
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Figure 6.1 An overview of the genetic regulation between the T3SS and the lateral flagella (LF) system in A. hydrophila AH-3. The regulators 
including ExsA, ExsD, ExsC, ExsE and LafK are shown in circles. Each two of the Exs protein are connected by blunt arrows showing the 
inhibitory interactions in between. The promoters in both the T3SS and the LF system are shown in bent arrows. The promoters in the T3SS are 
either (+) up-regulated by ExsA or (-) down-regulated by ExsA. The LF promoters are categorized into (I) Class I, (II) Class II or (III) Class III, in 
which only Class II and Class III promoters are up-regulated by the LF major regulator LafK. The T3SS master regulator ExsA has been shown 
to down-regulate the expression of the LF system but whether there is interaction between ExsA and LafK is unknown. . 
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Primers used in the project: 
exsC internal forward: CTCCACTTTGGTTTCGATGA 
exsC internal reverse: ATTGAACTGATACCAGTGAC 
 
exsC amplification forward: GGAGGAAATCATGGATGTAA 
exsC amplification reverse: ATCTTCATGGTTATACCCGC 
 
exsD F1 forward: 
GAGCTCGGTACCCGGGGATCCTCTAGAGTCATGAGTCAGCAAGATCACAA 
exsD F1 reverse: 
AAGCTGTCAAACATGAGAACCAAGGAGAATGATGCGATCTCCCAGCTGT 
exsD F2 forward: 
GAATTGTTTTAGTACCTAGCCAAGGTGTGCTCGCGCCTTGCTGTGGCACT 
exsD F2 reverse: 
AGAATACTCAAGCTTGCATGCCTGCAGGTCGCTATCTAGGGCTCGGCAGG 
 
exsE F1 forward: 
GAGCTCGGTACCCGGGGATCCTCTAGAGTCTCAATCGGCTGCTCACTGAG 
exsE F1 reverse: 
AAGCTGTCAAACATGAGAACCAAGGAGAAACTTGGCTCGCACTGGCTGG 
exsE F2 forward: 
GAATTGTTTTAGTACCTAGCCAAGGTGTGCGCACTTCTGCGACGCTCCAT 
exsE F2 reverse: 
AGAATACTCAAGCTTGCATGCCTGCAGGTCCAATGTTTGGGCTGCAATTG 
 
Kan forward: TTCTCCTTGGTTCTCATGTTTGACAGCTT 
Kan reverse: GCACACCTTGGCTAGGTACTAAAACAATTC 
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exsD_pGEM forward GCGAATTCATGAGTCACCAAGATCACAA     
exsD_pGEM reverse GCGAATTCGCTATCTAGGGCTCGGCAGG     
 
exsE_pGEM forward GCGAATTCTCAATCGGCTGCTCACTGAG 
exsE_pGEM reverse GCGAATTCCAATGTTTGGGCTGCAATTG 
 
exsA_pKT_forward GCCTCTAGAGATGAATGGCATTACTACTGCAG 
exsA_pKT_reverse GCGAATTCTTAATCAGTGCCATGTCTGGC 
exsC_pKT_forward GCTCTAGAGGATGTAACTGTCATCATCAA 
exsC_pKT_reverse GCGAATTCTTATACCCGCACTCCCATCA 
exsD_pKT_forward GCGCTCTAGACATGAGTCAGCAAGATCACAATTC 
exsD_pKT_reverse GAGAATTCCTAGGGCTCGGCAGGCTGCCA 
exsE_pKT_forward GCTCTAGAGAAGATTCAGGAATCACAAGG 
exsE_pKT_reverse GCGAATTCTCATAACACCCGGATCCGAC 
 
exsA_pKNT_forward GCGCAAGCTTGATGAATGGCATTACTACTGCAG 
exsA_pKNT_reverse GCTCTAGAGAATCAGTGCCATGTCTGGC 
exsC_pKNT_forward GCTCTAGAGGATGTAACTGTCATCATCAA 
exsC_pKNT_reverse GCGAATTCGATACCCGCACTCCCATCACCT 
exsD_pKNT_forward GCAAGCTTGATGAGTCAGCAAGATCACAATTC 
exsD_pKNT_reverse GCTCTAGATAGGGCTCGGCAGGCTGCCAGT 
exsE_pKNT_forward GCTCTAGAGAAGATTCAGGAATCACAAGG 
exsE_pKNT_reverse GCGAATTCGATAACACCCGGATCCGACGTT 
 
exsA_pUT_forward GCGCAAGCTTGATGAATGGCATTACTACTGCAG 
exsA_pUT_reverse GCTCTAGAGAATCAGTGCCATGTCTGGC 
exsC_pUT_forward GCTCTAGAGGATGTAACTGTCATCATCAA 
exsC_pUT_reverse GCGAATTCGATACCCGCACTCCCATCACCT 
exsD_pUT_forward GCAAGCTTGATGAGTCAGCAAGATCACAATTC 
exsD_pUT_reverse GCTCTAGATAGGGCTCGGCAGGCTGCCAGT 
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exsE_pUT_forward GCTCTAGAGAAGATTCAGGAATCACAAGG 
exsE_pUT_reverse GCGAATTCGATAACACCCGGATCCGACGTT 
 
exsA_pUT18C_forward GCCTCTAGAGATGAATGGCATTACTACTGCAG 
exsA_pUT18C_reverse GCGAATTCTTAATCAGTGCCATGTCTGGC 
exsC_pUT18C_forward GCTCTAGAGGATGTAACTGTCATCATCAA 
exsC_pUT18C_reverse GCGAATTCTTATACCCGCACTCCCATCA 
exsD_pUT18C_forward GCGCTCTAGACATGAGTCAGCAAGATCACAATTC 
exsD_pUT18C_reverse GAGAATTCCTAGGGCTCGGCAGGCTGCCA 
exsE_pUT18C_forward GCTCTAGAGAAGATTCAGGAATCACAAGG 
exsE_pUT18C_reverse GCGAATTCTCATAACACCCGGATCCGAC 
 
pKT25_screen forward GCACATGTTCGCCATTATGCCG 
pKT25_screen reverse GCATTCAGGCTGCGCAACTGTT 
pKNT25_screen forward GCACAGGTTTCCCGACTGGAAA 
pKNT25_screen reverse GCCGGAACATCAATGTGGCGTT 
pUT18_screen forward GCCACCCCAGGCTTTACACTTT 
pUT18_screen reverse GCTCACGCCGATATTCATGTGG 
pUT18C_screen forward GCAAAAGCCTGTTCGACGATGG 
pUT18C_screen reverse GCTCACAGCTTATCTGTAAGCG 
 
exsC for pET forward GCCATATGGATGTAACTGTC 
exsC for pET reverse GCAAGCTTTTATACCCGCAC 
exsD for pET forward GCCATATGAGTCAGCAAGAT 
exsD for pET reverse GCAAGCTTCTAGGGCTCGGC 
exsE for pET forward GCCATATGAAGATTCAGGAATCACAAGG 
exsE for pET reverse GCGAATTCTCATAACACCCGGATCCGACG 
 
T7 promoter (forward): TAATACGACTCACTATAGGG  
T7 terminator (reverse): GCTAGTTATTGCTCAGCGG 
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pMAL screening primer forward GGTCGTCAGACTGTCGATGAAGCC 
pMAL screening primer reverse TGTCCTACTCAGGAGAGCGTTCAC 
 
PfliM amplification forward GCAAGCTTAGATCCATGGCGTCAAGAAG 
PfliM amplification reverse GCGGATCCCAAAGTAACCGAGAAGGTGT 
PlafK amplification forward GCAAGCTTTGGATAGCTTTCCGGTTGAT 
PlafK amplification reverse GCGGATCCCGCAGGTCTGATCAATAACA 
PflgM amplification forward GCAAGCTTCGCAGTGACCCATTTGCCAC 
PflgM amplification reverse GCGGATCCCTGCAGCTGGGTTTGAACAT 
PflgA amplification forward GCAAGCTTGCAGTATTGCCATCCATGGA 
PflgA amplification reverse GCGGATCCGGGAAACAACACTTCCCCTT 
PflgB amplification forward GCAAGCTTTTCTCGACGAGATCTCCGGT 
PflgB amplification reverse GCGGATCCTAATCGACATCTCGGGCCAG 
Pmaf amplification forward GCAAGCTTTACAGTTCAGAGCGACTCGA 
Pmaf amplification reverse GCGGATCCGGTACGCTGTTGACATCCTG 
PlafA amplification forward GCAAGCTTGGAGCTCTATATCAAGACCC 
PlafA amplification reverse GCGGATCCCCAGCATCTTGTTGGTAGAG 
PlafB amplification forward GCAAGCTTTTCGATGCATCCACCAAAGT 
PlafB amplification reverse GCGGATCCCTCTGCTGACCTTTGATGCC 
PlafX amplification forward GCAAGCTTAGGCCATATTCTTGCCAAGC 
PlafX amplification reverse GCGGATCCGTTGCAAGATCAGACGACCC 
 
pKAGb2(-) screening primer bla (forward) TGCACCCAACTGATCTTCAG 
pKAGb2(-) screening primer lacZ (reverse) TTTCCCAGTCACGACGTTGT 
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DNA sequence of exs genes 
 
exsC 16742-17185(444bp): 
ATGGATGTAA CTGTCATCAT CAATCGGCTG CTCACTGAGT TTGCCACCAA ATATGGTTTG 
CCATCCCTGA CCCTGAATCA GGAGGGGGTT GCTGCGCTCT GTTTTGACGA GCAACTGCAA 
CTCAGCCTGA TCCTGGTATC GGAGCGGGAT CAGCTGGTGT TGCAGGCCGA CGTGGCCGAG 
CTCCATCAGG TAGGTGAGGG GATTTTTCGT CAGTTGGCCA GCTTCAATCG TCACTGGTAT 
CAGTTCAATC TCCACTTTGG TTTCGATGAA GAGAGCCTGA CGGTGCAACT TTATCGGCAG 
ATGACGGCAA GCCGGTTGAC CCTGGCATAC CTTGAAGAGA GTCTCGCCAG CATGCTGGAG 
CATGCCGAGT TCTGGCAAGA GTTGCTGCAA CCTGGTACTC GGGACGCAGG CGGTAGTGAT 
CAGGTGATGG GAGTGCGGGT ATAA 
 
 
exsE 17188-17421 (234bp): 
ATGAAGATTC AGGAATCACA AGGCGCACTG GCCCTGCATG CGGCAGAGCC GGGCAAGGTG 
GGGGGATTTG CTGGCAGAAC CATGAGTGCA CAGCCAGCCA GTGCGAGCCA AGTTCCCCTG 
TCGGCACTTC TGCGACGCTC CATTACCCTC AATCAAGTAC AGGAGCTGGC GCTTCAGCGA 
CTGCAACAGG GCGAGCATAC CTCACTGGCC GAACGTCGGA TCCGGGTGTT ATGA 
 
 
exsA 18165-18980 (816bp): 
ATGAATGGCA TTACTACTGC AGAGAAGGGC GATATGGCCC TGCTCCAGTG GTGCATGTCT 
GCTTTCAACG TCATCGAACA TCCGCAAGAG GGAATATATA TCCTTCTTGA AGGTTCGATA 
ACCTGGCAGG ACTGTACCGA TACCTACGAA CTCACCCCCA ACCAACTCCT GTTCGTGCGC 
CGTGGCAACT ACGCGGTTTG TACCGCTGGC AGCCCCTGCC GCCTGCTTTG GCTGCCCCTG 
TCAAACAGCT TTTTGCAAGG ATTCTTGCAA CGTTTCGGTT CCCTGTTGAG CGAAGTCGCC 
CGGCTGGAGG GGATGGCCCC GACGCTGTTG CCGTTTCACT CTTCCCCCCT GCTGACCCAA 
TGTATTCAGG GGCTGTACGG TTTGATTGAC CATGAGCATC CGCCCGCACT GGCCCAATTA 
CGCACCGAAG AGCTGCTGTT TCTACTCGCC TTTGGTGAGC AGGGGCCTCA ACTGATGTCA 
ATTTTGCGTC AGCTGAGCAA TCGTCAGGTC GAGCGGTTGC AACAGTTCAT GGAAAAGCAC 
TACTTGATGG AGTGGAAGCT CAGCGAATTT TCCAAAGAGT TCGGCATGGG GCTGACCACC 
TTCAAGGAGC TATTCGGCTC GATATATGGT GTCTCACCGC GAGCCTGGAT CAGTGAACGG 
CGGATCCTGT TCGCTCATCA GTTATTGCTC AATAGCCCTT CTAGCATCGT TGATATTGCG 
ATGGAGGCCG GTTTTTCCAG CCAATCTTAT TTTACCCAGA GTTATCGCCG TCGTTTTGGT 
TGTACGCCAA GTCGTGCCAG ACATGGCACT GATTAA 
 
 
exsD 19100-19915 (816bp): 
ATGAGTCAGC AAGATCACAA TTCATCTAAC CAAGGCCTGT TTGCAGGTCG TCGGGTTACC 
GTTGTTCAGC CAGATACCTT GAGTCGGGAT CGTCTGGTCG GCCAACTGTC CGTGCTCCGT 
TATCAGGATG CCGGCGTGAT CACCTCGCAG CAAATGGACC TGTTGCAACG GCTGTTGCCA 
AGAACCCGGC TGGAGAGCCT GCTGGAATCC CTCTGGTTCC AGCGTCGTCT GGATGCCGCG 
CTGAGCGTCT CTCGCGAAGA GCTGCAACAA ATTCTGCGGC TGGCGGGCAG TGAGCGATAC 
217 
GACTGGCTGC AACAGCTGGG AGATCGCATC AATCTGGCGG ATCGCGCCTT GCTGTGGCAC 
TGGGTCCTTC ACCCTTTGCA TCGCTGGTGG GTGCAGCGTC TGGAACCGCT CTACGGCGCT 
TGGCGCAACG AGCTGGTACA GCTGCAGGTT ATGCGCCGTC AACTCAATGC CCAGGCGGTG 
TTCTGGCAGA CAGTGGTCGA TGTGCCGGCG GATCTGGAGA GCCGGATCAC CGACCAGCTT 
GCGCAGTTGA GCCAGCGCGA GCAGGAGCTT ACACAACTGC ATTCCGATTG CGAAGCGCGT 
CTTCAGCTGG CTTGGCCCGC CTGGTATGGG CAGACCAGTC AGGAAGGCGA CCCGGCACTT 
CTTATGCCGG TACCGCTGGA GCTTGGCGTA TTCTGGCACG CCCTGCTGGC GCTGCCCCAC 
CAGGACGACG TGGCCCTTAC GTTGCACGAG TGGCTGGTCG GTCGGGGTAT TGCCCTGGGT 
CAGGATCACT TCTACTGGCA GCCTGCCGAG CCCTAG 
 
